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Abstract 
Inkoo virus is a mosquito-borne virus first isolated in Finland in 1964. It belongs to the 
California serogroup (genus Orthobunyavirus, family Bunyaviridae), which includes many 
important human pathogens and is described especially in the USA. The association of 
Inkoo virus infection with clinical disease has not been confirmed, but occasional cases of 
meningitis and encephalitis have been diagnosed. However, the true incidence of acute 
infections is not known because ongoing research and laboratory diagnostics of INKV 
infections have been neglected for decades in the countries where the virus circulates. 
 
We established a serological test (IFA) to detect Inkoo virus antibodies, and we also 
expressed the Inkoo virus N, Gc and Gn proteins with a baculovirus expression system to 
study protein-specific antibody responses. In a seroprevalence study, antibody prevalence 
in humans in Finland and Sweden showed that 40-50% of the population had been 
infected with Inkoo virus or a related California serogroup virus. The seroprevalence was 
higher in older age groups, and in Finland, the prevalence increased northwards. We 
found that acute-phase sera had a distinct granular fluorescence pattern in IgG IFA, 
whereas those with pre-existing immunity showed a diffuse pattern. Using recombinant 
Inkoo virus proteins as antigens, we noticed that the antibody response was 
predominantly against the N protein in early infection and also towards the Gc protein in 
the later stages of infection. 
 
We discovered a new California encephalitis virus isolate of the genus Orthobunyavirus in 
Finland from mosquitoes collected in 2007 and 2008 from Ilomantsi and Sotkamo 
municipalities in Eastern Finland. Four isolates were obtained in 2007: M07-1, M07-2-83, 
M07-2-84 and S07-1. One isolate, ILO-8-3, is from 2008 collections, and it exhibited 
minimal differences from previous Finnish strains in phylogenetic analysis. The vector for 
the virus is uncertain, but it is most likely Ochlerotatus sp. The new isolates were named 
the Möhkö isolates of Chatanga virus since the genetic and serological findings suggested 
that the new virus isolates were most closely related to clusters of Russian 
orthobunyavirus isolates named Chatanga virus (99% N protein identity) and then to 
Snowshoe hare virus and La Crosse virus (93% and 90% N protein identity, respectively).  
 
We screened serum samples for INKV IgM antibodies, using samples from patients with 
febrile illness or neurological symptoms collected in the summertime between 2001 and 
2013 to study the frequency of acute INKV infections and the clinical picture of the 
patients. We found the frequency to be under 1%, but interestingly, not only INKV but 
also CHATV were confirmed to cause human infections. Most patients were not 
hospitalized, and they had visited a doctor most often once, indicating very mild 
symptoms. The patients suffered from fever, headache, nausea/vomiting, 
disorientation/drowsiness, and seizures and had small changes in their EEG. INKV 
infections were more severe in children under 16 years, and CHATV infections were more 
severe in adults. 
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In this study, we found a new mosquito-borne virus (CHATV) from Finland and showed for 
the first time that this virus was associated with a clinical disease. In addition, we 
described the clinical picture of INKV infection and showed that the infection is more 
severe in children if neurologic symptoms appear. These viruses are common in Finland, 
and their association with clinical disease in the summertime should not be forgotten. 
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Review of the literature 
1 Introduction  
1.1 California serogroup 
California encephalitis virus (CEV) group, known as the California serogroup, belongs to 
genus Orthobunyavirus in the family Bunyaviridae. The serogroup consists of 13 
antigenically related but distinct virus isolates (Table 1). Phylogenetically, these viruses 
differ less than 10% in the amino acid sequences of their nucleocapsid proteins, and 
therefore, they all are classified as members of the California encephalitis virus species 
(as defined by ICTV). All virus isolates are transmitted by Aedes or Ochlerotatus 
mosquitoes, and many of them cause febrile illness or central nervous system (CNS) 
disease in humans (LeDuc 1987, 60S-68S)(LeDuc 1987). The majority of these viruses 
circulate in North America, but a few representatives are also found in Europe, Africa and 
Asia (Table 1). Most of the viruses were recovered decades ago, and despite their 
association with clinical illness, they have remained understudied and underdiagnosed in 
many countries. 
 
1.2 Arthropods and infectious diseases 
Many arthropods are associated with significant health problems for humans and 
animals, but only since the late 19th Century, when the so-called “golden age of medical 
entomology” started, have arthropods been shown to carry pathogens and demonstrated 
to spread diseases (Weaver et al. 2004). Although most often, mosquitoes, sandflies or 
ticks are involved in arthropod-borne diseases, a wide variety of arthropods can cause 
problems directly (blood feeding, biting, stinging) or indirectly (annoyance, crawling over, 
defecating upon and in stored food) for humans and animals.  
 
Arthropod-borne diseases are predominantly caused by a diverse group of viruses and 
bacteria but also by protozoa (malaria, trypanosomiasis, babesiosis) and filarial 
nematodes (river blindness, dog heart worm). Contact with arthropods not only causes 
transmission of the pathogens but also causes other medical problems, i.e., allergic 
reactions, inflammations and secondary infections in the bite area (Mullen, Durden 2002). 
There are two routes of transmission of the infectious agent to the new host: mechanical 
or biological transmission. The latter is by far the most efficient and common way. In 
biological transmission, the pathogen infects and multiplies in an arthropod and is 
transmitted further by blood-feeding. Mechanical transmission spreads the pathogens via 
exodigestive secretion or with contaminated mouthparts (Mullen, Durden 2002, Reisen 
2002).  
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Table 1. California serogroup isolates, their original isolation place and year, current 
geographical distribution area. 
Isolate Year and place of 
isolation 
Original isolate Distribution Reference 
California 
encephalitis virus 
(BFS-91) 
1943 
California, USA 
Ochlerotatus 
melanimon 
(dorsalis) 
California, Texas, Utah, 
Colorado, New Mexico, 
Alaska 
(Hammon, Reeves & 
Sather 1952) 
Trivittatus virus  
(Eklund strain) 
1948 
North Dakota, 
USA 
Ochlerotatus 
trivittatus 
USA (Sudia et al. 1971, 
Karabatsos 1985) 
Melao virus 
(TRVL9375) 
195 
Trinidad 
Ochlerotatus 
scapularis 
Trinidad, Brazil, 
Argentina 
 
(Spence et al. 1962b) 
Tahyna virus  
(92-Bardos) 
1958 
Czechoslovakia 
Ochlerotatus 
caspius 
Europe, Southern Siberia, 
Far East, China, Africa 
(Bardos, Danielova 1959) 
Snowshoe hare virus 1958  
Montana, USA 
Lepus americanus North East of USA, 
Canada 
(Burgdorfer, Newhouse & 
Thomas 1961) 
San Angelo virus 
(20230) 
1958  
Texas, USA 
Anopheles 
pseudopunctipen
nis 
Texas, USA (Sudia et al. 1971) 
South river virus  
(NJO-94F) 
1960  
New Jersey, USA 
Anopheles 
crucians 
North East of USA (Sudia et al. 1971) 
La Crosse virus  
(LaX 177) 
1960  
Wisconsin, USA 
Human brain 
tissues taken at 
autopsy 
Upper Midwest and 
Eastern USA 
(Thompson, Kalfayan & 
Anslow 1965) 
Jamestown canyon 
virus (61V2235) 
1961  
Colorado, USA 
Culiseta inornata USA (Karabatsos 1985) 
Keystone virus  
(B64-5587.05) 
1964  
Florida, USA 
Ochlerotatus  
atlanticus 
tormentor 
South USA (Bond et al. 1966) 
Inkoo virus  
(KN3641) 
1964 
Finland 
Ochlerotatus 
Commis/punctor 
Finland, Sweden, 
Norway, Russia 
(Brummer-Korvenkontio et 
al. 1973, Niklasson et al. 
1985, Traavik, Mehl & 
Wiger 1978) 
Serra do Navio virus 
(BeAr 103645) 
1966  
Amapa, Brazil 
Ochlerotatus 
fulvus 
Brazil (LeDuc 1987, Karabatsos 
1985) 
Chatanga virus 
(LEIV-9843) 
1983 Russia, 
Murmansk 
Aedes sp. Russia, Finland (Lavrent'ev et al. 2008, 
Putkuri et al. 2014) 
 
 
 
Viruses that are transmitted by arthropods are referred to as arthropod-borne viruses, or 
arboviruses. Arboviruses are categorized further by the arthropod they are carried by, 
i.e., mosquito-borne viruses or tick-borne viruses. The arthropod that carries the 
pathogen is referred to as the vector that can spread the pathogen, and hence these 
viruses cause vector-borne diseases (Reisen 2002).  
 
Mosquitoes are found all over the world, and there are over 3500 species and 43 genera 
recognized. In phylum Arthropoda, mosquitoes belong to class Insecta, order Diptera and 
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family Culicidae (Zhang 2011). Significant vector species spreading infectious agents exist 
in the Aedes, Ochlerotatus, Stegomyia, Anopheles, Culex, Haemagogus, Mansonia, 
Psorophora and Sobethes genera (Service 2008). 
 
Mosquitoes have four stages in their life cycles. Female mosquito lay eggs (I) after a 
blood-meal and can produce eggs several times during their lifetimes. Eggs are laid in the 
water or on damp surfaces, and it may take 2-14 days (Anopheles and Culex) or even 
months (Aedes and Psorophora) before the eggs hatch to larvae (II) depending on the 
temperature and flooding. The mosquitoes go through four larval forms before 
developing to pupae (III), and either larvae or pupae can survive desiccation. Finally, adult 
mosquitoes are developed 7-26 days from the egg hatching (Service 2008).  
 
Maintenance of mosquito-borne viruses occurs via vertical and/or horizontal transmission 
mechanisms. Uninfected female mosquitoes are infected with viruses through blood-
meals from infected animal hosts with sufficient viremia and are able to spread the virus 
further to new uninfected hosts (horizontal transmission). In addition, viruses are 
transmitted by transovarial transmission from infected female mosquitoes to their eggs, 
and the virus passes through all the mosquito life stages to adult mosquitoes (vertical 
transmission). This route produces both infected male and female mosquitoes. Male 
mosquitoes carrying the virus may infect female mosquitoes in mating (venereal 
transmission) (Reisen 2002, Borucki et al. 2002). Virus maintenance may involve several 
transmission routes in the natural life cycle. 
 
Diseases caused by mosquito-borne viruses are a major global health concern. Dengue 
and Zika viruses (flaviviruses) and Chikungunya virus (alphavirus) are among the most 
common and widespread causative agents of mosquito-borne diseases. Sindbis virus 
(alphavirus), a causative agent of Pogosta disease, is the most common mosquito-borne 
virus in northern Europe. 
 
2 Family Bunyaviridae 
Family Bunyaviridae is a large group of viruses mainly transmitted by arthropods. The 
family includes over 350 viruses in 5 genera, named Hantavirus, Nairovirus, 
Orthobunyavirus, Phlebovirus and Tospovirus (King et al. 2012). Hantavirus is the only 
genus of the family carried by rodents and insectivores; the other genera are carried by 
different arthropods (mosquitoes, ticks, sandflies and thrips). Nairoviruses are 
predominantly transmitted by ticks; orthobunyaviruses are transmitted by mosquitoes; 
phleboviruses are transmitted by sandflies; and tospoviruses are transmitted by thrips. 
Although the principal vectors for each genus are those mentioned above, other 
arthropods have been recognized as vectors as well (Elliott and Plyusnin 2011). 
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All viruses in the family Bunyaviridae have a negative-sense, single-stranded, 
trisegmented RNA genome. The segments are called large (L), medium (M) and small (S). 
Terminal sequences of segments are conserved and genus-specific. In addition, the 3’ and 
5’ terminal sequences are complementary to each other. The coding strategy is specific 
for structural proteins within the family. The L segment encodes RNA-dependent RNA 
polymerase (RdRp); the M segment encodes the polyprotein, which is cleaved into 
membrane glycoproteins (Gc and Gn); and the S segment encodes the nucleocapsid 
protein (N). The coding strategy varies depending on when/if the non-structural proteins 
NSs and NSm are encoded. While bunyaviruses share the same genomic structure, the 
sizes of the proteins and the length of the RNA segments differs between the genera but 
are similar within each genus (King et al. 2012, Schmaljohn, Hooper 2007). 
 
Morphologically, bunyavirus particles are enveloped, spherical or pleomorphic and 80–
120 nm in diameter (Murphy, Harrison & Whitfield 1973). Virions have two surface 
glycoproteins (Gc and Gn) and two internal proteins; the nucleocapsid and the L protein. 
Genomic segments are encapsidated with the N protein to form ribonucleoproteins 
(RNPs). 
 
Bunyaviruses are causative agents of wide variety of human, animal and plant diseases. In 
humans, hantaviruses cause hantaviral cardiopulmonary syndrome (HCPS) and 
haemorrhagic fever with renal syndrome (HFRS) (Vaheri et al. 2013). Orthobunyaviruses 
and phleboviruses cause mainly subclinical infections or mild febrile illness, similar to 
many other arboviruses, but in some cases, encephalitis may occur (La Crosse virus, 
Oropouche virus, Toscana virus)(Balfour et al. 1973, Bernardes-Terzian et al. 2009, Ehrnst 
et al. 1985). However, more severe diseases, such as haemorrhagic fevers, have been 
described for the Nairovirus, Phlebovirus and Orthobunyavirus genera (Crimean-Congo 
haemorrhagic fever virus, Rift Valley fever virus, Ngari virus)(Whitehouse 2004, Chevalier 
et al. 2010, Gerrard et al. 2004).  
 
The Bunyaviridae family also includes important veterinary pathogens that can cause 
abortion, foetal abnormalities and gastroenteritis in cattle and sheep (Akabane virus, 
Schmallenberg virus, Cache valley virus (orthobunyaviruses), Rift Valley virus 
(Phlebovirus), and Nairobi sheep disease(Nairovirus))(Parsonson, Della-Porta & Snowdon 
1977, Chung et al. 1990, Bird et al. 2009, Marczinke, Nichol 2002). The plant pathogenic 
tospoviruses have been a cause of massive losses in the yield and quality of vegetable and 
legume crops in many parts of the world because of the expanding distribution of the 
vector, western flower thrips (Pappu, Jones & Jain 2009). 
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3 Genus Orthobunyavirus 
3.1 Geographical distribution and reservoir hosts  
Genus Orthobunyavirus is a large group of viruses containing more than 200 different 
virus isolates in 48 different virus species. All isolates are divided into 18 serogroups; 
Anopheles A and B, Bakau, Bwamba, Bunyamwera, California, Capim, Gamboa, Group C, 
Guama, Koongol, Patois, Olifantsvlei, Minatitlan, Nyando, Tete, Turlock and Simbu  (King 
et al. 2012), as well as two possibly new serogroups, Wyeomyia and Mapputta (figure 1). 
All viruses within each serogroup are antigenically related but distinct. Orthobunyaviruses 
have been isolated all over the world from a large variety of vertebrates, leading to a 
large number of virus isolates (APPENDIX 1). Most viruses are transmitted by mosquitoes, 
but exceptions exist. Many viruses in the Simbu serogroup are transmitted by culicoides 
(biting midges), the Kaeng Khoi virus of the Nyando serogroup is transmitted by bed bugs, 
and several viruses of the Tete serogroup are transmitted by ticks. Many different 
mosquito species are involved in the transmission of orthobunyaviruses (APPENDIX 1).  
 
Orthobunyaviruses can replicate in mammals and arthropods, but the infection in 
arthropods is persistent, and no disease occurs. Mammals serve as natural reservoirs or 
amplifying hosts to orthobunyaviruses. Viruses have been isolated from a large variety of 
mammals, including bats, rodents, hares, wild birds, sloths, macaques and deer 
(APPENDIX 1). Reservoir hosts have low levels of antibodies against the virus they carry, 
and the infection can be persistent for a long time, similar to arthropods, with the host 
animals remaining healthy. Amplifying hosts serve a template for the virus to amplify and 
spread further to uninfected vectors. These animals do not remain infected for long, and 
the animals may develop disease. Because of the wide range of different host animals and 
vectors, orthobunyaviruses are found all over the world. 
  
Most serogroups are restricted to certain parts of the world. Out of 18 serogroups (and 
two possibly new serogroups), 9 have been found only in South America. These viruses 
are found mainly in mosquitoes (Anopheles A and B, Gamboa and Minatitlan serogroups) 
(Calisher et al. 1980, Lopes Ode et al. 1966, Roca-Garcia 1944, Calisher et al. 1981, 
Calisher et al. 1983), or their transmission cycle occurs between Culex sp. mosquitoes and 
rodents (Capim, Guama, Group C, Patois and Weyomyia serogroups). The Group C and 
Guama serogroups include isolates pathogenic to humans (Calisher et al. 1983, Calisher et 
al. 1983, Causey et al. 1961, Chowdhary et al. 2012)  (APPENDIX 1).  
 
The Bwamba and Olifantsvlei serogroups are known to circulate only in Africa. Bwamba 
virus isolates (Bwamba and Pongola) cause febrile illness in humans, and their distribution 
areas overlap. Both viruses were isolated from humans decades ago; however, the 
awareness of these viruses remains low, and clinical cases stay underdiagnosed, although 
serological studies have shown a high seroprevalence for both viruses (Smithburn, 
Mahaffy & Paul 1941, Lutwama et al. 2002, Kokernot et al. 1957, Groseth et al. 2014). 
Several different mosquito species can carry these viruses, but their natural reservoir is 
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unknown. Olifantsvlei group viruses have been found in mosquitoes only in South Africa, 
Sudan and Ethiopia (Karabatsos 1985, Ota et al. 1976). 
 
Australian orthobunyaviruses were primarily studied by Doherty et al. when the Koongol 
and Wongal isolates of the Koongol serogroup were isolated from Culex annulirostris 
mosquitoes in the beginning of the 1960s. In the same study, Mapputta virus (the 
prototype of the Mapputta serogroup) was recovered from the Anopheles meraukensis 
mosquito. Serological tests showed antibodies in various domestic and wild animals, but 
no virus isolations were recovered (Doherty et al. 1963). New isolates of the Mapputta 
serogroup and new unclassified viruses from Australia (Leanyer virus, Termeil virus, 
Murrumbidgee virus and Salt ash virus) have been later isolated only from mosquitoes in 
Australia, but the natural reservoir and possible disease associations have remained 
understudied, although some serological evidence exists (Gauci et al. 2015).  
 
The Bakau serogroup has a narrow range of hosts, and its circulation has been restricted 
to a small area in the Malaysian forest. Macaques have been identified as the natural host 
for these serogroup isolates, and their natural cycle involves Culex sp. mosquitoes. The 
only exception is the poorly studied Nola virus isolate, which was isolated from Culex 
perfuscus mosquitoes collected in 1970 in the former Central African Republic (Marchette 
1994).  
 
Viruses within the six serogroups are known to be geographically widely distributed. Tete 
and Turlock serogroup viruses have narrow host ranges, but their distribution area 
includes all continents except Australia and South America. Migratory and resident birds 
serve as a host, and none of the viruses have been associated with human disease. 
Interestingly, Tete viruses use ticks and biting midges as vectors, in contrast to most 
viruses in the genus (Calisher et al. 1990). The Nyando serogroup includes four species, 
and each species is found in a different geographical location (APPENDIX 1). Only two of 
these species - Nyando virus, an African representative causing a febrile illness, and Kaeng 
Khoi virus, a virus originating from Asia that uses bedbugs as a vector (Williams et al. 
1976) - have been officially classified within this serogroup. Recent phylogenetic data 
suggest that the Brazilian Mojui dos Campos virus (BeAn 2761) and Manéra virus (Eret 
147) from Ethiopia also belong to the same serogroup (Groseth et al. 2014). This 
serogroup also contains viruses isolated from bats, which is a rare exception in genus the 
Orthobunyavirus (APPENDIX 1). 
 
The California, Bunyamwera and Simbu serogroups are the largest serogroups in the 
genus Orthobunyavirus and include the most commonly known pathogens. These 
serogroups also have the most widespread distribution area, and the viruses use both 
domestic and wild animals as hosts.  
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Figure 1. The geographical distribution of orthobunyavirus serogroups (two provisionally 
unassigned serogroups, Wyeomyia and Mapputta, have been marked with an asterisk). 
Copyright © 2015 http://www.freeworldmaps.net/ 
3.2 Orthobunyavirus disease associations in humans and animals 
There are many important and well-known veterinary and human pathogens in the 
genus. The best studied human pathogens of the genus are La Crosse virus (LACV, 
California serogroup) and Oropouche virus (OROV, Simbu serogroup). LACV is the most 
common arboviral cause of paediatric CNS disease in the USA, causing 100-200 
neuroinvasive infections annually (Reimann et al. 2008). Infections occur primarily in 
children under 15 years, and the incidence of clinical disease is believed to be 20-
30/100 000 inhabitants. LACV infection can vary from non-specific fever to more severe 
meningitis and/or encephalitis (Haddow, Odoi 2009). OROV has been identified thus far in 
South America and is the second most frequent cause of arboviral febrile illness in Brazil 
after Dengue virus infection. Oropouche fever appears most often as large outbreaks, but 
sporadic human infections also occur. Clinical presentation often includes headache, 
myalgia, arthralgia, rash and occasional CNS disease (Pinheiro et al. 1981, Bastos Mde et 
al. 2012). Like other Simbu group viruses, OROV is mainly transmitted by biting midges, 
particularly Culicoides paraensis, but the mosquitoes Ochlerotatus serratus and Culex 
quinquefasciatus also play a role in transmitting the virus. The vertebrate host to OROV is 
sloths (Pinheiro et al. 1981). Tahyna virus (TAHV), a member of the California serogroup, 
is a cause of “Valice fever” in Central Europe and Asia. It was the second California 
serogroup virus isolated from humans (Bardos et al. 1975, Simkova, Sluka 1973). Although 
the California serogroup includes several known human pathogens, the majority of them 
have been associated with acute infections only by serological evidence (Grimstad et al. 
1982, Fauvel et al. 1980). In contrast, many Group C serogroup viruses have been isolated 
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from humans, but the disease association has remained understudied. Most of these 
human isolates have been obtained only from South America, where massive mosquito-
borne virus sample material collection took place during the 1950-60s, resulting in the 
identification of 9 new virus isolates (Causey et al. 1961). Several isolates of the 
bunyamwera serogroup are particularly important in Africa. Ngari virus causes febrile 
disease and haemorrhagic fever in humans (Gerrard et al. 2004, Briese et al. 2006), and 
Ilesha virus has been shown to cause febrile illness, erythema, occasional fatal 
meningoencephalitis and haemorrhagic fever in humans. Both Ngari and Ilesha viruses 
are reassortant viruses. 
 
Many significant cattle pathogens belong to the Simbu serogroup. Not only 
Schmallenberg virus (SCHV), which spread rapidly through Europe after 2011 (Hoffmann 
et al. 2012), but also many other viruses have been associated with similar diseases in 
ruminants for decades. The symptoms include malformation of the foetus, still birth, 
abortion and congenital defects. Culicoides midges are the main vectors for viruses in the 
Simbu serogroup. In particular, Akabane virus (AKAV) is an important pathogen 
throughout Asia, Australia and some parts of East Africa. It was first isolated in Japan from 
mosquitoes, but culicoides seem to play a more important role in spreading the virus (Oya 
et al. 1961). Most Simbu group viruses circulate in Asia and Australia, but a few are found 
in South and North America and Europe (APPENDIX 1). Especially in Australia, many 
viruses have been isolated and connected to disease in cattle and small ruminants 
(APPENDIX 1). Simbu serogroup virus outbreaks cause often major economic losses to 
farmers. Cache valley virus (CCV) is the BUNMW serogroup virus found in North and 
Central America. The most likely natural reservoir is in wild ruminants (deer). The virus is 
found to infect rodents and horses but also, most importantly, domestic ruminants, which 
suffer from embryonic death, stillbirths, mummification of foetuses, abortions and 
malformation of foetuses (Chung et al. 1990). Occasionally, CCV infects humans (Sexton 
et al. 1997, Campbell et al. 2006).  
 
Members of the genus orthobunyavirus are well known causes of equine encephalitis or 
neurologic diseases (APPENDIX 1). Several Bunuamwera serogroup viruses have been 
isolated from clinically ill horses. Main Drain virus (MDV) is a causative agent of equine 
encephalomyelitis (Emmons et al. 1983), Maguari virus (MAGV) is a cause of encephalitis 
(Spence, Downs 1968) and Kairi virus (KRIV) causes febrile illness in horses (Calisher et al. 
1988). Several Shuni serogroup viruses are associated with equine infections, especially in 
Australia, Asia and Africa (Akabane, Douglas, Peaton, Aino, Shuni viruses) (Yang et al. 
2008, St George et al. 1979, van Eeden et al. 2012). In addition, Snowshoe hare virus 
(SSHV), a member of the CEV group, is connected to CNS infections in horses in North 
America (Lynch, Binnington & Artsob 1985, Heath et al. 1989). 
 
Two orthobunyaviruses have been isolated from pigs. Oya (OYV) and Ingwavuma viruses 
(INGV) both belong to the Simbu serogroup but are distinct species. Oya virus was 
isolated from a symptomatic pig during a Nipah virus epidemic in Malaysia. The virus 
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caused respiratory illness in pigs and was first confused with Nipah virus disease (Kono et 
al. 2002). Oya virus was also isolated from mosquitoes in Vietnam, and the transmission 
cycle is believed to occur between mosquitoes and swine (Bryant et al. 2005). Swine are 
also suspected natural hosts for Ingwavuma virus, as no clear disease is observed in 
infected swine. Ingwavuma virus was first isolated from Culex sp. mosquitoes and the 
spectacled weaver bird Hyphanturgus ocularus. In contrast to Oya virus, Ingwavuna virus 
antibodies are found in humans, but only in India (Top et al. 1974, McIntosh, McGillivray 
& Dickinson 1965). 
 
3.3 Molecular biology of orthobunyaviruses 
The lengths of the large, medium and small genome segments are approximately 6.9 kb, 
4.5 kb and 1 kb, respectively (figure 2). Each segment has a 3’end non-coding region, a 
coding region and a 5’ end non-coding region. The length of the non-coding regions vary 
within genus; however, the length of the coding region is the same within viruses in the 
same serogroups (Elliott, Blakqori 2011). There is a unique terminal region at the 3’ end 
(UCAUCACAUG) and at the 5’ end (AGUAGUGUGC) in each segment. 
 
The L segment encodes a 259–263 kDa L protein, RNA-dependent RNA polymerase 
(RdRp), which is able to perform cap snatching of the capped 5’ ends of host mRNA 
(endonuclease) and to use these short nucleotides as primers for viral mRNA synthesis 
(RNA polymerase). RdRp of orthobunyaviruses is involved in both transcription and 
replication.  
 
The M segment encodes the 29–41 kDa Gn and 108–120 kDa Gc glycoproteins and a 15–
18 kDa NSm non-structural protein. Gc and Gn are integral membrane proteins. Gc shares 
structural similarities with fusion proteins, but Gn also plays an important role in fusion 
process (Garry, Garry 2004). The Gc fusion peptide is involved in neurovirulence (Soldan 
et al. 2010). The antigenic properties of the Gc and Gn glycoproteins are involved in 
haemagglutination and neutralization. NSm (Fazakerley et al. 1988) protein has been 
found in all sequenced orthobunyaviruses, and it seems to be involved in virus assembly 
and budding (Elliott 2014).  
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Figure 2. Structure and coding strategy of orthobunyaviruses. Small (S), medium (M) and 
large (L) segments encode nucleocapsid protein (N), membrane glycoproteins (Gc and 
Gn), RNA-dependent RNA polymerase (RdRp), and non-structural proteins, NSs and NSm. 
 
The S segment encodes the 19–26 kDa N and 10–13 kDa NSs proteins (King et al. 2012). N 
proteins are involved in genome encapsidation and in interactions with other viral and 
host cell proteins (Elliott, Blakqori 2011). They are also associated with complement 
fixation. The NSs protein inhibits the antiviral interferon system in mammalian hosts and 
is involved in apoptosis (Blakqori et al. 2007). It also has multiple roles in virus replication 
and mammalian host cell interaction; it inhibits translation and RNA synthesis (Elliott 
2014). However, viruses in the Anopheles A, Anopheles B, and Tete serogroups and 
Mapputta group viruses have been found to lack the NSs open reading frame (Gauci et al. 
2015, Mohamed, McLees & Elliott 2009).  
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3.4 Genetic reassortment 
Reassortments occur within the Orthobunyavirus genus, altering the virulence or vector 
specificity of the virus. Reassortment may occur when closely related viruses circulate in 
the same area and infect the host at the same time. Segments originally from different 
viruses end up in the new virus particle during virus assembly. The Bunyamwera 
serogroup virus Ngari virus (NGIV) is a natural reassortant, in which the S and L segments 
originate from Bunyamwera virus and the M segment originates from Batai virus. Ngari 
virus was first isolated from mosquitoes in 1979 and later from human serum samples 
(Zeller et al. 1996). During a large Rift Valley virus haemorrhagic fever epidemic between 
1997-1998, two cases were shown to be caused by Ngari virus (Bowen et al. 2001). The 
isolates were first named Garissa virus, but later more detailed sequence analysis showed 
that the Garissa virus isolates were in fact identical to Ngari virus (Gerrard et al. 2004). 
Bunyamwera and Batai viruses have never been associated with haemorrhagic fevers. 
(Gerrard et al. 2004, Briese et al. 2006).  
 
Reassortants have been mostly studied in the Bunyamwera serogroup, where, in addition 
to Ngari virus, Potosi virus (POTV) and Main Drain virus (MDV) are reassortants. Both 
have Cache Valley virus (CCV) S and L segments and a Kairi virus (KRIV) M segment. 
Interestingly, Kairi virus has never been isolated in the USA, where Potosi, Main Drain and 
Cache Valley viruses circulate. The question remains how these viruses have acquired the 
Kairi virus M segment (Briese, Kapoor & Lipkin 2007). Ilesha virus (ILEV), yet another 
Bunyamwera group virus, was first isolated in 1959 in Nigeria from a human blood 
sample. Ilesha virus is a Bunyamwera virus species isolate, but the M segment has a low 
similarity to all known orthobunyaviruses (Pachler, Ruzek & Nowotny 2013). Because of 
so many reassortant viruses in the same serogroup, it has been suggested that 
reassortment may be a driving force in the evolution of this serogroup (Briese, Kapoor & 
Lipkin 2007). One of the few reassortant viruses outside the Bunyamwera group is the 
newly identified Itaya virus from Peru. It has only been isolated from two febrile patients 
and has been shown to have identical S and L segments to Carabaru virus (CAPV); 
however, the M segment sequence is derived from another still unknown virus (Hontz et 
al. 2015).  
 
Some orthobunyaviruses have been incorrectly claimed to be reassortants. 
Schmallenberg virus (SCHV), which emerged in 2011 in Europe, causing severe disease in 
cattle, sheep and other ruminants, was thought to have evolved from the reassortment of 
the Sathuperi (SATHV) and Shamonda (SHAV) viruses in the Simbu serogroup (Yanase et 
al. 2012). However, another group of researchers demonstrated that Schmallenberg virus 
actually belongs to an old Sathuperi virus species and is possibly the ancestor to this 
species (Goller et al. 2012). A similar disagreement concerns Guaroa virus (GROV): in 
serological analysis, Guaroa virus is neutralized by California serogroup virus antibodies, 
but in complement fixation tests, it seems more similar to the Bunyamwera serogroup 
viruses (Whitman, Shope 1962). Sequence analysis showed that Guaroa virus is 
genetically closer to bunyamwera viruses than to California serogroup viruses (Briese, 
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Rambaut & Lipkin 2004, Dunn, Pritlove & Elliott 1994). However, Guaroa virus is most 
likely the bridge virus between the CEV and BUNW serogroups (Briese, Rambaut & Lipkin 
2004), which in fact was proposed immediately after the initial virus isolation (Whitman, 
Shope 1962)). 
 
Species- level classification is primarily performed by cross-neutralization and cross-
hemagglutination inhibition tests. In addition, according to the International Committee 
on Taxonomy of Viruses (ICTV), the N protein amino acid sequences of two virus species 
must differ by more than 10%. Virus isolates within the species can form reassortments, 
but this does not seem possible between viruses originating from different species. A 
limitation of the current classification system is that ICTV does not offer any guidance for 
classifying genotypes, strains or other isolates. In the genus Orthobunyavirus, there are 
many isolates that are insufficiently characterized, virus isolates that lack sequence data 
or new viruses that may have only sequence data available. Many orthobunyaviruses 
have been isolated and named, but more data are required to confirm all the isolates as 
the representative members of the genus. 
 
 
3.5 Orthobunyaviruses in Europe 
There are virus isolates from five different serogroups known to circulate in Europe. The 
California serogroup is the most common since four of its isolates (Inkoo, Tahyna, 
Chatanga and Snowshoe hare viruses) have been reported to circulate in Europe. Virus 
isolates belonging to the Bunyamwera, Simbu, Tete and Turlock serogroups have been 
recovered from different arthropods and vertebrates as well. 
 
Batai virus (BATV) is the only Bunyamwera serogroup virus found in Europe. The name 
originates from an isolate found from Malaysia in 1955, but the virus was isolated from 
three different locations in different parts of the world at the end of the 1950s. A Calovo 
virus isolate was recovered from mosquitoes from Slovakia in 1960, Chittoor virus was 
recovered in India in 1957, and Olyka virus was isolated from Ukraine. All of these isolates 
have been identified as Batai virus strains (Karabatsos 1985). Within Europe, Batai virus 
circulate mainly in central Europe, but it has been isolated from Sweden and Russia as 
well (Francy et al. 1989, Jöst et al. 2011). Serological evidence suggests that the virus is 
also present in Finland (Brummer-Korvenkontio 1973b). Outside Europe, Batai virus has 
been isolated in many parts of Asia and in Africa (Karabatsos 1985, Nashed, Olson & el-
Tigani 1993), where the Batai virus reassortant strains Ngari and Ilesha circulate (Briese et 
al. 2006). Batai virus seems to infect domestic animals, especially cattle, but until 
recently, all evidence was based on serological analysis. The first isolates from cattle were 
obtained in China (Liu et al. 2014). It has been isolated from wild birds, but their 
importance in the virus lifecycle is not known.  
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Simbu serogroup viruses were not important in Europe before Schmallenberg virus began 
to spread in 2011 from Germany and the Netherlands. The virus was found all the way 
from southern to northern Europe by the end of 2012. Only some eastern parts of Europe 
did not report any Schmallenberg virus cases. Schmallenberg virus infects not only 
domestic but also wild ruminants, and the virus is spread by the culicoides biting midges. 
The natural cycle might include wild ruminants as a reservoir host (Hoffmann et al. 2012, 
Laloy et al. 2014). Schmallenberg virus is not the only Simbu group virus found from 
Europe. Although understudied, Ingwavuma virus has been isolated from Muscicapa 
striata birds in Cyprus (Karabatsos 1985).  
 
In addition to Ingwavuna virus, there are several other less well known orthobunyaviruses 
in Europe that have been isolated from birds. The Tete serogroup Bahig and Matruh 
viruses circulate in Southern Europe, and both viruses use the Hyalomma marginatum 
tick as a vector and migrating birds/passerine birds as hosts. Both viruses were isolated 
twice from Fringilla montifringilla and Fringilla coelebs (Balducci et al. 1973) and share 
the same distribution area, consisting of Italy and Cyprus (and outside Europe, Egypt). 
Little is known about the actual distribution and host range of these viruses (Moussa et al. 
1974, Hubalek, Rudolf 2012). Lednice virus, in the Turlock serogroup, has a natural cycle 
between waterfowl and mosquitoes. The virus was isolated in Czechoslovakia from the 
Culex modestus mosquito, which seems to be the only vector for the virus. No vertebrate 
host is known, and the virus distribution area is restricted to Czechoslovakia and Romania 
(Karabatsos 1985, Hubalek 2008). Another virus from Czechoslovakia was isolated once 
from the blood of reed warblers collected in 1984 from Moravia (Hubalek et al. 1990). 
Sedlec virus (SEDV) was shown to belong to the family Bunyaviridae by morphological 
analysis, but a more detailed analysis of the relationship to other orthobunyaviruses 
suggested that it forms its own group and is most related to Leanyer virus and the Simbu 
serogroup. However, only partial sequences have been published, and Sedlec virus 
remains an unclassified virus within the genus Orthobunyavirus (Bakonyi et al. 2013).  
 
4 California serogroup (California encephalitis virus group, 
CEV group) 
4.1 Members of the CEV group 
California encephalitis virus (CEV) is considered the only species in the serogroup, which 
contains 13 virus isolates (Table 1, figure 3.). It was the first isolate in the California 
serogroup, recovered from Ochlerotatus melanimon (dorsalis) mosquitoes collected from 
San Joaquin Valley of California in 1943. The virus causes encephalitis in laboratory mice, 
rats and hamsters (Hammon, Reeves & Sather 1952). Antibodies were found in humans, 
horses, cows, rabbits, and ground squirrels, and serological evidence demonstrated that 
California encephalitis virus can cause encephalitis in humans (Hammon, Reeves 1952). 
The virus has never been isolated from humans, and only three human cases have been 
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confirmed. It took 50 years to find the fourth California encephalitis virus case in 
California (Eldridge et al. 2001), suggesting that various arboviruses should be considered 
when a patient suffers from a CNS infection. 
 
Dr. Carl Eklund isolated a virus from Och.  trivittatus mosquitoes in North Dakota and 
showed its close relationship to California encephalitis virus in cross-neutralization tests. 
The virus was named Trivittatus virus (TVTV) (Hammon, Reeves & Sather 1952). 
Trivittatus virus is widespread in the USA and Southern Canada, and human infections 
occur in all age groups (LeDuc 1987, SUDIA et al. 1971, Monath et al. 1970). A recent 
study from North Dakota showed that Trivittatus virus was the most common CEV isolate 
in the area, and its occurrence lasts throughout the summer and until the end of October, 
in contrast to other CEV viruses. The majority of the isolates have been obtained from 
Och. trivittatus mosquitoes (78%), and some strains still resemble the prototype isolate 
(Anderson et al. 2015). Phylogenetic analysis of several Trivittatus virus isolates suggest 
that Trivittatus virus is positioned between the California and Bwamba serogroups, and 
the divergence at the amino acid level suggests that it is actually distinct enough to be a 
virus species of its own (Groseth et al. 2015). 
 
The first South American representative, Melao virus (MELV), was isolated from Trinidad 
in 1955. The virus was isolated from Ochlerotatus scapularis mosquitoes, but no human 
isolates were recovered from 2500 human serum samples obtained from patients with 
undiagnosed fever within the same area. Only one serum partially neutralized the virus in 
a very limited serological survey (Spence et al. 1962b). The virus has been identified in 
areas from Trinidad to Brazil (Carvalho et al. 2009), and antibodies have been found in 
humans and horses in Argentina, yet no association with clinical disease has been 
observed (Calisher et al. 1987). Phylogenetic analysis shows that the closest relatives of 
Melao virus are Keystone and Serra do Navio viruses (Carvalho et al. 2009). 
 
Tahyna virus (TAHV) circulates in an area extending from central Europe to China but is 
also found in Africa (Kokernot et al. 1962, Lu et al. 2011). Norway is the only country in 
northern Europe where Tahyna virus has been reported to circulate and was recovered 
from mosquitoes (Ochlerotatus sticticus and diantaius) (Traavik, Mehl & Wiger 1978). The 
African isolate was first named Lumbo virus, but the virus proved to be identical with the 
Eastern Slovakia Tahyna virus isolate (prototype 92 Bardos). The vertebrate hosts are 
hares (Lepus europaeus), hedgehogs and rodents (Hubalek 2008), and the virus is 
maintained by horizontal and transovarial transmission in mosquitoes (Traavik, Mehl & 
Wiger 1978, Bardos, Ryba & Hubalek 1975). Tahyna virus is associated with febrile illness, 
occasionally causing more severe disease (Bardos et al. 1975, Simkova, Sluka 1973). 
 
Snowshoe hare virus (SSHV) was initially isolated from Lepus americanus (snowshoe hare) 
from Montana and it is common in the northern USA and Canada, where the reservoir 
hosts Lepus americanus and arctic lemmings (Dicrostonyx torquatus) are widely 
distributed (Burgdorfer, Newhouse & Thomas 1961, Ritter, Feltz 1974). There are several 
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cases of Snowshoe hare virus infection described as encephalitis in humans and horses 
(Lynch, Binnington & Artsob 1985, Kettyls et al. 1972, Meier-Stephenson et al. 2007). 
Previously, Snowshoe hare virus was thought to circulate in Russia (Vanlandingham et al. 
2002), and some serological evidence supported this finding (Butenko et al. 1991). 
However, all the strains presented in the Vanlandingham et al. paper (Vanlandingham et 
al. 2002) appear to have been re-classified as Chatanga virus strains based on NCBI 
GenBank data, and only one partial Snowshoe hare virus sequence (LEIV-SSH, AF393325) 
from Russia remains. More studies are required to conclude whether Snowshoe hare 
virus is actually present in Russia or not. 
 
San Angelo virus (SAV) was first isolated by Grimes et al. in 1958 in Texas from Anopheles 
pseudopunctipennis mosquitoes (Hammon, Sather 1966). In total, 3 isolates were 
recovered during the 1960s, all from Texas; however, since then, the virus has been 
largely forgotten. Different mosquito species, including Psorophora confinnis, 
Ochlerotatus atlanticus-infirmatus, and Anopheles pseudopunctipennis, are involved in 
virus maintenance, but no natural host has been identified thus far (Sudia et al. 1971). 
Low levels of antibodies have been found in white-tailed deer (Issel, Hoff & Trainer 1973). 
No clinical disease in humans has been identified, and only one confirmed San Angelo 
virus antibody-positive human individual is known (Karabatsos 1985). 
 
A limited number of studies are available for South river virus (SORV) (NJO-94F), which 
was isolated from Anopheles crucians mosquitoes in New Jersey in 1960. Later virus 
isolates have been obtained from Ochlerotatus sollicitans and Culiseta melanura 
mosquitoes from the same area (Sudia et al. 1971) and from Pennsylvania and Georgia 
(Wills et al. 1974, Blitvich et al. 2012d). More recently, South River virus was identified as 
a cause of an infection in horses, sheep and dogs in Mexico (Blitvich et al. 2012c). No 
evidence of human infection exists. 
 
La Crosse virus (LACV) was initially isolated from the brain tissue of a 4-year-old girl with 
fatal encephalitis in 1960 (Thompson, Kalfayan & Anslow 1965). She lived in Wisconsin, 
where the virus-amplifying hosts, chipmunks, were shown to carry the virus. La Crosse 
virus is mainly transmitted by the tree-hole mosquito, Ochlerotatus triseriatus (Gauld et 
al. 1975, Thompson et al. 1972), and the virus is maintained in nature by transovarial and 
horizontal transmission cycles between vectors and hosts (Watts et al. 1973). Aedes 
triseriatus hatch late in the spring, which results in the appearance of La Crosse virus 
encephalitis cases as a sharp peak later in the summer, typically between July and 
September. It circulates in the Appalachian and Midwestern regions of the USA (Haddow, 
Odoi 2009)and was isolated from Tennessee from non-native Aedes albopictus 
mosquitoes in 1991 (Gerhardt et al. 2001). This finding suggests that new vector species 
for La Crosse virus may affect the virus distribution and the number of clinical cases could 
increase. 
 
25 
 
Jamestown canyon virus (JCV) was isolated for the first time from Culiseta inornata 
collected from Colorado in 1961 (DeFoliart et al. 1969), and since then, the virus has been 
isolated from most of the USA and Canada (Fulhorst et al. 1996, Boromisa, Greyson 1990, 
Srihongse, Greyson & Deibel 1984). Boreal mosquito species are the principal vectors, but 
the virus is also carried by deer and horse flies (DeFoliart et al. 1969, Andreadis et al. 
2008). The natural cycle involves white-tailed deer and other wild ruminants as an 
amplification host (Issel, Hoff & Trainer 1973, Zamparo et al. 1997). Although the deer 
populations have increased recent years, it has not affected the Jamestown canyon virus 
prevalence in mosquitoes, indicating that transovarial transmission is important for virus 
survival (Anderson et al. 2015). Humans are a dead-end host to the virus, and the 
symptoms of the disease may vary from mild febrile illness to encephalitis (Pastula et al. 
2015). 
 
Keystone viruses (KEYV) circulate in the south and southeast regions of the USA. Many 
hundreds of isolates have been recovered from mosquitoes, mostly from Ochlerotatus 
atlanticus mosquitoes between 1943 and 1970. Almost 95% of all Keystone virus isolates 
have been recovered from Och. infirmatus and Och. taeniorhynchus (Sudia et al. 1971). 
The virus life cycle probably involves cotton rats, the distribution of which is restricted to 
southeastern USA (Taylor et al. 1971). Transovarial transmission has been shown to be 
important in virus maintenance and transmission, as the virus has been isolated several 
times from mosquito larvae and male mosquitoes (LeDuc et al. 1975). Keystone virus can 
infect humans, but clinical disease from this virus has not been observed. Studies show a 
16-22% antibody prevalence among the human populations studied (Parkin, Hammon & 
Sather 1972). 
 
Inkoo virus (INKV) is one of the European CEV representatives, and its distribution is 
limited to northern Europe, Finland, Sweden, Norway and Russia (Brummer-Korvenkontio 
et al. 1973, Niklasson et al. 1985, Traavik, Mehl & Wiger 1978, Butenko et al. 1991). INKV 
was found in 1964 from Ochlerotatus communis/punctor mosquitoes. Antibodies have 
been found in many vertebrates (Brummer-Korvenkontio 1973a), but the natural 
reservoir remains unknown. It has been speculated that moose or deer take part in the 
natural cycle of the virus. Lepus timidus populations also have a high INKV 
seroprevalence. INKV seems common in Northern Europe, where the seroprevalence 
among humans is 20-40% (Niklasson et al. 1985, Brummer-Korvenkontio 1973a, Traavik, 
Mehl & Wiger 1985), but no clinical disease has been reported yet. Interestingly, INKV is 
phylogenetically closely related to Jamestown canyon virus (96,6% S segment aa identity), 
although the geographical distribution of these viruses is widespread (Vapalahti et al. 
1996). 
 
The second South American representative, Serra do Navio virus (SDNV), was isolated 
from Ochlerotatus fulvus collected in Amaba, Brazil in 1966. No other virus isolates have 
been recovered, and although antibodies were found in humans, spiny rats and 
opossums, there is no association with any disease. The natural life cycle of the virus is 
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not known (LeDuc 1987, Karabatsos 1985). Phylogenetic studies have shown that the 
virus is most closely related to Inkoo, Jamestown canyon, South River and Keystone 
viruses (Huang et al. 1996). 
 
Chatanga virus (CHATV) isolates were first obtained from mosquitoes collected in 
Murmansk, Russia in 1983. Several isolates were recovered from mosquitoes collected all 
over Russia between 1983 and 1989. The distribution area covers all of Russia and eastern 
parts of Finland. It overlaps with Inkoo and Tahyna virus distribution in western parts of 
Russia (Lavrent'ev et al. 2008). There are no data available on the host range and disease 
association of CHATV. CHATV is closely related to Snowshoe hare and La Crosse virus in 
phylogenetic analysis (Putkuri et al. 2014).  
  
 
Figure 3. Neighbour-joining phylogenetic tree of the S segment of California serogroup 
viruses. 
 
4.2 Transmission cycle of the CEV group 
All CEV group viruses have a unique transmission cycle, using vertebrate hosts to persist 
in nature (APPENDIX 1). Humans are not an essential part of the transmission cycle, and 
they are referred to as dead end hosts since the plasma viremia level remains too low to 
infect new mosquito vectors. Viruses may have several different host cycles (Gauld et al. 
1975, Ksiazek, Yuill 1977, Goff, Whitney & Drebot 2012), and the vector species 
transmitting the virus may differ in each cycle. The maintenance of these cycles is 
dependent on the transmission of the virus to the next generation of mosquitoes (or 
eggs) and to new uninfected hosts.  
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Figure 4. The La Crosse virus natural cycle involves chipmunks, deer and the tree-hole 
mosquito Aedes triseriatus. The figure demonstrates the horizontal and vertical 
transmission route for La Crosse virus. Modified from (Reisen 2002, Borucki et al. 2002). 
 
The predominant way for transmission for the CEV group is horizontal maintenance, 
which involves vector-host cycles, or mating between infected male and uninfected 
female mosquitoes (venereal transmission) (figure 4) (Thompson, Beaty 1977). The 
plasma viremia is brief in the host animals; for example, viremia of La Crosse virus-
infected chipmunks is high enough to infect mosquitoes for 2 to 4 days only. However, 
experimental infections have shown that the majority of the mosquitoes become infected 
after a blood meal during viremia (Pantuwatana et al. 1972). However, venereal 
transmission is considered to be at least as important method of virus maintenance. The 
venereal transmission efficiency is somewhat influenced by the timing of the female 
blood meal. Blood meal consumption before mating enhances the likelihood of venereal 
infection (Thompson 1983). It has been shown that mosquitoes are more eager to mate if 
they carry the virus (Reese et al. 2009) and are also more motivated to obtain the blood 
meal if the vector is infected with the virus (Jackson, Brewster & Paulson 2012) 
 
Several viruses in the CEV group use vertical transmission maintenance, where the virus is 
transmitted from infected females to progeny (transovarial transmission)(Watts et al. 
1973, LeDuc et al. 1975). La Crosse, Trivittatus, Jamestown canyon, Snowshoe hare and 
Keystone viruses have been isolated from mosquito larvae and male mosquitoes, which 
demonstrates that the virus is transmitted into mosquito eggs by transovarial 
transmission (Anderson et al. 2015, Watts et al. 1973, LeDuc et al. 1975, Mclintock et al. 
Horizontal  
transmission 
cycle 
Vertical 
transmission 
cycle 
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1976, Andrews et al. 1977). This serves as an additional winter-season reservoir for 
viruses and enables the virus to resume the transmission cycle early in the spring (Watts 
et al. 1974). Interestingly, transovarial transmission seems to be a more important 
feature for mosquitoes in the north, where the number of infected progeny is higher than 
similar mosquito species in south. On the other hand, the number of viable eggs were 
lower if they carried the virus (Woodring et al. 1998). 
 
The timing of a possible disease peak in the human population during the mosquito 
season depends on the method of virus transmission (Anderson et al. 2015). If horizontal 
transmission is the primary method to amplify the virus, more infections occur later in the 
summer/early autumn, when the virus prevalence is higher in mosquito vectors (Cache 
Valley Virus). Vertically transmitted viruses primarily cause a disease peak early in the 
season. If both methods are used to transmit the virus (e.g., Jamestown Canyon virus), 
infections may be found throughout the mosquito season (figure 5).  
 
 
 
Figure 5. Examples of virus maintenance and the influence of the route of transmission on 
the amount of virus present during the summer months. Modified from (Anderson et al. 
2015). a) The pattern if the virus uses vertical and horizontal transmission in 
maintenance, b) the pattern if horizontal transmission only is used and c) the pattern if 
vertical transmission only is used. Columns show the amount of virus isolated, and the 
curve shows the amount of mosquitoes present.  
 
The presence of antibodies in wild mammals is not direct evidence that the animals have 
developed a sufficient level of viremia to infect vectors. Experimental studies on hosts for 
La Crosse virus have shown that the virus titre and the duration of the sufficient titre may 
vary between host species. In chipmunks, the virus titre stays high enough for 3 days, 
whereas in foxes, the titre never reaches the same level, yet the viremia lasts longer (Yuill 
1983). Interestingly, the predators (foxes) could become infected by eating the prey 
(chipmunks), but the infection was not acquired while drinking water with the mosquito 
larvae carrying the virus (Yuill 1983, Amundson, Yuill 1981). 
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4.3 CEV replication 
CEV enters cells by receptor-mediated endocytosis (Hollidge et al. 2012). Glycoprotein Gc 
is more important in vertebrate cell attachment, and Gn is more important in arthropod 
cell attachment (Ludwig et al. 1991). However, other studies show that Gc is involved in 
infecting both cell types (Hacker, Hardy 1997). The receptor involved in virus-cell 
attachment is unknown. La Crosse virus uses clathrin-mediated endocytosis to enter 
mammalian cells, but other CEV viruses are less well studied. Endosomal trafficking 
transports the virus through the plasma membrane and protects from immune 
surveillance. This route also enables the virus to enter the primary neurons, which may 
lead to CNS infection. After entry, the virus is transported in endocytic vesicles into the 
early endosomes, and this transport is regulated by the Rab5 GTPase (Hollidge et al. 
2012). Low pH in the early endosome is required for the uncoating of the virus and fusion 
of the viral membrane with the endosomal membrane (Gonzalez-Scarano, Pobjecky & 
Nathanson 1984). Gc is involved not only in cell attachment but also in membrane fusion 
(Plassmeyer et al. 2007).  
 
After uncoating, the nucleocapsids are released into the cytoplasm, where replication 
takes place. Genomic RNA is transcribed into positive-sense mRNA by RdRp (primary 
transcription). The L protein of La Crosse virus contains a primer-stimulated RNA 
polymerase and a methylated cap-dependent endonuclease. Primary transcription is 
primer-dependent, and RdRp uses nucleotides originating from the host as primers to 
transcribe the viral mRNA. The primers are host mRNAs that have been cleaved from the 
5’ end by viral RdRp in a process called cap snatching and hence lack the capped 
oligonucleotides (Patterson, Holloway & Kolakofsky 1984). Translation of viral proteins 
from mRNA is required for transcription to occur. The on-going protein synthesis in host 
cell ribosomes guarantees the production of full-length viral mRNAs (premature 
termination of transcription) (Bellocq, Kolakofsky 1987). 
 
The switch from transcription to genome replication happens when a sufficient level of N 
protein is available in the cell for encapsidation. Only the L and N proteins are needed for 
replication. Genomic viral RNA is used to produce anti-genome as a template for 
replication. The produced RNA segments are encapsidated by the N protein and 
associated with the L protein, forming nucleocapsids (RNPs) that appear circular in the 
virion and in infected cells (Elliott 2014). N protein encapsidates both genomic and 
antigenomic RNA to inhibit the formation of dsRNA and prevent the host immune 
response and interaction with transcription (Ogg, Patterson 2007). 
  
The virus particles assemble and mature by budding from the Golgi apparatus. The Gn 
and Gc glycoproteins accumulate at the Golgi complex membrane after glycosylation in 
the ER. Nucleocapsids are transported to the modified Golgi membrane and bud through 
into the Golgi membrane-derived vesicle. Maturation of the virus particle happens during 
transport from the Golgi stacks to the trans-Golgi. This changes the glycoproteins Gn and 
Gc and forms intermediate particles (Madoff, Lenard 1982). The particles are transported 
from the Golgi to the cell surface. Fusion of the particle membrane with the plasma 
membrane leads to the release of infectious virions (Elliott 2014).  
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4.4 CEV pathogenicity 
The viral infectivity and virulence of CEV has been mostly studied with La Crosse virus 
(LACV) and Tahyna virus (TAHV) in mice. Susceptibility to infection is dependent on the 
age of the host; young hosts suffer from more severe infection than adults (Johnson 
1983). It seems that virus strains that cause encephalitis in mice after peripheral 
inoculation can cause encephalitis in humans (Tignor et al. 1983). In mice, LACV infects 
peripheral tissues near the inoculation site, where the initial virus replication happens 
(Taylor, Peterson 2014). The virus enters the bloodstream after 24 hours, causing plasma 
viremia. However, the virus can already be found replicating in the brain after 6 hours of 
infection because of its spread via the subarachnoid space into the brain (Johnson 1983). 
It has been suggested that LACV presumably gains access to the CNS via olfactory neurons 
(Bennett et al. 2008). Plasma viremia leads to infection in the muscles and brown fat. 
Orthobunyaviruses establish plasma viremia rapidly in order to be transferred to new 
insect vectors. Viruses use the NSs protein to overcome the fast-responding innate 
immune defence of the mammalian host (Blakqori et al. 2007). Viremia lasts 1-3 days, and 
at the end, the infection is widespread and the virus is present in most of the tissues 
(skeletal, cardiac and smooth muscles and their small arteries and veins) (Johnson 1983). 
During plasma viremia, a high level of replication happens in the respiratory tissue as 
well, and CNS infection appears subsequently. The highest level of viremia during the 
infection is found in the nasal turbinates, brain and spinal cord. Infection of adult mice 
rarely leads to clinical disease (Bennett et al. 2008).  
 
Inoculation of rhesus monkeys with LACV, TAHV and Jamestown canyon virus (JCV) did 
not lead to clinical disease. All viruses produced a strong neutralizing antibody response 
that was first detectable 6 to 8 days after infection. Plasma viremia was not detectable 
after TAHV and LACV infections; however, JCV caused viremia 2 to 4 days after infection 
(Bennett et al. 2008, Bennett et al. 2011a, Bennett et al. 2011b). LACV was found in the 
lymph nodes, but replication could not be detected (Bennett et al. 2008). The level of 
plasma viremia seems to correlate with the neutralizing antibody levels, and non-human 
primates seem to mimic the infection in humans, with a low incidence of clinical disease 
(Bennett et al. 2011a).  
 
The virus infection is not harmful to the invertebrate vector and leads to persistent 
infection. Viruses infect and begin replicating in the midgut epithelial cells of the 
mosquito within a few hours after the blood meal. During the next 5 to 6 days, infection is 
not apparent and not even detectable; this is referred to as an eclipse phase. A few days 
later, the virus particles pass through from the gut epithelial cells into the haemocoel, 
which enables the particles to spread further and infect various organs. The salivary 
glands are the last tissues to be infected (Tesh, Beaty 1983). After replicating in the 
salivary glands, the glandular lumen is packed with virus particles, and mosquitoes are 
ready to transfer the virus into a new uninfected animal host. The time period from initial 
infection until the vector is ready to spread the virus is 7-14 days for California 
encephalitis virus (Watts, DeFoliart & Yuill 1976, Chernesky 1968). Transovarial 
transmission can happen after the virus has reached the mosquito ovaries, which means 
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that after the initial blood meal, a mosquito’s first batch of eggs is virus-free. It is not 
known how the virus enters the eggs. However, transovarially infected mosquitoes are 
instantly ready to spread the virus (Miller, DeFoliart & Yuill 1979). 
 
The mechanism of persistent infection in invertebrates is not well known. Insects do not 
develop antibodies against the virus; instead, they use the RNAi response for the specific 
recognition and destruction of viral-RNA (Sanchez-Vargas et al. 2004). La Crosse virus 
infection is known to cause a strong RNAi response in infected insect cells. However, in 
contrast to mammalian host infections, the anti-RNAi activity of the NSs protein to 
prevent the RNAi response is not observed in mosquitoes (Blakqori et al. 2007). 
Orthobunyaviruses replicate rapidly, and new infectious viruses are released from the cell 
without rupturing the endomembranes of the cell (Golgi stacks). At the same time, the 
viral proteins seem to aggregate into large complexes, which helps the virus to escape the 
cell response. Additionally, morphological changes are observed in mosquito cells (Lopez-
Montero, Risco 2011). Noncytopathic persistent infection in mosquito cells has been 
suggested to occur because of the reduction of the synthesis of the host mRNAs, which 
are used as transcriptional primers for viral synthesis. In addition, the virus appears to 
self-limit the production of the N protein by encapsidation of S segment-derived mRNA, 
which means that the switch from transcription to genome replication does not happen 
(Hacker, Raju & Kolakofsky 1989).  
 
 
4.5 Clinical disease in humans 
Only two of the California serogroup viruses have been isolated from humans thus far; 
TAHV and LACV. TAHV circulates in central Europe, and the human isolates have been 
obtained from sick children living in southern Moravia in the former Czechoslovakia. The 
first patient had fever, conjunctivitis and pharyngitis two days after the onset of 
symptoms. The second child showed meningeal symptoms with fever and sore throat one 
day after falling ill. Both patients were under 10 years old, and the virus was isolated from 
blood samples (Bardos et al. 1975). Both patients were treated in Valtice hospital, which 
designated TAHV disease as Valtice fever. The clinical picture of Valtice fever is most 
often similar to influenza-like or pulmonary disease (70%). In fewer cases, the patients 
suffer from abdominal or rheumatic disease (20%), tonsillitis (7%) or CNS symptoms (3%). 
One study presented cases over a 4-year period and included 58 patients, mostly male 
(65%). The incubation period observed for the TAHV disease was 3-4 days, and the 
disease was not connected to a specific age group (Sluka 1969). 
 
Several large retrospective studies have been published of the association of LACV with 
encephalitis in children (Balfour et al. 1973, Haddow, Odoi 2009, McJunkin et al. 2001). 
Most patients were under 15 years old (83%), but adults also became infected (Haddow, 
Odoi 2009). In the studies mentioned above, 60% to 70% of those infected were males. 
Fever and headache were the most prevalent symptoms (70-80%) in addition to altered 
consciousness, gastrointestinal symptoms and seizures (Balfour et al. 1973, McJunkin et 
al. 2001). The cases occurred from July to September. LACV infections have been divided 
into mild and severe forms. The mild form usually presents with headache, fever and 
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gastrointestinal symptoms, whereas the more severe forms manifests with 
meningoencephalitis, encephalitis or meningitis (Balfour et al. 1973, Haddow, Odoi 2009). 
Severe cases have become more frequent over the years (Haddow, Odoi 2009); however, 
the virus is rarely isolated from patients with CNS involvement (McJunkin et al. 2001). The 
case fatality rate for human LACV infections is 1.9% (Haddow, Odoi 2009), and the virus 
isolates from fatal cases belong to a very narrow range of virus isolates that circulate 
mainly in Midwestern USA (Huang et al. 1997, Lambert et al. 2015). 
 
Jamestown Canyon virus (JCV) infections have been underdiagnosed for years in the USA; 
the number of diagnosed cases increased by 50% due to the implementation of specific 
IgM tests for JCV at the CDC in 2013 (Pastula et al. 2015). CNS involvement is found in up 
to 50% of cases, but many studies have concentrated on patients with neuroinvasive 
disease. Compared to LACV infection, JCV is more prevalent in adults than in children 
(Grimstad et al. 1982, Pastula et al. 2015, Grimstad et al. 1986). JCV is neuropathogenic, 
but the symptoms are less severe than those in LACV infection in children. Most of the 
cases are diagnosed from July to September, yet the disease peak is not as high as those 
of other arboviral diseases. JCV infections occur throughout summer because the so-
called early season mosquitoes are involved in virus transmission (transovarial 
transmission to mosquito eggs) and may infect humans early in the summer (Pastula et al. 
2015). In addition, different mosquito species transmit the virus at different times of the 
summer (Andreadis et al. 2008). The average patient is a 40-59-year-old male, and typical 
CNS involvement includes meningoencephalitis and meningitis (Srihongse, Greyson & 
Deibel 1984, Pastula et al. 2015, Centers for Disease Control and Prevention (CDC) 2011).  
 
Snowshoe hare virus (SSHV) is the most frequent in Canada, where one symptomatic 
infection is recorded every year (Meier-Stephenson et al. 2007). Several cases of SSHV 
encephalitis have been published, and all of these cases have been confirmed with 
serological tests from the paired serum samples. Typically, patients with SSHV 
encephalitis are children under 11 years old, and the symptoms are similar to those of 
LACV and JCV infections (fever, headache, vomiting) (Fauvel et al. 1980, Embil, Camfield & 
Artsob 1985, Embil et al. 1982). The patients seem to recover rapidly; they are discharged 
from the hospital within one week, and all have recovered completely. The antibody 
levels rise quickly, indicating short-lasting viremia, which might be responsible for the 
poor success of virus isolation from infected humans (Fauvel et al. 1980, Meier-
Stephenson et al. 2007). Most published cases have been diagnosed in August. 
 
California encephalitis virus was identified as a cause of encephalitis two years after the 
discovery of the virus (Hammon, Reeves 1952), but it took more than 50 years to find the 
next case of California encephalitis (Eldridge et al. 2001).  
 
Infections in humans caused by the rest of the CEV group viruses have been inadequately 
described. Trivittatus virus antibodies have been found in all age groups in the USA, but 
the seroprevalence seems higher in the elderly (Monath et al. 1970). The situation is 
similar to that of the human Inkoo virus antibody prevalence in northern Europe 
(Brummer-Korvenkontio 1973a, Traavik, Mehl & Wiger 1985). Keystone virus antibodies 
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have been found only in residents of Louisiana and Florida (Parkin, Hammon & Sather 
1972), whereas there is less evidence of Melao and Derra do Navio virus infections in 
humans. Evidence of Melao infection in humans is based on a single serum sample from 
Trinidad (Spence et al. 1962b) and two positive samples out of 20 from Argentina 
(Calisher et al. 1987). Serra de Navio virus antibodies have been found in humans in 
Amaba, where the virus was also originally isolated (Karabatsos 1985).  
 
 
4.6 California serogroup viruses in Northern Europe 
The geographical distribution of Inkoo virus (INKV) is limited to Northern Europe 
(Brummer-Korvenkontio et al. 1973, Francy et al. 1989). The prototype strain (KN3641) 
was isolated from Ochlerotatus (Aedes) communis/punctor mosquitoes collected in a 
municipality in south Finland in 1964 (Brummer-Korvenkontio et al. 1973). The virus was 
identified with cross-complement fixation, cross-haemagglutination inhibition and cross-
neutralization tests as a member of the California serogroup within orthobunyaviruses. In 
addition, electron microscopy was used to study the morphology of the virus. To date, 
three different Inkoo virus strains have been isolated from Finland; two from the place 
called Inkoo and one from the nearby municipality Kirkkonummi. The second isolate from 
Inkoo (KN5213) was recovered from Aedes mosquitoes collected one month after the 
prototype strain. The third isolate (KN8110) was recovered from a pool of Aedes and 
Culiseta mosquitoes collected 2 years later (Brummer-Korvenkontio et al. 1973). The 
isolations were carried out in suckling mice. Inkoo virus antibodies were found in humans, 
cows, reindeer and wildlife (moose, foxes, Lepus timidus hares), and the antibody 
prevalence was higher in northern Finland (70%) than in the south (11%) (Brummer-
Korvenkontio 1973a). In phylogenetic analysis, INKV was most closely related to 
Jamestown Canyon virus, which is known to circulate in the USA only (Vapalahti et al. 
1996). The disease association of INKV infection has been poorly characterized, although 
some evidence for human disease has been reported in the Russian scientific literature 
(Demikhov, Chaitsev 1995, Demikhov 1995). 
 
Since the isolation of INKV in Finland, the virus has also been recovered from Sweden, 
Norway and western Russia (west of the Ural Mountains). The isolates have originated 
from Ochlerotatus communis collected from central Sweden, near Sundvall and Eddsbyn 
(Niklasson et al. 1985, Francy et al. 1989), Ochlerotatus diantaeus from the town of Masi 
in northern Norway (Traavik, Mehl & Wiger 1978) and Och. communis, Och. punctor and 
Ae. flavescens mosquitoes from a widely distributed geographical area in Russia (Butenko 
et al. 1991, Mitchell et al. 1993). The isolate from Norway was recovered from a male 
mosquito, indicating the ability of INKV to be transovarially transmitted. The recently 
isolated INKV strain Lovanger RNA from Ochlerotatus communis larvae from Sweden 
supports this finding (Tingström et al. 2016). Interestingly, the Norwegian isolate has 
never been sequenced, and its characterization was based on serological comparison to 
TAHV. It had a less close relationship with TAHV than did the two other tested isolates. 
Norway is the only country in northern Europe where Tahyna virus has been shown to 
circulate (Traavik, Mehl & Wiger 1985).  
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4.7 Diagnostic methods for CEV infections 
Diagnosing California serogroup virus infection is still mainly accomplished by serological 
testing. The strains in the California serogroup are closely related but antigenically 
distinct. This poses a challenge for serodiagnostic testing and makes neutralization tests 
(NT) still the most reliable method to identify the cause of a CEV infection. Historically, 
haemagglutination inhibition (HI) and complement fixation (CF) tests were used in 
serological screening (Clarke, Casals 1958, Chappell et al. 1969), and paired serum 
samples were requested to confirm the result. However, it has been shown that CF is not 
useful for rapid diagnosis; CF may take almost three times longer after the onset of 
symptoms to demonstrate seroconversion between paired samples than HI and NT tests 
(Calisher, Bailey 1981). Several less laborious approaches have been published and used 
in diagnostic laboratories, such as indirect fluorescence assays (IFAs) and enzyme 
immunoassays (EIAs). IFA tests have proven to be sensitive enough, and antibodies are 
detected soon after the onset of symptoms (Beaty et al. 1982). EIA/ELISA tests are most 
often targeted to detect IgM antibodies and used for testing acute phase samples. Both 
IFA and EIA/ELISA methods are useful for the rapid primary serodiagnosis of CEV infection 
but require NT as a confirmatory test because different virus strains cross-react in these 
tests (Calisher et al. 1986) . 
 
There are increasing numbers of nucleic acid amplification systems available, and many of 
the PCR systems are designed to find California serogroup virus RNA from mosquito 
samples. The S segment is the most usual genomic region targeted (Kuno et al. 1996, 
Lambert et al. 2005). These methods also work when detecting RNA from human tissue 
samples, and PCR systems have replaced old-fashioned virus isolations and suckling 
mouse experiments. However, little is known about their usability to detect RNA from 
serum and CSF since the viremia caused by California serogroup viruses is short and the 
viral load is low in humans. The virus is not typically able to cross the blood-brain barrier.  
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5 Aim of the study 
Inkoo virus has been known to circulate in Finland for several decades, yet the awareness 
of the virus among the physicians is poor, and no modern diagnostic tools to detect the 
infection exist. The possible disease associations have not been systematically studied, 
although the virus is known to infect humans, and closely related isolates from the same 
serogroup have been associated with encephalitis.  
 
In 1974, in the doctoral thesis of Markus Brummer-Korvenkontio, it was suggested that 
another California serogroup virus was circulating in Finland based on conflicting results 
from the serological analysis of hare samples. However, no attempts to isolate the virus 
from mosquitoes have been conducted during the last few decades.  
 
The specific aims of the thesis were: 
 
- Develop diagnostic methods for the detection of Inkoo virus and other California 
serogroup virus infections 
 
- Study Inkoo virus and California encephalitis virus seroprevalence in humans in 
Northern Europe and to determine the frequency of acute infections 
 
- Characterize the clinical picture of Inkoo virus infections in humans 
 
- Isolate California serogroup viruses from Finnish mosquitoes 
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6 Materials and methods 
 
6.1 Samples 
6.1.1 Patient serum samples (original publications I, III, IV) 
All patient serum samples collected in Finland are shown in the original publication III in 
table 1. Suspected Puumala virus infection samples (n=1294) from 2001 were used for 
INKV seroprevalence studies and the evaluation of new serological methods. All samples 
were used to find acute Californian serogroup virus infections. All samples were originally 
sent to Helsinki University Central Hospital laboratory when Puumala or Inkoo virus 
infections were suspected or when the patients were screened for causative agents of 
neurological infections. In addition, two previously confirmed INKV cases were included in 
the study of the characterization of the INKV clinical picture. A panel of CSF samples 
(n=832) was tested for INKV IgM antibodies. 
    
To study INKV seroprevalence in Northern Sweden, a total of 1729 serum samples were 
screened. The study material was part of the WHO MONICA Study (Eriksson et al. 2011), 
which was a population-based survey and included randomly selected subjects between 
25-74 years of age selected from population registers and was stratified for age and 
gender. The samples used for INKV seroprevalence screening were collected from January 
to April, 2009. 
6.1.2 Mosquitoes (original publication II) 
A summary of the mosquito collections is presented in table 2. The mosquitoes were 
collected using hand nets (human bait) or a BG-sentinel mosquito trap system (luring 
substance bait) both in the morning and in the evening in wetland areas. Traps were also 
sometimes left to collect overnight. The collected mosquitoes were briefly frozen alive at 
-20 degrees, tubed and stored on dry ice before long-term storage in a -70 freezer. Before 
isolation attempts, the mosquitoes were pooled in 10 mosquitoes per pool and pulverized 
with a pestle in Dulbecco’s 0.2% BSA. 
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Table 2. Summary of mosquito collection between 2004 and 2009. Number of collected 
mosquitoes, collection time and place are presented in the table. 
Year  Place Time Number of Individuals 
2004 Rääkkylä, East Finland  25.-27.6. 537 
 Konnevesi, Central Finland  7.-9.7.  1870 
 Lammi, South Finland  24.8.  1460 
2005 
 
Mekrijärvi, (Ilomantsi), East 
Finland    
1.-3.7.  
23.-25.8.  
1639 
210 
 Tvärminne, South Finland  8.7.  
19.8.  
740 
360 
2006  Mekrijärvi, East Finland  29.6.-1.7. 1639 
2007 Sotkamo, Kainuu 21.8.-22.8.  800 
 Mekrijärvi, East Finland  23.8.-25.8.  560 
2008 Mekrijärvi, East Finland  22.-24.8.  1639 
2009 Inkoo, South Finland  14.9.  90 
 Mekrijärvi, East Finland  17.-19.8. 1500 
   11,430 mosquitoes and 
670 mosquito larvae 
 
 
6.2 Serological methods (original publications I, III and IV) 
IFA (I, III, IV)  
Vero E6 cells were grown in 75 cm2 cell culture bottles (Greinerbio-one, Germany) and 
were infected with the selected virus when 80-90% confluent. The cell monolayers were 
washed with PBS and incubated at 37°C for one hour with 400 μl of virus suspension (final 
concentration 500-1000 pfu per 1 ml) before adding 20 ml Eagle’s minimal essential 
medium (MEM) media. The cells were harvested with trypsin-EDTA after 24 hours. The 
cells were washed 3 times with PBS before suspending in 7 ml of the final concentration, 
and 20 μl were added to each well on slides (Immuno-cell). The slides were air dried and 
fixed with acetone for 7 minutes.  
 
An IFA test was used to screen Inkoo virus IgG and IgM antibodies from human serum 
samples. In addition, California, Bunyamwera and Simbu serogroup IgG antibodies from 
hare, dog, rodent and horse whole blood and serum samples were screened with an IFA 
test. IgG and IgM tests were performed by incubating the serum/blood dilutions at 37°C 
for one and four hours, respectively. The slides were washed with cold PBS, stained with 
fluorescein isothiocyanate-conjugated anti-human IgG or IgM (Jackson ImmunoResearch 
laboratories) for 30 minutes at 37°C and washed with PBS before examining with a 
fluorescence microscope. 
 
CPE neutralization tests (I, IV) 
A mini-scale neutralization test was performed in 96-well plates, where Vero E6 cells 
were grown to full confluence. Selected viruses were diluted to optimal concentrations 
(500 to 1,000 PFU per ml), and serum samples were first inactivated for 10 min in 50°C 
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and then serially twofold diluted starting from 1:20. Serum dilutions and diluted viruses 
were combined in a 1:1 ratio, incubated for 1 h at +37°C, and then added to the cells for 1 
h. The cells were inoculated with the virus-serum suspensions and observed after 2 days 
to detect CPE. The neutralization titre was defined as the final serum dilution that 
completely inhibited the cytopathogenic effect (CPE). A CPE neutralization test was used 
to screen California, Bunyamwera and Simbu serogroup antibodies from deer blood 
samples. 
 
Plaque reduction neutralization test (PRNT) (III, IV)  
PRNT test protocol followed that described for the CPE neutralization test. The only 
exception is that Vero E6 cells were grown on 6-well plates to full confluence. After both 
incubations, the virus serum dilution suspensions were removed before 3 ml cell media 
(EMEM) agar solution was added containing a 1% low-melting-point agarose, antibiotics, 
glutamine and 10% FBS. The plaques were counted after 3–7 days by crystal violet 
staining. The titre was defined as the final dilution that reduced 60% of the plaques. PRNT 
was used to confirm the IFA and CPE neutralization results. 
 
6.3 Virus isolation attempts (original publications II and III) 
For isolation attempts from mosquito samples, green monkey kidney cells (Vero cells, 
ATCC CCL-81™) and Aedes albopictus clone C6/36 cells were used for cell-culture 
screening, while for human serum samples, Vero E6 cells (CRL-1586™) were used. Both 
Vero cell lines were grown at 5% CO2 at 37°C, and C6/36 cells were grown at room 
temperature to 80–90% confluence in a cell monolayer in 25 cm2 flasks.  
 
For infection, 200 μl of the unfiltered mosquito suspension was added to Vero cells, and 
filtrated suspension was added to C6/36 cells. One hundred microliters of serum samples 
were used to infect Vero E6 cells. The samples were incubated on cells under cell culture 
conditions for 1 hour before media was added. The media used for both Vero cells was 
EMEM with foetal bovine serum to a final concentration of 2% and glutamine, penicillin, 
and streptomycin. C6/36 cells were grown on L-15 media with 2% foetal bovine serum 
and antibiotics. The media were changed after one day, and the cells were observed daily 
for the occurrence of (CPE) during a two-week cultivation period. After two weeks, if no 
CPE was observed earlier, 3 aliquots of supernatant were stored at -70°C, and the cells 
were harvested to produce IFA slides from all samples. 
 
IFA slides were prepared as described earlier and stained using a selected panel of 
antisera of the genera Alphavirus (Sindbis-virus), Flavivirus and Orthobunyavirus 
(California serogroup (Tahyna polyclonal) and bunyamwera serogroup (Batai polyclonal)). 
The slides were stained by incubating first with antisera followed by anti-human IgG or 
anti-mouse FITC conjugate. The slides were investigated with a fluorescence microscope. 
If CPE was observed, an additional 10 μl of supernatant was used for EM studies. For EM 
studies, the samples were placed onto copper grids and were negatively stained with 2% 
KPTA tungstophosphoric acid (pH 6.0) and inspected with a transmission electron 
microscope (JEOL JEM-1400). 
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6.4 Molecular methods 
6.4.1 PCR methods for screening (original publications II and III) 
New virus isolates were initially confirmed with RT-PCR and, if positive, with sequencing. 
Total RNA was extracted using a QIAamp viral RNA mini kit (Qiagen) according to the 
manufacturer’s instructions. Reverse transcription was performed using Expand Reverse 
Transcriptase with the specific PCR primers Ink-S-FP 5′-agt agt gtg ctc cac ttg aat act and 
Ink-S-RP 5′-agt agt gtg ctc cac tga ata cat tt. The PCR was performed using Taq DNA 
polymerase with standard PCR protocols with the same primers. 
 
Human serum samples of IgM-positive patients were screened with previously published 
PCR methods (Kuno et al. 1996, Fischer et al. 2013) that were modified to the Phusion 
flash PCR format. The PCR methods targeted regions of both the S and L segments. 
 
6.4.2 Sequencing (original publication II) 
All new virus isolates were grown in Cellmaster roller bottles (Greiner Bio-one) to gain a 
maximum amount of virus in the supernatant. The supernatant was ultracentrifuged for 
20 hours at 24 000 rpm in an SW28 rotor, and the virus pellet was eluted in 200 μl TNE 
buffer (10 mM Tris-HCl, 1 mM EDTA, 150 mM NaCl). RNA was extracted as previously 
described using a Qiagen QIAamp viral RNA mini kit. 
 
Sequencing primers for the complete S segment were Ink-S-FP 5′-agt agt gtg ctc cac ttg 
aat act and Ink-S-RP 5′-agt agt gtg ctc cac tga ata cat tt, and for the M segment, the 
primers were published previously (Campbell, Huang 1999). The beginning of the L 
segment was sequenced with the primers L-548 5′-tga aag tcg cac atg gtg at and L-3801 
5′-tgc gca atc tcc tac aga tg. The last part of the L segment was sequenced using the 
primers in Appendix 2.  
  
Sanger sequencing was used to complete sequencing of the S segment and the end of the 
L segment. Next-generation sequencing was performed with a 454 GS FLX genome 
sequencer using Titanium chemistry (Roche) as an outsourcing service at the Institute of 
Biotechnology, University of Helsinki and used for sequencing of the complete M gene 
and the beginning of the L segment. 
 
6.4.3 Genomic and phylogenetic analysis (original publication II) 
The Lasergene Seqman programme was used for raw data sequence analysis, and Mega5 
(Molecular Evolutionary Genetics Analysis program), available online at 
http://megasoftware.net/ was used to obtain the similarity data. 
Multiple alignments of the nucleotide sequences were calculated with the Clustal W 
programme, and phylogenetic trees were constructed by a Bayesian approach as 
implemented in the programme BEAST. 
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6.5 Viral protein expression and metabolic labelling (original 
publication I) 
INKV RNA extraction and reverse transcription was performed as described above. The N, 
Gc and Gn protein coding regions were produced by PCR with specific primers containing 
suitable restriction sites. PCR products were digested, purified and ligated into the 
pAcYML1 vector, and constructs were transformed into E. coli DH5α. Bacteria containing 
the correct constructs were grown on a larger scale, and purified plasmids were 
transfected with baculovirus DNA and applied to Spodoptera frugiperda cells (Sf-9). Sf-9 
cells expressing the correct proteins were harvested and used for the production of IFA 
slides or immunoprecipitation. 
 
Native virus and expressed proteins were labelled with 50 μCi/ml L-[35S] methionine and 
cysteine or 50 μCi/ml L-[35S] methionine (Amersham Pharmacia Biotech) and 
immunoprecipitated with selected antibodies. Acute and convalescent serum samples 
and mouse hyperimmune ascites fluid (MHAF) were used. Briefly, infected cells were 
harvested after labelling, lysed and incubated with antibodies overnight. The proteins 
were allowed to bind with 20% G-Sepharose, subjected to sodium dodecyl sulfate-10% 
polyacrylamide gel electrophoresis, transferred to membranes, and detected on an X-ray 
film. 
 
 
7 Results and discussion 
7.1 Serodiagnostics 
7.1.1 IgG and IgM IFA test for detecting California encephalitis virus 
infections (I) 
A serological test was established to detect California serogroup virus antibodies from 
serum, blood and CFS samples. The test is used to detect IgG and IgM antibodies; the 
sensitivity, 87.5%, and the specificity, 90.7%, was determined by the gold standard 
neutralization assay. An IFA test is easy to perform in the laboratory compared to 
traditional NT and HI tests, and the results are obtained faster (within the same day); 
therefore, IFA using INKV-infected Vero E6 cells was established for routine laboratory 
use. The INKV IgG IFA assay was able to separate acute infection from pre-existing 
immunity with a distinct fluorescence pattern. Fluorescence of the acute phase serum 
appeared granular within the cell (figure 6b), while the fluorescence from previously 
immune serum was diffused throughout the entire infected cell (figure 6a). These results 
were also confirmed by protein-specific assays and immunoprecipitation assays. A similar 
IFA pattern was observed with other Bunyaviridae–family viruses, such as Puumala virus 
(Vapalahti et al. 1995). However, in practice, all suspected acute infections are confirmed 
with INKV IgM IFA. 
 
The advantage of the IFA test is that all viral antigens are present and detected, compared 
with the NT and HI tests, which involve only glycoproteins. N protein is important in 
complement fixation. IFA is also suitable for specifically detecting IgM antibodies, and the 
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hands-on time is much shorter than that for conventional methods. The biggest 
disadvantage of the IFA test is the sensitivity of the assay; some of the infections may 
presumably not be due to Inkoo virus but another California serogroup virus.  
 
 
  
Figure 6. Fluorescence pattern in the INKV IFA test. a) previously immune sample in IgG 
IFA b) acute serum sample in IgG IFA. 
 
In addition to the IFA assay, two different enzyme-linked immunosorbent assays (ELISAs) 
were established to detect INKV IgM antibodies. INKV-N protein, expressed by a 
baculovirus system, was used as antigen in μ-capture INKV IgM-ELISA, and concentrated 
whole INKV was used for direct ELISA (unpublished data). Both methods for INKV IgM 
antibody detection were sensitive, but the specificity did not reach the required 
standards. Both tests produced false positive results, i.e., cytomegalovirus and Epstein-
Barr virus-positive samples were falsely identified as positive, and still, the cross-reaction 
ability within serogroups seemed lower than in IFA. Additionally, the repetitive 
production of the antigens proved difficult, and the stability in storage remained low 
(unpublished data).  
 
7.1.2 Antibody response in INKV infection (I) 
A baculovirus expression system and immunoprecipitation of the native virus was used in 
more detailed studies of the INKV antibody response, protein specificity and kinetics. 
Expression of the Inkoo virus N, Gc and Gn proteins was conducted to study the different 
fluorescence patterns observed in INKV IgG IFA between acute and previously immune 
serum samples. The successful production of INKV proteins was confirmed by IFA 
staining, where Sf-9 cells with baculovirus-expressed proteins were used as antigens. 
Slides were stained with acute, previously immune and MHAF antibodies (Original 
publication I, figure 4). The antibody response in the acute phase was primarily directed 
towards the N protein, while the response in previously immune samples was primarily 
directed towards glycoproteins (Original publication I, figure 4). Other studies have also 
shown that the antibodies against the N protein are mainly IgM class (Gonzalez-Scarano 
et al. 1982). 
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IFA studies with expressed proteins as antigens showed clearly how acute sera recognized 
only N protein and previously immune sera recognized Gc protein. The Gn protein 
expression level was presumably too low for the IFA format. Only high-titre mouse ascites 
could give a positive fluorescent signal. Gc protein fusion was feasible in transfected or 
infected Sf-9 cells. Sf-9 cells were fused during infection with recombinant baculovirus 
expressing the Gc protein, but a similar phenomenon was not observed with N and Gn 
protein constructs. Fusion was visible not only during cell culture (figure 7) but also in IFA 
slides (Original publication I, figure 4), although the cells were washed and suspended 
several times before fixing to the slides. A good production level of N proteins and the 
ability to recognize IgM antibodies give a good basis to use the protein as an antigen in 
IgM tests despite the fact the N protein cross-reacts between all California serogroup 
viruses. The Gc protein is needed for tests used in seroprevalence studies and to 
distinguish viruses in the serogroup from each other. 
 
   
Figure 7. Sf-9 cells infected with baculovirus expressing a) INKV Gc protein b) INKV Gn 
protein and c) INKV N protein. 
 
Similar to the results of IFAs using INKV protein-expressing cells, immunoprecipitation 
with acute and previously immune human serum samples demonstrated that the 
antibody response against the N protein is prevalent in acute infection and eventually the 
response develops against glycoproteins (original publication I, figure 5). IgM-positive 
samples were able to precipitate strongly with N protein (original publication I, figure 5a). 
However, when infection progressed, immunoprecipitation showed that the N protein 
response remained but weakened (original publication I, figure 5b). When evaluating the 
ratio between the N and Gc protein antibody response intensities, the value was smaller 
in the acute phase than in samples from previously infected individuals (original 
publication I, figure 5a and b).  
 
The granular fluorescence pattern seems to occur as a result of N protein packing into the 
inclusion bodies (Tao et al. 1987). Furthermore, electron microscopy analysis has shown 
that the orthobunyavirus RNP has a highly ordered helical appearance, which might also 
be observed in the cytoplasm (Reguera et al. 2013). Because the specific response to N 
protein is strong throughout the acute infection, these structures are observed and the 
granular fluorescence pattern is observed in IFA. When a more extensive anti-Gc 
response is developed, the granular fluorescence is overpowered, and the cells 
fluorescence look more diffuse. 
 
43 
 
7.1.3 Seroprevalence of INKV infection in humans (I, IV) 
Seroprevalence proved to be high (40-50%) in the studied populations, which indicates 
that California serogroup viruses frequently circulate in Finland and northern Sweden. 
The seroprevalence in Finland was 51% (males 59%, females 40%, figure 8) and in 
northern Sweden, it was 41% (male 47%, female 35%) (figure 9). The seroprevalence has 
increased in Finland from the previous studies; however, it was already then recognized 
to be high in northern Finland, with an up to 80% prevalence in the rural area of Lapland 
(Brummer-Korvenkontio 1973a). There are no previous data from Sweden of the 
California serogroup virus antibody prevalence in humans. The Ryazan region in Russia 
shares the same seroprevalence (41%) in humans as that observed in our studies. Yet this 
study from Russia did not distinguish the proportions of the total prevalence belonging to 
INKV and TAHV (Butenko et al. 1995). Similar to the INKV prevalence in Finland, TAHV 
infections seem to be frequent in Czechoslovakia, as 60% of the elderly have antibodies 
for TAHV (Hubalek 2008).  
 
 
 
Figure 8. INKV IgG seroprevalence with respect to gender and age in Finland in 2001. 
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Figure 9. INKV IgG seroprevalence with respect to gender and age in northern Sweden in 
2009. 
 
The earlier INKV seroprevalence in southern and central Finland was 16%, in northern 
Finland was 44% and in most northern parts of Lapland was 69% (Brummer-Korvenkontio 
1973a). In our study (figure 10), the seroprevalence differences between hospital districts 
are not as clear. The seroprevalence results show that infections with the California 
serogroup viruses have become more common in Finland. The seroprevalence in most 
districts is between 50-65%. Most likely, migration to the large cities from the countryside 
and the citizens' free time activities in summer cottages even out the differences in 
geographical seroprevalence. However, lacking knowledge on the natural reservoir of 
INKV and the abundance of the vectors, it is difficult to conclude the real reason for the 
current frequency. In addition, there are no real data regarding the CHATV 
seroprevalence in humans. Because there are also acute CHATV human infections 
(Putkuri et al. 2016), CHATV may have played a role in the increasing seroprevalence 
during the last decades. The INKV seroprevalence increased throughout all age groups 
and was somewhat higher in men. In Finland, children under 10 years had a relatively 
high seroprevalence, but the number of samples studied was low (69 out of 1292). The 
data indicate that INKV is encountered early in life and lifelong immunity is gained after 
the infection. 
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Figure 10. Geographical distribution (hospital districts) of INKV seroprevalence in Finland 
in 2001. The seroprevalence of each hospital district is shown as the percentage and total 
number of samples per hospital district. 
7.2 New California serogroup viruses in Finland (II) 
New California serogroup viruses were isolated in cell culture from mosquitoes collected 
in eastern Finland in 2007 and 2008 (original publication II, figure 1 and table 1). 
Altogether, five isolates were recovered in virus isolation attempts on mammalian cells; 
the viruses were named M07-1, M07-2-83, M07-2-84, S07-1 and ILO8-3. All except one of 
the positive isolates were collected in 2007; three of them originated from the Ilomantsi 
region in eastern Finland, and one was from the Sotkamo region. Only one isolate was 
obtained in 2008 from mosquitoes collected in the Ilomatsi region (original publication II, 
table 1). The first of these virus isolates was obtained from mosquitoes collected in 
Möhkö village of Ilomantsi, designating these as "Möhkö isolates". Since the collected 
mosquitoes were pooled in the process without prior entomological identification, little 
information is known about the host vectors. Suggestive results indicate that 
Ochlerotatus sp. and Aedes sp. mosquitoes are the most likely host vectors.  
 
Morphologically, Möhkö isolates were similar with other viruses in family Bunyaviridae 
(figure 11). The virus particles were round and 80-110 nm in diameter. Sequencing 
revealed that the open reading frames (ORFs) of the S, M and L segments were 707 bp, 
4328 bp and 6791 bp, respectively. The S segment was found to encode the putative ORF 
for the N and NSs proteins (235 and 79 amino acids); the M segment Gn, NSm and Gc 
proteins (299, 156, and 983 amino acids); and the L segment RNA polymerase coding 
region (2264 amino acids). All isolates were very similar, differing by less than 2% at the 
amino acid level from each other. 
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Figure 11. Electron microscopy image of Chatanga virus Möhkö isolate.  
Segment similarity studies showed that the isolates had the highest similarity with CHATV 
(Table 3-5), which was originally found in mosquitoes collected in Taymarya, Russia in 
1985 (Lavrent'ev et al. 2008). The N protein amino acid sequence similarity was less than 
10% compared to other CEV isolates; therefore, as ICTV instructions indicate, the Möhkö 
isolates do not represent a new species in the genus. Instead, Möhkö isolates represent a 
new strain of CHATV. In Russia, a large quantity of viruses has been isolated from 
mosquitoes collected between 1985 and 1991; a total of 45 isolates of CHATV have been 
recovered thus far from mosquitoes collected throughout Russia (all sequences found in 
GenBank at NCBI). Finnish CHATV isolates were closely related to viruses isolated from 
the Komi region and areas close to Finland (Karelia, Archangel, and Murmansk). Yet, the 
amino acid identities with all CHATV isolates were at least 95,3%, 89,4% and 97,6% for N 
protein, glycoprotein and RNA polymerase, respectively (Table 3-5). When compared to 
the rest of the California serogroup viruses, Möhkö isolates proved to be most similar to 
SSHV and LACV. 
 
Phylogenetic analysis based on the S segment and the partial M segment demonstrated 
that the CHATV isolates form 4 phylogroups instead of 3 in contrast to previous studies 
(figure 12) (Lavrent'ev et al. 2008, Poglazov, Shliapnikova & Prilipov 2011). The CHATV 
isolates close to Finland’s eastern border formed their own phylogroup with the Möhkö 
isolates (phylogroup 1, Möhkö phylogroup)(original publication II, figure 3). In addition, 
phylogroup 3 could be divided into two subgroups, a and b; however, this was based on 
only S and partial M segment analysis since the isolates from group 3a were not fully 
sequenced and comparison analysis with these viruses could not be performed with 
complete M and L segments (original publication II, figure 3).  
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Table 3. L segment (longer than the ORF of RNA polymerase) amino acid similarity (%) 
within the California serogroup, including all Möhkö isolates from Finland. The isolates 
named LEIV-15854, LEIV- 17756, LEIV-18733 and LEIV-22712 are different Chatanga virus 
isolates from Russia, and ILO8-3, M07-1, M07-2-83, M07-2-84 and S07-2 are different 
Möhkö isolates from Finland.  
 
 
 
The phylogroups seemed to have some geographic association (original publication II, 
figure 1). Only the Tyumen region in Russia had several isolates from different 
phylogroups circulating in the same area. Phylogroup 1 (Möhkö phylogroup) circulates in 
eastern Finland and western parts of Russia, phylogroup 2 in eastern Russia and northern 
parts of east Siberia (north Yakutia), phylogroup 3a in southern Siberia (Altai), 3b in 
southern parts of east Siberia (south Yakutia) and phylogroup 4 in western Siberia 
(Tyumen) (Lavrent'ev et al. 2008). Phylogenetic analysis confirmed that CHATV strains are 
more closely related to the California serogroup viruses circulating mostly in USA and 
previously known to belong to California encephalitis virus complex. Additionally, INKV is 
more distinct from CHATV than the third European representative of the California 
serogroup, TAHV. Interestingly, the closest of both viruses circulating in Finland are found 
in the USA. INKV is almost identical with JCV, and CHATV shares 86-96% of the genome 
similarity with SSHV (Putkuri et al. 2014, Vapalahti et al. 1996). It is possible that CHATV 
originates from SSHV, the distribution of has been thought to reach Russia based on the 
serological data. However, the genomic similarity of SSHV to CHATV might have caused 
the cross-reaction and the false result of SSHV existence in Russia.  
 
 
 INKV JCV TAHV LEIV- 15854 
LEIV- 
17756 
LEIV- 
18733 
LEIV- 
22712 SSHV LACV ILO8-3 M07-1 M07-2-83 M07-2-84 S07-2 
INKV ID 96,7 82,4 83,1 83,0 83,0 83,2  83,0  82,9  83,1  82,9  82,9  83,0  82,9  
JCV 96,7  ID 83,1  83,3  83,2  83,3  83,2  83,3  83,4  83,2  83,1  83,1  83,2  83,1  
TAHV 82,4  83,1  ID 89,3  89,6  89,7  89,1  89,9  89,1  89,3  89,2  89,2  89,3  89,2  
LEIV-15854 83,1  83,3  89,3  ID 97,9  97,9  97,8  95,9  93,9  99,6  99,3  99,3  99,4  99,3  
LEIV-17756 83,0  83,2  89,6  97,9  ID 99,5  98,1  96,0  93,6  97,8  97,7  97,7  97,7  97,7  
LEIV-18733 83,0  83,3  89,7  97,9  99,5  ID 98,0  96,1  93,7  97,8  97,7  97,7  97,7  97,7  
LEIV-22712 83,2  83,2  89,1  97,8  98,1  98,0  ID 95,4  93,6  97,7  97,7  97,6  97,7  97,6  
SSHV 83,0  83,3  89,9  95,9  96,0  96,1  95,4  ID 94,6  96,0  95,9  95,8  95,9  95,8  
LACV 82,9  83,4  89,1  93,9  93,6  93,7  93,6  94,6  ID 93,9  93,7  93,7  93,8  93,7  
ILO8-3 83,1  83,2  89,3  99,6  97,8  97,8  97,7  96,0  93,9  ID 99,5  99,5  99,6  99,5  
M07-1 82,9  83,1  89,2  99,3  97,7  97,7  97,7  95,9  93,7  99,5  ID 99,7  99,8  99,8  
M07-2-83 82,9  83,1  89,2  99,3  97,7  97,7  97,6  95,8  93,7  99,5  99,7  ID 99,8  99,7  
M07-2-84 83,0  83,2  89,3  99,4  97,7  97,7  97,7  95,9  93,8  99,6  99,8  99,8  ID 99,8  
S07-2 82,9  83,1  89,2  99,3  97,7  97,7  97,6  95,8  93,7  99,5  99,8  99,7  99,8  ID 
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The principal host for CHATV is not known. The SSHV host Lepus americanus (Burgdorfer, 
Newhouse & Thomas 1961) is widespread in North America, whereas Lepus timidus 
(mountain hare) is found from eastern Siberia to Fennoscandia. The geographic range of 
Lepus timidus seems to resemble CHATV distribution. Molecular clock analysis shows that 
these viruses seem to have had intercontinental spread, and according to M segment 
phylogeny, the direction might have been from North America (with more ancestral 
nodes) to northeast Russia (unpublished data). It could be possible that the host switch of 
SSHV from Lepus americanus to Lepus timidus has created CHATV, which has evolved 
later. However, the S and L phylogenies show the American and European snowshoe 
hare-like viruses as sister taxa without the ability to confirm the direction of the 
intercontinental spread. The vertebrate host of INKV is still unclear, but it is most likely a 
bigger mammal, such as moose or deer. Because INKV is closely related to Jamestown 
canyon virus, the vertebrate host of which is known to be white-tailed deer, it is tempting 
to speculate whether the ancestor of INKV (aka JCV) was introduced to Finland when the 
Minnesota Finns Deer Committee gave white-tailed deer as a gift to Finland in 1934 and 
1948 and that the virus has then adapted to the local deer/moose population and 
mutated into INKV. 
 
Möhkö prototype isolate (M07-1) was compared using cross-neutralization and 
haemagglutination inhibition analysis to INKV, SSHV and TAHV viruses, and INKV and 
TAHV antibodies antibodies were used (original publication II, Table 3). The results 
confirm that Möhkö isolates belong to the California serogroup (could be neutralized by 
other virus antibodies), but the titre difference between the viruses remained small. 
Clearer results could be achieved if specific antibodies against each tested virus were 
available. The infectivity of prototype Möhkö isolate(s) was tested with different cell 
types, and the result did not differ from those obtained with INKV.  
 
With regard to the vector species of Möhkö isolates, the retrospective genetic 
identification of the mosquito species suggests that the vector(s) most probably belong to 
Ochlerotatus (former Aedes species) or Aedes species. Most of the cox I clone sequences 
obtained from MÖHKV-positive pools resembled Ochlerotatus cantans, Ochlerotatus 
annulipes or Aedes cinereus, which therefore could be the possible host vector. However, 
Ochlerotatus punctor and Ochlerotatus communis, which are the primary vectors for 
INKV, cannot be excluded either. The results are approximate because the studied 
mosquitoes were pooled. The mosquito population density is the largest during the 
midsummer, and yet it seems that the MÖHKV prevalence in mosquitoes seems to be 
highest at the end of the autumn. 
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Figure 12. Phylogenetic tree of a partial S segment (length 596 nucleotides) of California 
serogroup viruses (unpublished results). The phylogenetic tree was constructed using the 
neighbour-joining method.  
 
 
California encephalitis group viruses are capable of forming reassortments between virus 
isolates. European CEV have appear to circulate in distinct areas. TAHV is circulating in 
central Europe, Norway and European Russia; INKV circulates in Scandinavia and western 
Russia; and SSHV circulates in northern Russia. Thus, European Russia and Norway have 
been the only places in Europe where more than one of these viruses have been reported 
to circulate in the same area. Here, we demonstrate that Finland is also an area where 
two California encephalitis virus isolates circulate – or at least have been circulating. 
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7.3 INKV and CHATV infections in humans (III) 
7.3.1 Frequency of acute infections in humans 
Serum samples from selected patient groups were screened for INKV IgM antibodies in 
order to study the frequency of acute Inkoo virus infection. The samples were initially 
screened for the causative agents of CNS infection (HSV1, HSV2, HHV6, VZV, Mycoplasma 
pneumoniae), Puumala virus or specifically for INKV during the mosquito season. Study 
material had been collected since 2001, and 7961 serum and 832 CSF samples were 
tested. In total, 15 IgM-positive patients were identified by screening of serum samples, 
five of those with suspected Puumala virus infection and nine with neurological 
symptoms. One patient sample was sent to the laboratory specifically for INKV antibody 
testing, and it tested positive. All CSF samples screened were negative. Data from two 
acute Inkoo virus infections identified earlier in 1976 and 1980 were also included. The 
case reports of these patients had been published earlier in a domestic medical journal 
(Putkuri et al. 2004). 
 
The serological results were confirmed with a neutralization test. Interestingly, among the 
15 IgM-positive samples both INKV and CHATV positivity was confirmed by PRNT (Table 
6). INKV was more prevalent (14/17); however, at least 2/17 patients were confirmed as 
CHATV-positive; the titre was 4 times higher than with the other viruses. This is the first 
time that CHATV has been shown to infect humans. The titre difference in one sample did 
not reach the 4-fold level required to meet diagnostic criteria, but presumably, this 
patient has had CHATV infection rather than INKV since no travel history was found in the 
patient files. 
  
The IgG and IgM titres varied considerably between samples. All but two individuals 
already had IgG antibodies at the time they were identified as IgM-positive. The 
neutralisation titre was higher than 20 000 in one of the CHATV-positive samples (Table 
6). 
 
The annual number of samples, age range and gender ratio of the IgM-positive cases is 
shown in original publication III in Table 1. The frequency of acute INKV and CHATV 
infections in the studied patient groups in Finland varied from 0 to 5 cases per year. The 
percentage of IgM-positive serum samples among patients with CNS symptoms, 
suspected Puumala virus or INKV infection were 0,21% (9/4214), 0,14% (5/3574) and 
0,58% (1/173), respectively. In comparison diagnosed LACV infections in the USA can 
reach up to 200 cases annually; 50-200 cases have been diagnosed annually between 
1964 and 2013 (data published by CDC), while 5-20 clinical TAHV infections are diagnosed 
annually (Hubalek 2008, Sluka 1969). Other CEV isolates are less frequently diagnosed 
and associated with clinical disease (SSHV and JCV) in North America. In our study, the 
number of acute INKV and CHATV infections found annually in Finland was comparable to 
that of LACV infections in the USA.  
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Table 6. Serological analysis of all IgM-positive patient samples. The table shows the IgG 
and IgM IFA results and the plaque reduction neutralization test results for INKV, TAHV 
and CHATV. 
 
 
IgG 
IFA 
titre 
IgM IFA 
titre 
PRNT50 titre 
INKV CHATV TAHV 
1 160 160 320 40 40 
3 120 40 320 40 40 
5 † 160 +/ND ND ND ND 
6 † 320 +/ ND ND ND ND 
7 80 >320 >640 40 80 
8 320 40 320 <20 <20 
9 80 80 160 40 <40 
10 40 20 160 20 40 
11 320 >320 320 40 80 
12 <20 40 320 20 40 
13 160 120 160 40 40 
14 <20 120 >640 <20 20 
15 320 120 640 40 40 
17 80 30 320 <20 <20 
16 960 40 1280  5120 1280 
2 80 40 320 640 40 
4 >640 >320 320  20480 5120 
 
 
The majority of the IgM-positive cases (88%) were detected in August or later. This 
indicates that INKV and CHATV are spread mainly by horizontal transmission; the number 
of infected mosquitoes increases during the summer months, when more mosquitoes 
come in contact with the amplifying hosts. However, there is some evidence of 
transovarial transmission since reports from Russia show another peak of acute cases in 
May, which could mean the first generation of mosquitoes hatched from eggs are 
carrying the virus (Butenko et al. 1995). LACV is transmitted by both horizontal and 
vertical transmission, and acute human cases are found in all summer months (Haddow, 
Odoi 2009).  
 
La Crosse virus infection is a well-known arboviral neuroinvasive disease in children in the 
USA, and the majority of the reported acute SSHV infections have also been diagnosed in 
children under 10 years old (Grimstad et al. 1982, Fauvel et al. 1980, Meier-Stephenson et 
al. 2007, Embil, Camfield & Artsob 1985, Embil et al. 1982, Artsob 1985) or in young 
adults (Artsob et al. 1981). A recent study showed that JCV is a more important pathogen 
for adults based on the number of acute cases; 84% of the acute cases found were in 
individuals over 20 years old (Pastula et al. 2015). In our study, acute Inkoo virus 
infections were found in all age groups, and the age range of the patients was from 7 to 
81 years. IgM antibodies to INKV were most commonly observed in patients under 19  
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Table 7. Confirmed INKV and CHATV infections found in samples collected between 2001 
and 2013 shown by age group, sex of the patients and geographical distribution. Modified 
from Table 2 from original publication III. 
Variables  INKV 
infection 
CHATV 
infection 
Positivity 
rate Age range  Total no. of patients 
0-9  670 1 - 0,15 
10-19  717 2 - 0,28 
20-29  905 - - - 
30-39  1062 1 - 0,10 
40-49  1180 2 1 0,25 
50-59  1377 5 1 0,44 
60-69  1093 1 - 0,09 
>70  957 - 1 0,11 
Sex  N  
Female  3786 8 - 0,21 
Male  4129 4 3 0,17 
Region  N    
Lappi 118 - - - 
Länsi-Pohja 19 - - - 
Kainuu 162 - - - 
Pohjois-Pohjanmaa 29 - - - 
Keski-Pohjanmaa 131 - - - 
Etelä-Pohjanmaa 75 - - - 
Pohjois-Karjala 338 - 1 0,30 
Pohjois-Savo 88 - - - 
Itä-Savo 122 2 - 1,63 
Etelä-Karjala 117 - - - 
Etelä-Savo 146 - - - 
Keski-Suomi 722 1 - 0,14 
Vaasa 152 - - - 
Satakunta 41 - - - 
Pirkanmaa 331 - 1 0,30 
Kanta-Häme 309 - - - 
Päijät-Häme 256 1 - 0,39 
Kymenlaakso 419 - - - 
Uusimaa 4311 8 1 0,21 
Varsinais-Suomi 5 - - - 
Ahvenanmaa 70 - - - 
-; no cases, INKV=Inkoo virus, CHATV=Chatanga virus. 
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years (20%) or those between 50 and 59 (33%) (Table 7). Previous studies have shown 
that 80-90% of La Crosse virus infections occur in children under 15 years, and 
approximately 65% occur in males (Haddow, Odoi 2009, Kappus et al. 1983). Only 20% of 
the acute INKV cases were identified in children under 16 years, but the disease seemed 
more severe. The INKV infection risk did not seem generally higher in males; the gender 
distribution was even (8 females, 6 males). Yet 3 out 4 children with INKV infection were 
males. In contrast, the CHATV cases were all male patients over 40 years old (Table 7 and 
original publication III, table 4).  
 
Geographically, most of the confirmed cases were from southern Finland (9/15) (Table 7 
and original publication III, figure 1). However, in our study 54% of samples were 
collected in health care settings in southern Finland. The highest cluster of cases was in 
the Helsinki region, but the positivity rate in this region was below avarage (Table 7). Only 
4% of the samples were from northern parts of Finland (Lappi), where at least 60% of the 
population has previously been shown to be infected with INKV (Table 7). If we are able 
to identify acute CEV cases from the lowest seroprevalence areas annually, it is 
reasonable to assume that in northern Finland, acute cases could more prevalent. 
Interestingly, in eastern Finland the positivity rate was 7 times higher in certain areas (Itä-
Savo) compared to southern Finland. The low IgM prevalence in selected patient groups 
could indicate that INKV and CHATV infections are mostly mild infections and rarely 
require visits to health care facilities. However, the true incidence rate remains to be 
studied when more samples are investigated from other regions of Finland. In 
comparison, the LACV mean incidence risk is 30,2 per 100 000 persons for children 15 
years and younger (Haddow, Odoi 2009, Kappus et al. 1983).    
 
 
7.3.2 Clinical characteristics of the acute disease in humans 
A clinical history of 17 patients with acute Inkoo virus or Chatanga virus infection was 
reviewed from medical notes. Most of the patients with acute INKV and CHATV infection 
were not hospitalized. Most of the patients (10/17) were treated because of some other 
diagnosed infectious diseases or underlying disease, but the role of INKV or CHATV 
infection in these patients is unclear. Patients who presented symptoms that were likely 
due to acute INKV or CHATV infections (7/17) did not have any other underlying disease 
or laboratory findings implying another infection (Table 3 from original publication III). 
One patient out of the 7 presumed acute INKV and CHATV infections visited an outpatient 
clinic presenting fever and flu-like illness and recovered fully after 3 days. The rest of the 
patients (6/7) were hospitalized, and the patient histories are presented in table 8.  
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Table 8. Patient histories of the hospitalized INKV and CHATV IgM-positive patients. 
Modified from table 4 from original publication III. 
Patient 
history 1  INKV 2  INKV 3  INKV 4  INKV 1  CHATV 2  CHATV 
8 years old 
 
Day 1:  Fever, 
38°C, flu-like 
symptoms 
 
Day 3:  
Disoriented 
 
Day 6: 
Hospitalized, 
abnormal EEG 
CAL IgM+ 
 
Day 7: Psychotic, 
compulsory 
thoughts, 
discharged 
 
Day 10: EEG: still 
same 
abnormalities 
 
3 months later: 
EEG almost 
normal 
17 years old 
 
Day 1: Fever, 
39.5°C, headache, 
nuchal rigidity. Sore 
throat before fever 
=> Hospitalized 
 
Day 2: Nuchal 
rigidity and 
headache 
deteriorating. 
Slowness, yet 
oriented 
 
Day 3: Discharged 
CAL IgM+ 
 
Day 5: Headache 
again => 
hospitalized. Still no 
abnormal laboratory 
findings. 
 
Day 6: Discharged 
again 
12 years old 
 
Day 1: Vomiting 
=> Hospitalized 
 
Day 2: Stomach 
pain, diarrhoea, 
seizures 
 
Day 3: Fever, 
38.3°C, 
drowsiness, 
convulsions 
 
Day 4: More 
seizures, small 
changes in EEG 
 
Day 5:  CAL IgM+ 
 
Day 8: 
Discharged 
16 years old 
 
Day 1: Fever, 
37.9°C, sore throat 
 
Day 3:  CAL IgM+ 
 
Day 4: Nausea and 
vomiting 
 
Day 5: Fever, 
39°C, headache, 
nuchal rigidity => 
hospitalized 
 
Day 10: Recovered 
totally, discharged 
82 years old 
 
Day 1: 
Vomiting 
continues for 3 
days 
 
Day 4: Fever 
=> 
Hospitalized, 
disoriented 
during night 
 
Day 7: Frontal 
headache. 
Head CT 
normal, 
abdominal 
ultrasound 
normal 
 
Day 12: 
Discharged, 
CAL IgM+ 
54 years old 
Back injury 
two weeks 
earlier 
 
Day 1: Fever 
39°C, back 
pain 
 
Day 7: 
Hospitalized, 
high fever, 
back pain 
almost 
resolved 
 
Day 7-22: 
Temporal 
pain, 
trembling of 
hands, 
fluctuating 
fever 
 
Day 17: CAL 
IgM+ 
 
Day 23: 
Discharged 
  
  
  
  
  
  
  
  
 
The patient histories from these six patients indicated they presented to the hospital with 
febrile or flu-like symptoms (table 8). In our study, the most prominent symptom was 
fever (6/6), often together with sore throat. Other symptoms included headache (5/6), 
nausea and/or vomiting (3/6), disorientation (2/6), nuchal rigidity (2/6) and drowsiness 
(1/6). Seizures were present in one patient, whereas LACV infection is associated more 
often with seizures (46%; (McJunkin et al. 2001)). These symptoms are in line with the 
clinical characteristics of other CEV infections (LACV, JCV, TAHV) in humans (Pastula et al. 
2015, Sluka 1969, McJunkin et al. 2001). 
 
 
Adults suffered febrile illness, in contrast to children, who had CNS symptoms. 
Hospitalization was required in 6 out of 7 cases because of the acute INKV or CHATV 
infection. All hospitalized patients recovered fully. Most importantly, all children under 16 
years with acute INKV infection were hospitalized because of more severe disease. This 
resembles the features of neuroinvasive LACV infection (Haddow, Odoi 2009). Yet, all 
children were discharged within one week from admission, similar to the duration of 
illness from LACV infection, which typically lasts from 3 to 9 days (McJunkin et al. 2001). 
Adult patients with acute INKV infections in our study visited outpatient clinics only and 
did not require hospitalization.  
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In contrast to INKV infection, acute CHATV infection was found only in adults. In addition, 
2 out of 3 patients were hospitalized, and the hospital stay took more than a week before 
the patients recovered fully. CHATV infection somewhat resamples JCV infection, which 
also infects more adults (Pastula et al. 2015). However, JCV has been shown to cause 
meningoencephalitis in 65% of cases, whereas no CNS disease was diagnosed among the 
CHATV patients in our study. The most recently published JCV case was a 62-year-old 
male (Rogstad et al. 2015). The clinical picture of this patient was considered viral sepsis 
rather than flu-like illness or neuroinvasive disease, differing from the previous findings. 
Taking this into consideration, our patient material was highly selective and concentrated 
on finding CNS disease. The frequency of acute infections was low, and it raised the 
question of whether these viruses can be associated with symptoms other than those 
experienced by the patients included in our material. 
 
In our study, co-infections with other pathogens were quite usual (6/17). Few patients 
were coinfected with herpes virus (cold sores), which has also been described in TAHV 
infections (Sluka 1969). In addition, acute Puumala virus infection, an Escherichia coli 
urosepsis and impetigo contagiosa were diagnosed. Studies in Russia indicated that mixed 
infections generated more severe INKV infection (Demikhov, Chaitsev 1995). Other 
infectious diseases and trauma seem to predispose patients to INKV infection. This may 
reflect the inability of INKV to infect healthy adults, which would explain why the virus is 
associated with more severe disease in children. Weakening of the immune system of 
adults might be necessary for INKV to cause clinical disease.  
 
None of our IgM-positive samples were PCR-positive; therefore, virus isolation from 
humans or isolated INKV or CHATV RNA from human samples remains unsuccessful. This 
would be important since LACV strains isolated from fatal cases have shown that the 
human isolates form one separate linage together with mosquito isolates obtained from 
the same area (Huang et al. 1997, Lambert et al. 2015). This indicates that a restricted 
range of LACV genotypes is associated with severe clinical cases. This could also be the 
case with INKV and CHATV; only certain strains with a low frequency in mosquitoes might 
be responsible for the acute infections that require medical attention.        
 
8 Concluding remarks and future prospects 
The Californian serogroup includes important human pathogens and is widely distributed. 
This serogroup is more well-recognized in the USA, where LACV is the most important 
arbovirus causing CNS disease in children. Elsewhere, the California serogroup has been 
largely forgotten, yet there is an abundance of serological data indicating that these 
viruses commonly infect humans. In our studies, both in Finland and Sweden, the 
seroprevalence in the studied populations reached 50%. Human contact with these 
viruses occurs early in life. 
 
INKV and CHATV are the OBV representatives found in Finland. CHATV was isolated from 
East Finland, yet the true distribution area here requires more research. We established a 
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serological IgG and IgM IFA test to detect these infections and to simplify the current 
diagnostic process. The IgG IFA test could be used solely since it can distinguish serum 
samples from those with acute infections and those with pre-existing immunity using 
distinct fluorescent signals. Serological studies showed that California serogroup virus 
infections are common since the seroprevalence in the studied populations remains high. 
The INKV seroprevalence among humans was shown to already be high when the virus 
was isolated in the 1970s. In our study, there was not as large a geographical difference in 
seroprevalence as there used to be. Although now there are two California serogroup 
viruses circulating in Finland, INKV is still more abundant.  
 
California serogroup virus infections are most often subclinical; however, we showed that 
especially INKV can cause severe disease in children. Like LACV infections in children, CNS 
disease was observed and required hospitalization. Yet the severe cases were rare. For 
the first time, we identified CHATV as a causative agent of summertime febrile disease in 
humans. In contrast to acute INKV infection, CHATV infection was observed in adults. 
Both INKV and CHATV caused fever together with sore throat, nausea and vomiting and 
neurological symptoms including disorientation, nuchal rigidity, headache and/or 
drowsiness. All these symptoms are similar to those described in other California 
serogroup virus infections. 
 
The incidence of INKV infection in children requires further studies. In addition, more 
detailed information about the CHATV geographic distribution as well as the frequency of 
both viruses in mosquitoes would be valuable. These viruses circulate in the same areas 
and evidently cause disease in humans. However, no isolates have been recovered from 
infected humans. These human virus isolates could be useful in understanding why so few 
clinical human cases appear and, when they do, why they manifest as CNS disease. 
Acknowledgements 
This work was carried out at the Department of Virology in Haartman Institute, Faculty of 
Medicine, University of Helsinki. I want to thank my supervisors, Professor Olli Vapalahti 
for the freedom to find my own way to finalize this project, and professor emeritus Antti 
Vaheri for advises and guidance during these years. I would like to thank the head of the 
department, Professor Kalle Saksela, for providing appropritate working facilities and 
good atmosphere. 
 
I would like to express my gratitude to the pre-examiners Docent Heli Harvala and Docent 
Pamela Österlund for their critical and helpful comments and suggestions. Especially I am 
grateful for Heli for giving such an encouraging comments and making me see the latest 
results in a different light. I am grateful to Docent Tarja Sironen for being the “third 
supervisor” for me. Since the article of Möhkö virus you have been more than a co-
author. You were always willing to help and most importantly, your support has been 
invaluable during the past years.  
 
 59 
 
Co-authors Clas Ahlm, Magnus Evander, Satu Kurkela, Lev Levanov, Eili Huhtamo, Ilkka 
Kivistö, Anu Kantele and Markus Brummer-Korvenkontio have been participating in the 
original publications of this thesis and are thanked for their expertise and help.  
 
I’m proud to be a member of the viral zoonosis group and I want to thank the past and 
the present members and all the outliers. You are the reason why coming to work has 
always been fun and easy. Not only work but all the extracurricular activities have made 
the working environment so fruitful and motivating. There was never a reason too small 
for skumppa on Friday at our 4th floor coffee room. 
 
I´m forever grateful to Tytti Manni who introduced me to virus isolation experiments and 
cell work. Thank you for all the knowledge you gave me and the enthusiasm for virus 
isolations you implanted me. I never forget the moment when we first time realised we 
had isolated Californian serogroup virus from mosquitoes although it was just some cells 
giving fluorescent signal on IFA slide. 
 
Leena Kostamovaara, Pirjo Sarjakivi and Irina Suomalainen are thanked for the excellent 
technical assistance as well as the newest members of the lab staff Mira Utriainen, 
Johanna Martikainen and Kirsi Aaltonen. Also I want to thank the employees at HUSLAB 
zoonosis unit for all the help with the serum samples and Irja Luoto for all the EM pictures 
you provided. 
 
I thank the Turku team H222, Piritta Peri and Riikka Österback, for being such a support 
for the past few months and kicking me to finish this thing and reassuring me when I felt 
this was never going to happen. I’m grateful for all the tips you both have given me on 
this road to hell public humiliation examination. 
 
Most of all I would like to thank my friends outside lab and work for their friendship. 
Especially I want to thank Tuija Kokko and Katarina Leivo for dragging me out with the 
dogs to get some fresh air and talking about something else than science. It has been 
convenient to have one friend in Turku and the other in Vantaa. 
 
My family is warmly thanked for their support even though most of the times I probably 
couldn’t explain what I was working on and how my clinical microbiology training and 
research are linked together. Last, thank you Eetu for being there and believing in me 
while I kept changing my plans and constantly moving to different cities in Finland. 
Without you and TennisBall I would have never been able to finish this project. 
 
This work has been financially supported by The Finnish Concordia Fund, 
Laboratoriolääketieteen säätiö, Paulon Foundation, The Finnish Cultural Foundation, 
Virustutkimus säätiö and Niemisäätiö. 
 
 
 
Niina Putkuri   Helsinki, September 2016 
60 
 
References 
Bahig (BAH) strain. Eg B 90, 1970a, The American Journal of Tropical Medicine and 
Hygiene, 19, 6,  Suppl:1147-8.  
 Juan Diaz (JD) strain. MARU 8563, 1970b, The American Journal of Tropical Medicine and 
Hygiene, 19, 6,  Suppl:1149-50.  
 Lokern (LOK) strain. FMS 4332, 1970c, The American Journal of Tropical Medicine and 
Hygiene, 19, 6,  Suppl:1111-2.  
 Tete (TETE) strain. AN 3518, 1970d, The American Journal of Tropical Medicine and 
Hygiene, 19, 6,  Suppl:1159-60.  
 Trubanaman (TRU) strain. MRM 3630, 1970e, The American Journal of Tropical Medicine 
and Hygiene, 19, 6,  Suppl:1101-2.  
Amundson, T.E. & Yuill, T.M. 1981,  Natural La Crosse virus infection in the red fox (Vulpes 
fulva), gray fox (urocyon cinereoargenteus), raccoon (Procyon lotor), and opossum 
(Didelphis virginiana), The American Journal of Tropical Medicine and Hygiene,  30,  
3,  706-714.  
Anderson, C.R., Aitken, T.H., Spence, L.P. & Downs, W.G. 1960,  Kairi virus, a new virus 
from Trinidadian forest mosquitoes, The American Journal of Tropical Medicine and 
Hygiene,  9,  70-72.  
Anderson, C.R., Spence, L., Downs, W.G. & Aitken, T.H. 1961,  Oropouche virus: a new 
human disease agent from Trinidad, West Indies, The American Journal of Tropical 
Medicine and Hygiene,  10,  574-578.  
Anderson, C.R., Spence, L.P., Downs, W.G. & Aitken, T.H. 1960, Manzanilla virus: a new 
virus isolated from the blood of a howler monkey in Trinidad, W.I, The American 
Journal of Tropical Medicine and Hygiene,  9,  78-80.  
Anderson, J.F., Main, A.J., Armstrong, P.M., Andreadis, T.G. & Ferrandino, F.J. 2015, 
Arboviruses in North Dakota, 2003-2006, The American Journal of Tropical Medicine 
and Hygiene,  92,  2,  377-393.  
Andreadis, T.G., Anderson, J.F., Armstrong, P.M. & Main, A.J. 2008,  Isolations of 
Jamestown Canyon virus (Bunyaviridae: Orthobunyavirus) from field-collected 
mosquitoes (Diptera: Culicidae) in Connecticut, USA: a ten-year analysis, 1997-2006, 
Vector borne and zoonotic diseases (Larchmont, N.Y.),  8,  2,  175-188.  
Andreadis, T.G., Armstrong, P.M., Anderson, J.F. & Main, A.J. 2014, Spatial-temporal 
analysis of Cache Valley virus (Bunyaviridae: Orthobunyavirus) infection in 
anopheline and culicine mosquitoes (Diptera: Culicidae) in the northeastern United 
States, 1997-2012, Vector borne and zoonotic diseases (Larchmont, N.Y.),  14,  10,  
763-773.  
Andrews, W.N., Rowley, W.A., Wong, Y.W., Dorsey, D.C. & Hausler, W.J.,Jr 1977,  Isolation 
of trivittatus virus from larvae and adults reared from field-collected larvae of Aedes 
trivittatus (Diptera: Culicidae), Journal of medical entomology,  13,  6,  699-701.  
61 
 
Artsob, H. 1985, Arbovirus activity in Canada in 1984, CMAJ : Canadian Medical 
Association journal = journal de l'Association medicale canadienne,  133,  10,  1026.  
Artsob, H., Spence, L., Caughey, W.C. & Wherrett, J.R. 1981,  Aseptic meningitis in 
Ontario, Canadian Medical Association journal,  125,  9,  958, 962.  
Bakonyi, T., Kolodziejek, J., Rudolf, I., Bercic, R., Nowotny, N. & Hubalek, Z. 2013,  Partial 
genetic characterization of Sedlec virus (Orthobunyavirus, Bunyaviridae), Infection, 
genetics and evolution : journal of molecular epidemiology and evolutionary genetics 
in infectious diseases,  19,  244-249.  
Balducci, M., Verani, P., Lopes, M.C. & Gregorig, B. 1973,  Isolation in italy of bahig and 
matruh viruses (tete group) from migratory birds, Ann. Microbiol.,  124b,  231-237.  
Balfour, H.H.,Jr, Siem, R.A., Bauer, H. & Quie, P.G. 1973,  California arbovirus (La Crosse) 
infection I. Clinical and laboratory findings in 66 children with meningoencephalitis, 
Pediatrics,  52,  5,  680-691.  
Bardos, V. & Danielova, V. 1959,  The Tahyna virus--a virus isolated from mosquitoes in 
Czechoslovakia, Journal of hygiene, epidemiology, microbiology, and immunology,  3,  
264-276.  
Bardos, V., Medek, M., Kania, V. & Hubalek, Z. 1975, Isolation of Tahyna virus from the 
blood of sick children, Acta Virologica. English ed,  19,  5,  447.  
Bardos, V., Ryba, J. & Hubalek, Z. 1975, Isolation of Tahyna virus from field collected 
Culiseta annulata (Schrk.) larvae, Acta Virologica. English ed,  19,  5,  446.  
Bastos Mde, S., Figueiredo, L.T., Naveca, F.G., Monte, R.L., Lessa, N., Pinto de Figueiredo, 
R.M., Gimaque, J.B., Pivoto Joao, G., Ramasawmy, R. & Mourao, M.P. 2012, 
Identification of Oropouche Orthobunyavirus in the cerebrospinal fluid of three 
patients in the Amazonas, Brazil, The American Journal of Tropical Medicine and 
Hygiene,  86,  4,  732-735.  
Beaty, B.J., Casals, J., Brown, K.L., Gundersen, C.B., Nelson, D., McPherson, J.T. & 
Thompson, W.H. 1982, Indirect fluorescent-antibody technique for serological 
diagnosis of La Crosse (California) virus infections, Journal of clinical microbiology,  
15,  3,  429-434.  
Bellocq, C. & Kolakofsky, D. 1987, Translational requirement for La Crosse virus S-mRNA 
synthesis: a possible mechanism, Journal of virology,  61,  12,  3960-3967.  
Bennett, R.S., Cress, C.M., Ward, J.M., Firestone, C.Y., Murphy, B.R. & Whitehead, S.S. 
2008, La Crosse virus infectivity, pathogenesis, and immunogenicity in mice and 
monkeys, Virology journal,  5,  25-422X-5-25.  
Bennett, R.S., Gresko, A.K., Murphy, B.R. & Whitehead, S.S. 2011a, Tahyna virus genetics, 
infectivity, and immunogenicity in mice and monkeys, Virology journal,  8,  135-
422X-8-135.  
Bennett, R.S., Nelson, J.T., Gresko, A.K., Murphy, B.R. & Whitehead, S.S. 2011b, The full 
genome sequence of three strains of Jamestown Canyon virus and their 
pathogenesis in mice or monkeys, Virology journal,  8,  136-422X-8-136.   
62 
 
Bernardes-Terzian, A.C., de-Moraes-Bronzoni, R.V., Drumond, B.P., Da Silva-Nunes, M., 
da-Silva, N.S., Urbano-Ferreira, M., Speranca, M.A. & Nogueira, M.L. 2009, Sporadic 
oropouche virus infection, acre, Brazil, Emerging infectious diseases,  15,  2,  348-
350.  
Bird, B.H., Ksiazek, T.G., Nichol, S.T. & Maclachlan, N.J. 2009, Rift Valley fever virus, 
Journal of the American Veterinary Medical Association,  234,  7,  883-893.  
Blakqori, G., Delhaye, S., Habjan, M., Blair, C.D., Sanchez-Vargas, I., Olson, K.E., 
Attarzadeh-Yazdi, G., Fragkoudis, R., Kohl, A., Kalinke, U., Weiss, S., Michiels, T., 
Staeheli, P. & Weber, F. 2007, La Crosse bunyavirus nonstructural protein NSs serves 
to suppress the type I interferon system of mammalian hosts, Journal of virology,  
81,  10,  4991-4999.  
Blitvich, B.J., Saiyasombat, R., Dorman, K.S., Garcia-Rejon, J.E., Farfan-Ale, J.A. & Lorono-
Pino, M.A. 2012a, Sequence and phylogenetic data indicate that an orthobunyavirus 
recently detected in the Yucatan Peninsula of Mexico is a novel reassortant of Potosi 
and Cache Valley viruses, Archives of Virology,  157,  6,  1199-1204.  
Blitvich, B.J., Saiyasombat, R., Talavera-Aguilar, L.G., Garcia-Rejon, J.E., Farfan-Ale, J.A., 
Machain-Williams, C. & Lorono-Pino, M.A. 2012b, Orthobunyavirus antibodies in 
humans, Yucatan Peninsula, Mexico, Emerging infectious diseases,  18,  10,  1629-
1632.  
Blitvich, B.J., Saiyasombat, R., Travassos da Rosa, A., Tesh, R.B., Calisher, C.H., Garcia-
Rejon, J.E., Farfan-Ale, J.A., Lorono, R.E., Bates, A. & Lorono-Pino, M.A. 2012c, 
Orthobunyaviruses, a common cause of infection of livestock in the Yucatan 
peninsula of Mexico, The American Journal of Tropical Medicine and Hygiene,  87,  6,  
1132-1139.   
Blitvich, B.J., Staley, M., Lorono-Pino, M.A., Garcia-Rejon, J.E., Farfan-Ale, J.A. & Dorman, 
K.S. 2012d, Identification of a novel subtype of South River virus (family 
Bunyaviridae), Archives of Virology,  157,  6,  1205-1209.  
Bond, J.O., Hammon, W.M., Lewis, A.L., Sather, G.E. & Taylor, D.J. 1966, California group 
arboviruses in Florida and report of a new strain, Keystone virus, Public health 
reports,  81,  7,  607-613.  
Boromisa, R.D. & Grayson, M.A. 1990, Incrimination of Aedes provocans as a vector of 
Jamestown Canyon virus in an enzootic focus of northeastern New York, Journal of 
the American Mosquito Control Association,  6,  3,  504-509.  
Borucki, M.K., Kempf, B.J., Blitvich, B.J., Blair, C.D. & Beaty, B.J. 2002, La Crosse virus: 
replication in vertebrate and invertebrate hosts, Microbes and infection / Institut 
Pasteur,  4,  3,  341-350.  
Bowen, M.D., Trappier, S.G., Sanchez, A.J., Meyer, R.F., Goldsmith, C.S., Zaki, S.R., 
Dunster, L.M., Peters, C.J., Ksiazek, T.G., Nichol, S.T. & RVF Task Force 2001, A 
reassortant bunyavirus isolated from acute hemorrhagic fever cases in Kenya and 
Somalia, Virology,  291,  2,  185-190.  
63 
 
Briese, T., Bird, B., Kapoor, V., Nichol, S.T. & Lipkin, W.I. 2006, Batai and Ngari viruses: M 
segment reassortment and association with severe febrile disease outbreaks in East 
Africa, Journal of virology,  80,  11,  5627-5630.  
Briese, T., Kapoor, V. & Lipkin, W.I. 2007, Natural M-segment reassortment in Potosi and 
Main Drain viruses: implications for the evolution of orthobunyaviruses, Archives of 
Virology,  152,  12,  2237-2247.  
Briese, T., Rambaut, A. & Lipkin, W.I. 2004, Analysis of the medium (M) segment 
sequence of Guaroa virus and its comparison to other orthobunyaviruses, The 
Journal of general virology,  85,  Pt 10,  3071-3077.  
Brummer-Korvenkontio, M. 1973a, Arboviruses in Finland. V. Serological survey of 
antibodies against Inkoo virus (California group) in human, cow, reindeer, and 
wildlife sera, The American Journal of Tropical Medicine and Hygiene,  22,  5,  654-
661.  
Brummer-Korvenkontio, M. 1973b, Batai (Calovo) arbovirus neutralising antibodies in 
Finland, Annales Medicinae Experimentalis et Biologiae Fenniae,  51,  4,  158-161.  
Brummer-Korvenkontio, M., Saikku, P., Korhonen, P., Ulmanen, I., Reunala, T. & 
Karvonen, J. 1973, Arboviruses in Finland. IV. Isolation and characterization of Inkoo 
virus, a Finnish representative of the California group, The American Journal of 
Tropical Medicine and Hygiene,  22,  3,  404-413.  
Bryant, J.E., Crabtree, M.B., Nam, V.S., Yen, N.T., Duc, H.M. & Miller, B.R. 2005, Isolation 
of arboviruses from mosquitoes collected in northern Vietnam, The American 
Journal of Tropical Medicine and Hygiene,  73,  2,  470-473.  
Buescher, E.L., Byrne, R.J., Clarke, G.C., Gould, D.J., Russell, P.K., Scheider, F.G. & Yuill, 
T.M. 1970, Cache Valley virus in the Del Mar Va Peninsula. I. Virologic and serologic 
evidence of infection, The American Journal of Tropical Medicine and Hygiene,  19,  
3,  493-502.  
Burgdorfer, W., Newhouse, V.F. & Thomas, L.A. 1961, Isolation of California encephalitis 
virus from the blood of a snowshoe hare (Lepus americanus) in western Montana, 
American journal of hygiene,  73,  344-349.  
Butenko, A.M., Demikhov, V.G., Nedialkova, M.S. & Lavrova, N.A. 1995, Serodiagnosis and 
epidemiology of a California encephalitis group of infections in the Ryazan' region, 
Voprosy virusologii,  40,  1,  17-21.  
Butenko, A.M., Vladimirtseva, E.A., Lvov, S.D., Calisher, C.H. & Karabatsos, N. 1991, 
California serogroup viruses from mosquitoes collected in the USSR, The American 
Journal of Tropical Medicine and Hygiene,  45,  3,  366-370.  
Calisher, C.H. 1983, Taxonomy, classification, and geographic distribution of California 
serogroup bunyaviruses, Progress in clinical and biological research,  123,  1-16.  
Calisher, C.H., Ahmann, S.J., Grimstad, P.R., Hamm, J.G. & Parsons, M.A. 1981, 
Distribution and prevalence of Mermet virus infections in the central United States, 
The American Journal of Tropical Medicine and Hygiene,  30,  2,  473-476.  
64 
 
Calisher, C.H. & Bailey, R.E. 1981, Serodiagnosis of La Crosse virus infections in humans, 
Journal of clinical microbiology,  13,  2,  344-350.  
Calisher, C.H., Chappell, W.A., Maness, K.S., Lord, R.D. & Sudia, W.D. 1971, Isolations of 
Nepuyo virus strains from Honduras, 1967, The American Journal of Tropical 
Medicine and Hygiene,  20,  2,  331-337.  
Calisher, C.H., Coimbra, T.L., Lopez Ode, S., Muth, D.J., Sacchetta Lde, A., Francy, D.B., 
Lazuick, J.S. & Cropp, C.B. 1983, Identification of new Guama and Group C serogroup 
bunyaviruses and an ungrouped virus from Southern Brazil, The American Journal of 
Tropical Medicine and Hygiene,  32,  2,  424-431.  
Calisher, C.H., Francy, D.B., Smith, G.C., Muth, D.J., Lazuick, J.S., Karabatsos, N., Jakob, 
W.L. & McLean, R.G. 1986, Distribution of Bunyamwera serogroup viruses in North 
America, 1956-1984, The American Journal of Tropical Medicine and Hygiene,  35,  2,  
429-443.  
Calisher, C.H., Gutierrez, E., Francy, D.B., Alava, A., Muth, D.J. & Lazuick, J.S. 1983, 
Identification of hitherto unrecognized arboviruses from Ecuador: members of 
serogroups B, C, Bunyamwera, Patois, and Minatitlan, The American Journal of 
Tropical Medicine and Hygiene,  32,  4,  877-885.  
Calisher, C.H., Kokernot, R.H., De Moore, J.F., Boyd, K.R., Hayes, J. & Chappell, W.A. 1969, 
Arbovirus studies in the Ohio-Mississippi Basin, 1964-1967. VI. Mermet: A Simbu-
group arbovirus, The American Journal of Tropical Medicine and Hygiene,  18,  5,  
779-788.  
Calisher, C.H., Lazuick, J.S., Justines, G., Francy, D.B., Monath, T.P., Gutierrez, E., Sabattini, 
M.S., Bowen, G.S. & Jakob, W.L. 1981, Viruses isolated from Aedeomyia 
squamipennis mosquitoes collected in Panama, Ecuador, and Argentina: 
establishment of the Gamboa serogroup, The American Journal of Tropical Medicine 
and Hygiene,  30,  1,  219-223.  
Calisher, C.H., Lazuick, J.S., Muth, D.J., de Souza Lopes, O., Crane, G.T., Elbel, R.E. & Shope, 
R.E. 1980, Antigenic relationships among Tacaiuma complex viruses of the 
Anopheles A serogroup (Bunyaviridae), Bulletin of the Pan American Health 
Organization,  14,  4,  386-391.  
Calisher, C.H., Lazuick, J.S., Wolff, K.L. & Muth, D.J. 1984, Antigenic relationships among 
Turlock serogroup Bunyaviruses as determined by neutralization tests, Acta 
virologica,  28,  2,  148-151.  
Calisher, C.H., McLean, R.G., Zeller, H.G., Francy, D.B., Karabatsos, N. & Bowen, R.A. 1990, 
Isolation of Tete serogroup bunyaviruses from Ceratopogonidae collected in 
Colorado, The American Journal of Tropical Medicine and Hygiene,  43,  3,  314-318.  
Calisher, C.H., Monath, T.P., Sabattini, M.S., Mitchell, C.J., Lazuick, J.S., Tesh, R.B. & Cropp, 
C.B. 1987, A newly recognized vesiculovirus, Calchaqui virus, and subtypes of Melao 
and Maguari viruses from Argentina, with serologic evidence for infections of 
humans and horses, The American Journal of Tropical Medicine and Hygiene,  36,  1,  
114-119.  
65 
 
Calisher, C.H., Oro, J.G., Lord, R.D., Sabattini, M.S. & Karabatsos, N. 1988, Kairi virus 
identified from a febrile horse in Argentina, The American Journal of Tropical 
Medicine and Hygiene,  39,  5,  519-521.  
Calisher, C.H., Pretzman, C.I., Muth, D.J., Parsons, M.A. & Peterson, E.D. 1986, 
Serodiagnosis of La Crosse virus infections in humans by detection of 
immunoglobulin M class antibodies, Journal of clinical microbiology,  23,  4,  667-
671.  
Calisher, C.H., Sabattini, M.S., Monath, T.P. & Wolff, K.L. 1988, Cross-neutralization tests 
among Cache Valley virus isolates revealing the existence of multiple subtypes, The 
American Journal of Tropical Medicine and Hygiene,  39,  2,  202-205.  
Calisher, C.H., Sasso, D.R., Maness, K.S., Gheorghiu, V.N. & Shope, R.E. 1973, 
Relationships of anopheles A group arboviruses, Proceedings of the Society for 
Experimental Biology and Medicine.Society for Experimental Biology and Medicine 
(New York, N.Y.),  143,  2,  465-468.  
Campbell, G.L., Hardy, J.L., Eldridge, B.F. & Reeves, W.C. 1991, Isolation of Northway 
serotype and other Bunyamwera serogroup bunyaviruses from California and 
Oregon mosquitoes, 1969-1985, The American Journal of Tropical Medicine and 
Hygiene,  44,  6,  581-588.  
Campbell, G.L., Mataczynski, J.D., Reisdorf, E.S., Powell, J.W., Martin, D.A., Lambert, A.J., 
Haupt, T.E., Davis, J.P. & Lanciotti, R.S. 2006, Second human case of Cache Valley 
virus disease, Emerging infectious diseases,  12,  5,  854-856.   
Campbell, W.P. & Huang, C. 1999, Sequence comparisons of medium RNA segment 
among 15 California serogroup viruses, Virus research,  61,  2,  137-144. doi: 
S0168170299000337 [pii].  
Carey, D.E., Reuben, R., George, S., Shope, R.E. & Myers, R.M. 1971, Kammavanpettai, 
Kannamangalam, Sembalam and Thimiri viruses: four unrelated new agents isolated 
from birds in India, The Indian journal of medical research,  59,  11,  1708-1711.  
Carvalho, V.L., Nunes, M.R., da Silva, E.V., Vieira, C.M., Gomes, M., Casseb, S.M., 
Rodrigues, S.G., Nunes-Neto, J.P., Quaresma, J.A. & Vasconcelos, P.F. 2009, Genetic 
characterization of orthobunyavirus Melao, strains BE AR633512 and BE AR8033, 
and experimental infection in golden hamsters (Mesocricetus auratus), The Journal 
of general virology,  90,  Pt 1,  223-233.  
Causey, O.R., Causey, C.E., Maroja, O.M. & Macedo, D.G. 1961, The isolation of 
arthropod-borne viruses, including members of two hitherto undescribed serological 
groups, in the Amazon region of Brazil, The American Journal of Tropical Medicine 
and Hygiene,  10,  227-249.  
Causey, O.R., Kemp, G.E., Causey, C.E. & Lee, V.H. 1972, Isolations of Simbu-group viruses 
in Ibadan, Nigeria 1964-69, including the new types Sango, Shamonda, Sabo and 
Shuni, Annals of Tropical Medicine and Parasitology,  66,  3,  357-362.  
66 
 
Centers for Disease Control and Prevention (CDC) 2011, Human Jamestown canyon virus 
infection - Montana, 2009, MMWR.Morbidity and mortality weekly report,  60,  20,  
652-655.  
Chamberlain, R.W., Sudia, W.D. & Coleman, P.H. 1969, Isolations of an arbovirus of the 
Bunyamwera group (Tensaw virus) from mosquitoes in the Southeastern United 
States, 1960-1963, The American Journal of Tropical Medicine and Hygiene,  18,  1,  
92-97.  
Chappell, W.A., Halonen, P.E., Toole, R.F., Calisher, C.H. & Chester, L. 1969, Preparation of 
La Crosse virus hemagglutinating antigen in BHK-21 suspension cell cultures, Applied 
Microbiology,  18,  3,  433-437.  
Chernesky, M.A. 1968, Transmission of California encephalitis virus by mosquitoes, 
Canadian journal of microbiology,  14,  1,  19-23.  
Chevalier, V., Pepin, M., Plee, L. & Lancelot, R. 2010, Rift Valley fever--a threat for 
Europe?, Euro surveillance : bulletin Europeen sur les maladies transmissibles = 
European communicable disease bulletin,  15,  10,  19506.  
Chowdhary, R., Street, C., Travassos da Rosa, A., Nunes, M.R., Tee, K.K., Hutchison, S.K., 
Vasconcelos, P.F., Tesh, R.B., Lipkin, W.I. & Briese, T. 2012, Genetic characterization 
of the Wyeomyia group of orthobunyaviruses and their phylogenetic relationships, 
The Journal of general virology,  93,  Pt 5,  1023-1034.  
Chung, S.I., Livingston, C.W.,Jr, Edwards, J.F., Crandell, R.W., Shope, R.E., Shelton, M.J. & 
Collisson, E.W. 1990, Evidence that Cache Valley virus induces congenital 
malformations in sheep, Veterinary microbiology,  21,  4,  297-307.  
Clarke, D.H. & Casals, J. 1958, Techniques for hemagglutination and hemagglutination-
inhibition with arthropod-borne viruses, The American Journal of Tropical Medicine 
and Hygiene,  7,  5,  561-573.  
Coffey, L.L., Page, B.L., Greninger, A.L., Herring, B.L., Russell, R.C., Doggett, S.L., Haniotis, 
J., Wang, C., Deng, X. & Delwart, E.L. 2014, Enhanced arbovirus surveillance with 
deep sequencing: Identification of novel rhabdoviruses and bunyaviruses in 
Australian mosquitoes, Virology,  448,  146-158.  
Coleman, P.H. 1969, Tensaw virus, a new member of the Bunyamwera arbovirus group 
from the Southern United States, The American Journal of Tropical Medicine and 
Hygiene,  18,  1,  81-91.  
Coleman, P.H., Ryder, S. & Work, T.H. 1969, Mahogany hammock virus, a new Guama 
group arbovirus from the Florida everglades, American Journal of Epidemiology,  89,  
2,  217-221.  
Cybinski, D.H. 1984, Douglas and Tinaroo viruses: two Simbu group arboviruses infecting 
Culicoides brevitarsis and livestock in Australia, Australian Journal of Biological 
Sciences,  37,  3,  91-97.  
De Souza Lopes, O., DE Abreu Sacchetta, L., Fonseca, I.E. & Lacerda, J.P. 1975, Bertioga 
(Guama group) and Anhembi (Bunyamwera group), two new arboviruses isolated in 
67 
 
Sao Paulo, Brazil, The American Journal of Tropical Medicine and Hygiene,  24,  1,  
131-134.  
DeFoliart, G.R., Anslow, R.O., Hanson, R.P., Morris, C.D., Papadopoulos, O. & Sather, G.E. 
1969, Isolation of Jamestown Canyon serotype of California encephalitis virus from 
naturally infected Aedes mosquitoes and tabanids, The American Journal of Tropical 
Medicine and Hygiene,  18,  3,  440-447.  
Demikhov, V.G. 1995, Outcomes and prognosis of diseases caused by Inkoo and Tahyna 
viruses, Voprosy virusologii,  40,  2,  72-74.  
Demikhov, V.G. & Chaitsev, V.G. 1995, Neurologic characteristics of diseases caused by 
Inkoo and Tahyna viruses, Voprosy virusologii,  40,  1,  21-25.  
Derodaniche, E., Paesdeandrade, A. & Galindo, P. 1964, Isolation of Two Antigenically 
Distinct Arthropod-Borne Viruses of Group C in Panama, The American Journal of 
Tropical Medicine and Hygiene,  13,  839-843.  
Doherty, R.L., Carley, J.G., Filippich, C., Kay, B.H., Gorman, B.M. & Rajapaksa, N. 1977, 
Isolation of Sindbis (alphavirus) and Leanyer viruses from mosquitoes collected in 
the Northern Territory of Australia, 1974, The Australian Journal of Experimental 
Biology and Medical Science,  55,  4,  485-489.  
Doherty, R.L., Carley, J.G., Kay, B.H., Filippich, C., Marks, E.N. & Frazier, C.L. 1979, Isolation 
of virus strains from mosquitoes collected in Queensland, 1972-1976, The Australian 
Journal of Experimental Biology and Medical Science,  57,  5,  509-520.  
Doherty, R.L., Carley, J.G., Mackerras, M.J. & Marks, E.N. 1963, Studies of arthropod-
borne virus infections in Queensland. III. Isolation and characterization of virus 
strains from wild-caught mosquitoes in North Queensland, The Australian Journal of 
Experimental Biology and Medical Science,  41,  17-39.  
Doherty, R.L., Carley, J.G., Standfast, H.A., Dyce, A.L. & Snowdon, W.A. 1972, Virus strains 
isolated from arthropods during an epizootic of bovine ephemeral fever in 
Queensland, Australian Veterinary Journal,  48,  3,  81-86.  
Doherty, R.L., Whitehead, R.H., Wetters, E.J., Gorman, B.M. & Carley, J.G. 1970, A survey 
of antibody to 10 arboviruses (Koongol group, Mapputta group and ungrouped) 
isolated in Queensland, Transactions of the Royal Society of Tropical Medicine and 
Hygiene,  64,  5,  748-753.  
Dunn, E.F., Pritlove, D.C. & Elliott, R.M. 1994, The S RNA genome segments of Batai, 
Cache Valley, Guaroa, Kairi, Lumbo, Main Drain and Northway bunyaviruses: 
sequence determination and analysis, The Journal of general virology,  75 ( Pt 3),  Pt 
3,  597-608.  
Ehrnst, A., Peters, C.J., Niklasson, B., Svedmyr, A. & Holmgren, B. 1985, Neurovirulent 
Toscana virus (a sandfly fever virus) in Swedish man after visit to Portugal, Lancet,  1,  
8439,  1212-1213.  
68 
 
Eldridge, B.F., Glaser, C., Pedrin, R.E. & Chiles, R.E. 2001, The first reported case of 
California encephalitis in more than 50 years, Emerging infectious diseases,  7,  3,  
451-452.  
Elliott, R.M. 2014, Orthobunyaviruses: recent genetic and structural insights, Nature 
reviews.Microbiology,  12,  10,  673-685.  
Elliott, R.M. & Blakqori, G. 2011, Molecular Biology of Orthobunyaviruses in book 
Bunyaviridae: Molecular and Cellular Biology, Caister Academic Press.  
Embil, J.A., Camfield, P.R. & Artsob, H. 1985, California encephalitis in New Brunswick, 
Canadian Medical Association journal,  132,  10,  1166.  
Embil, J.A., Camfield, P.R., Artsob, H. & Rozee, K.R. 1982, California encephalitis in Nova 
Scotia, Canadian Medical Association journal,  127,  10,  957, 959.  
Emmons, R.W., Woodie, J.D., Laub, R.L. & Oshiro, L.S. 1983, Main Drain virus as a cause of 
equine encephalomyelitis, Journal of the American Veterinary Medical Association,  
183,  5,  555-558.  
Eriksson, M., Holmgren, L., Janlert, U., Jansson, J.H., Lundblad, D., Stegmayr, B., 
Soderberg, S. & Eliasson, M. 2011, Large improvements in major cardiovascular risk 
factors in the population of northern Sweden: the MONICA study 1986-2009, Journal 
of internal medicine,  269,  2,  219-231.  
Fauvel, M., Artsob, H., Calisher, C.H., Davignon, L., Chagnon, A., Skvorc-Ranko, R. & 
Belloncik, S. 1980, California group virus encephalitis in three children from Quebec: 
clinical and serologic findings, Canadian Medical Association journal,  122,  1,  60-2, 
64.  
Fazakerley, J.K., Gonzalez-Scarano, F., Strickler, J., Dietzschold, B., Karush, F. & Nathanson, 
N. 1988, Organization of the middle RNA segment of snowshoe hare Bunyavirus, 
Virology,  167,  2,  422-432.  
Feng, Y., Fu, S.H., Yang, W.H., Zhang, Y.Z., He, B., Tu, C.C., Liang, G.D. & Zhang, H.L. 2015, 
Isolation and full-length genome analysis of mosquito-borne Manzanilla virus from 
Yunnan Province, China, BMC research notes,  8,  255-015-1198-5.  
Fields, B.N., Henderson, B.E., Coleman, P.H. & Work, T.H. 1969, Pahayokee and Shark 
River, two new arboviruses related to Patois and Zegla from the Florida everglades, 
American Journal of Epidemiology,  89,  2,  222-226.  
Fischer, M., Schirrmeier, H., Wernike, K., Wegelt, A., Beer, M. & Hoffmann, B. 2013, 
Development of a pan-Simbu real-time reverse transcriptase PCR for the detection 
of Simbu serogroup viruses and comparison with SBV diagnostic PCR systems, 
Virology journal,  10,  327-422X-10-327.  
Francy, D.B., Jaenson, T.G., Lundstrom, J.O., Schildt, E.B., Espmark, A., Henriksson, B. & 
Niklasson, B. 1989, Ecologic studies of mosquitoes and birds as hosts of Ockelbo 
virus in Sweden and isolation of Inkoo and Batai viruses from mosquitoes, The 
American Journal of Tropical Medicine and Hygiene,  41,  3,  355-363.  
69 
 
Francy, D.B., Karabatsos, N., Wesson, D.M., Moore, C.G.,Jr, Lazuick, J.S., Niebylski, M.L., 
Tsai, T.F. & Craig, G.B.,Jr 1990, A new arbovirus from Aedes albopictus, an Asian 
mosquito established in the United States, Science (New York, N.Y.),  250,  4988,  
1738-1740.  
Fulhorst, C.F., Hardy, J.L., Eldridge, B.F., Chiles, R.E. & Reeves, W.C. 1996, Ecology of 
Jamestown Canyon virus (Bunyaviridae: California serogroup) in coastal California, 
The American Journal of Tropical Medicine and Hygiene,  55,  2,  185-189.  
Gard, G., Marshall, I.D. & Woodroofe, G.M. 1973, Annually recurrent epidemic 
polyarthritis and Ross River virus activity in a coastal area of New South Wales. II. 
Mosquitoes, viruses, and wildlife, The American Journal of Tropical Medicine and 
Hygiene,  22,  4,  551-560.  
Garry, C.E. & Garry, R.F. 2004, Proteomics computational analyses suggest that the 
carboxyl terminal glycoproteins of Bunyaviruses are class II viral fusion protein (beta-
penetrenes), Theoretical biology & medical modelling,  1,  10.  
Gauci, P.J., McAllister, J., Mitchell, I.R., Boyle, D.B., Bulach, D.M., Weir, R.P., Melville, L.F. 
& Gubala, A.J. 2015, Genomic characterisation of three Mapputta group viruses, a 
serogroup of Australian and Papua New Guinean bunyaviruses associated with 
human disease, PloS one,  10,  1,  e0116561.  
Gauld, L.W., Yuill, T.M., Hanson, R.P. & Sinha, S.K. 1975, Isolation of La Crosse virus 
(California encephalitis group) from the chipmunk (Tamias striatus), an amplifier 
host, The American Journal of Tropical Medicine and Hygiene,  24,  6 Pt 1,  999-1005.  
Gerhardt, R.R., Gottfried, K.L., Apperson, C.S., Davis, B.S., Erwin, P.C., Smith, A.B., Panella, 
N.A., Powell, E.E. & Nasci, R.S. 2001, First isolation of La Crosse virus from naturally 
infected Aedes albopictus, Emerging infectious diseases,  7,  5,  807-811.  
Gerrard, S.R., Li, L., Barrett, A.D. & Nichol, S.T. 2004, Ngari virus is a Bunyamwera virus 
reassortant that can be associated with large outbreaks of hemorrhagic fever in 
Africa, Journal of virology,  78,  16,  8922-8926.  
Gibbs, C.J.,Jr, Bruckner, E.A. & Schenker, S. 1964, A Case of Apeu Virus Infection, The 
American Journal of Tropical Medicine and Hygiene,  13,  108-113.  
Goff, G., Whitney, H. & Drebot, M.A. 2012, Roles of host species, geographic separation, 
and isolation in the seroprevalence of Jamestown Canyon and snowshoe hare 
viruses in Newfoundland, Applied and Environmental Microbiology,  78,  18,  6734-
6740.   
Goller, K.V., Hoper, D., Schirrmeier, H., Mettenleiter, T.C. & Beer, M. 2012, Schmallenberg 
virus as possible ancestor of Shamonda virus, Emerging infectious diseases,  18,  10,  
1644-1646. doi: 10.3201/eid1810.120835 [doi].  
Gonzalez-Scarano, F., Pobjecky, N. & Nathanson, N. 1984, La Crosse bunyavirus can 
mediate pH-dependent fusion from without, Virology,  132,  1,  222-225.  
70 
 
Gonzalez-Scarano, F., Shope, R.E., Calisher, C.E. & Nathanson, N. 1982, Characterization of 
monoclonal antibodies against the G1 and N proteins of LaCrosse and Tahyna, two 
California serogroup bunyaviruses, Virology,  120,  1,  42-53.  
Grimstad, P.R., Calisher, C.H., Harroff, R.N. & Wentworth, B.B. 1986, Jamestown Canyon 
virus (California serogroup) is the etiologic agent of widespread infection in Michigan 
humans, The American Journal of Tropical Medicine and Hygiene,  35,  2,  376-386.  
Grimstad, P.R., Shabino, C.L., Calisher, C.H. & Waldman, R.J. 1982, A case of encephalitis 
in a human associated with a serologic rise to Jamestown Canyon virus, The 
American Journal of Tropical Medicine and Hygiene,  31,  6,  1238-1244.  
Groot, H., Oya, A., Bernal, C. & Barreto-Reyes, P. 1959, Guaroa virus, a new agent isolated 
in Colombia, South America, The American Journal of Tropical Medicine and Hygiene,  
8,  604-609.  
Groseth, A., Mampilli, V., Weisend, C., Dahlstrom, E., Porcella, S.F., Russell, B.J., Tesh, R.B. 
& Ebihara, H. 2014, Molecular Characterization of Human Pathogenic Bunyaviruses 
of the Nyando and Bwamba/Pongola Virus Groups Leads to the Genetic 
Identification of Mojui dos Campos and Kaeng Khoi Virus, PLoS neglected tropical 
diseases,  8,  9,  3147.  
Groseth, A., Vine, V., Weisend, C. & Ebihara, H. 2015, Complete genome sequence of 
trivittatus virus, Archives of Virology, 160, 2637-9. 
Hacker, D., Raju, R. & Kolakofsky, D. 1989, La Crosse virus nucleocapsid protein controls 
its own synthesis in mosquito cells by encapsidating its mRNA, Journal of virology,  
63,  12,  5166-5174.  
Hacker, J.K. & Hardy, J.L. 1997, Adsorptive endocytosis of California encephalitis virus into 
mosquito and mammalian cells: a role for G1, Virology,  235,  1,  40-47.  
Haddow, A.D. & Odoi, A. 2009, The incidence risk, clustering, and clinical presentation of 
La Crosse virus infections in the eastern United States, 2003-2007, PloS one,  4,  7,  
e6145.  
Hammon, W.M. & Reeves, W.C. 1952, California encephalitis virus, a newly described 
agent. Part l.Evidence of Natural Infection in Man and Other Animals, California 
medicine,  77,  5,  303-309.  
Hammon, W.M., Reeves, W.C. & Sather, G. 1952, California encephalitis virus, a newly 
described agent. II. Isolations and attempts to identify and characterize the agent, 
Journal of immunology (Baltimore, Md.: 1950),  69,  5,  493-510.  
Hammon, W.M. & Sather, G. 1966, History and recent reappearance of viruses in the 
California encephalitis group, The American Journal of Tropical Medicine and 
Hygiene,  15,  2,  199-204.  
Hang, J., Forshey, B.M., Yang, Y., Solorzano, V.F., Kuschner, R.A., Halsey, E.S., Jarman, R.G. 
& Kochel, T.J. 2014, Genomic characterization of group C Orthobunyavirus reference 
strains and recent South American clinical isolates, PloS one,  9,  3,  e92114.  
71 
 
Hayes, R.O., LaMotte, L.C. & Holden, P. 1967, Ecology of arboviruses in Hale County, 
Texas, during 1965, The American Journal of Tropical Medicine and Hygiene,  16,  5,  
675-687.  
Heath, S.E., Artsob, H., Bell, R.J. & Harland, R.J. 1989, Equine encephalitis caused by 
snowshoe hare (California serogroup) virus, The Canadian veterinary journal.La 
revue veterinaire canadienne,  30,  8,  669-671.  
Henderson, B.E., Calisher, C.H., Coleman, P.H., Fields, B.N. & Work, T.H. 1969, Gumbo 
Limbo, a new group C arbovirus from the Florida everglades, American Journal of 
Epidemiology,  89,  2,  227-231.  
Henderson, B.E., McCrae, A.W., Kirya, B.G., Ssenkubuge, Y. & Sempala, S.D. 1972, 
Arbovirus epizootics involving man, mosquitoes and vertebrates at Lunyo, Uganda 
1968, Annals of Tropical Medicine and Parasitology,  66,  3,  343-355.  
Hoffmann, B., Scheuch, M., Hoper, D., Jungblut, R., Holsteg, M., Schirrmeier, H., 
Eschbaumer, M., Goller, K.V., Wernike, K., Fischer, M., Breithaupt, A., Mettenleiter, 
T.C. & Beer, M. 2012, Novel orthobunyavirus in Cattle, Europe, 2011, Emerging 
infectious diseases,  18,  3,  469-472.  
Holden, P. & Hess, A.D. 1959, Cache Valley virus, a previously undescribed mosquito-
borne agent, Science (New York, N.Y.),  130,  3383,  1187-1188.  
Hollidge, B.S., Nedelsky, N.B., Salzano, M.V., Fraser, J.W., Gonzalez-Scarano, F. & Soldan, 
S.S. 2012, Orthobunyavirus entry into neurons and other mammalian cells occurs via 
clathrin-mediated endocytosis and requires trafficking into early endosomes, Journal 
of virology,  86,  15,  7988-8001.  
Hontz, R.D., Guevara, C., Halsey, E.S., Silvas, J., Santiago, F.W., Widen, S.G., Wood, T.G., 
Casanova, W., Vasilakis, N., Watts, D.M., Kochel, T.J., Ebihara, H. & Aguilar, P.V. 
2015, Itaya virus, a Novel Orthobunyavirus Associated with Human Febrile Illness, 
Peru, Emerging infectious diseases,  21,  5,  781-788.  
Huang, C., Shope, R.E., Spargo, B. & Campbell, W.P. 1996, The S RNA genomic sequences 
of Inkoo, San Angelo, Serra do Navio, South River and Tahyna bunyaviruses, The 
Journal of general virology,  77,  Pt 8,  1761-1768.  
Huang, C., Thompson, W.H., Karabatsos, N., Grady, L. & Campbell, W.P. 1997, Evidence 
that fatal human infections with La Crosse virus may be associated with a narrow 
range of genotypes, Virus research,  48,  2,  143-148.  
Hubalek, Z. 2008, Mosquito-borne viruses in Europe, Parasitology research,  103 Suppl 1,  
S29-43.  
Hubalek, Z., Juricova, Z., Halouzka, J., Butenko, A.M., Kondrasina, N.G., Guscina, E.A. & 
Morozova, T.N. 1990, Isolation and characterization of Sedlec virus, a new 
bunyavirus from birds, Acta virologica,  34,  4,  339-345.  
Hubalek, Z. & Rudolf, I. 2012, Tick-borne viruses in Europe, Parasitology research,  111,  1,  
9-36.  
72 
 
Hunt, A.R. & Calisher, C.H. 1979, Relationships of bunyamwera group viruses by 
neutralization, The American Journal of Tropical Medicine and Hygiene,  28,  4,  740-
749.  
Issel, C.J., Hoff, G.L. & Trainer, D.O. 1973, SEROLOGIC EVIDENCE OF INFECTION OF WHITE-
TAILED DEER IN TEXAS WITH THREE CALIFORNIA GROUP ARBOVIRUSES, 
(JAMESTOWN CANYON, SAN ANGELO, AND KEYSTONE), Journal of wildlife diseases,  
9,  3,  245-248.  
Iversson, L.B., Travassos da Rosa, A.P., Coimbra, T.L., Ferreira, I.B. & Nassar Eda, S. 1987, 
Human disease in Ribeira Valley, Brazil caused by Caraparu, a group C arbovirus--
report of a case, Revista do Instituto de Medicina Tropical de Sao Paulo,  29,  2,  112-
117.  
Jackson, B.T., Brewster, C.C. & Paulson, S.L. 2012, La Crosse virus infection alters blood 
feeding behavior in Aedes triseriatus and Aedes albopictus (Diptera: Culicidae), 
Journal of medical entomology,  49,  6,  1424-1429.  
Johnson, R.T. 1983, Pathogenesis of La Crosse virus in mice, Progress in clinical and 
biological research,  123,  139-144.  
Jonkers, A.H., Metselaar, D., de Andrade, A.H. & Tikasingh, E.S. 1967, Restan virus, a new 
group C arbovirus from Trinidad and Surinam, The American Journal of Tropical 
Medicine and Hygiene,  16,  1,  74-78.  
Jonkers, A.H., Spence, L., Downs, W.G., Aitken, T.H. & Tikasingh, E.S. 1968a, Arbovirus 
studies in Bush Bush forest, Trinidad, W. I., September 1959-December 1964. V. 
Virus isolations, The American Journal of Tropical Medicine and Hygiene,  17,  2,  
276-284.  
Jonkers, A.H., Spence, L., Downs, W.G., Aitken, T.H. & Worth, C.B. 1968b, Arobovirus 
studies in Bush Bush Forest, Trinidad, W. I., September 1959-December 1964. VI. 
Rodent-associated viruses (VEE and agents of groups C and Guama): isolations and 
further studies, The American Journal of Tropical Medicine and Hygiene,  17,  2,  285-
298.  
Jöst, H., Bialonski, A., Schmetz, C., Günther, S., Becker, N. & Schmidt-Chanasit, J. 2011, 
Isolation and Phylogenetic Analysis of Batai Virus, Germany, The American Journal of 
Tropical Medicine and Hygiene,  84,  2,  241-243.   
Kalunda, M., Lwanga-Ssozi, C., Lule, M. & Mukuye, A. 1985, Isolation of Chikungunya and 
Pongola viruses from patients in Uganda, Transactions of the Royal Society of 
Tropical Medicine and Hygiene,  79,  4,  567.  
Kappus, K.D., Monath, T.P., Kaminski, R.M. & Calisher, C.H. 1983, Reported encephalitis 
associated with California serogroup virus infections in the United States, 1963-
1981, Progress in clinical and biological research,  123,  31-41.  
Karabatsos, N. 1985, International catalogue of arboviruses, including certain other 
viruses of vertebrates,  3,  1-1147.  
73 
 
Kettyls, G.D., Verrall, V.M., Wilton, L.D., Clapp, J.B., Clarke, D.A. & Rublee, J.D. 1972, 
Arbovirus infections in man in British Columbia, Canadian Medical Association 
journal,  106,  11,  1175-1179.  
King, A.M.Q., Lefkowitz, E., Adams, M.J. & Carstens, E.B. 2012, Virus taxonomy: 
classification and nomenclature of viruses: Ninth Report of the International 
Committee on Taxonomy of Viruses: Family - Bunyaviridae i Virus Taxonomy, red. 
Andrew M.Q. King, Elliot Lefkowitz, Michael J.Adams & Eric B. Carstens, Elsevier, San 
Diego,  725-741.  
Kinney, R.M. & Calisher, C.H. 1981, Antigenic relationships among Simbu serogroup 
(Bunyaviridae) viruses, The American Journal of Tropical Medicine and Hygiene,  30,  
6,  1307-1318.  
Klimas, R.A., Ushijima, H., Clerx-Van Haaster, C.M. & Bishop, D.H. 1981, Radioimmune 
assays and molecular studies that place Anopheles B and Turlock serogroup viruses 
in the Bunyavirus genus (Bunyaviridae), The American Journal of Tropical Medicine 
and Hygiene,  30,  4,  876-887.  
Kokernot, R.H., McIntosh, B.M., Worth, C.B., De, M.O.R.A.I.S.T. & Weinbren, M.P. 1962, 
Isolation of viruses from mosquitoes collected at Lumbo, Mozambique. I. Lumbo 
virus, a new virus isolated from Aedes (Skusea) pembaensis Theobald, The American 
Journal of Tropical Medicine and Hygiene,  11,  678-682.  
Kokernot, R.H., Smithburn, K.C., De Meillon, B. & Paterson, H.E. 1958, Isolation of 
Bunyamwera virus from a naturally infected human being and further isolations 
from Aedes (Banksinella) circumluteolus theo, The American Journal of Tropical 
Medicine and Hygiene,  7,  6,  579-584.  
Kokernot, R.H., Smithburn, K.C., Paterson, H.E. & McIntosh, B.M. 1960, Isolation of 
Germiston virus, a hitherto unknown agent, from culicine mosquitoes, and a report 
of infection in two laboratory workers, The American Journal of Tropical Medicine 
and Hygiene,  9,  62-69.  
Kokernot, R.H., Smithburn, K.C., Weinbren, M.P. & De Meillon, B. 1957, Studies on 
arthropod-borne viruses of Tongaland. VI. Isolation of Pongola virus from Aedes 
(Banksinella) circumluteolus Theo, The South African journal of medical sciences,  22,  
2-3,  81-92.  
Kokernot, R.H., Szlamp, E.L., Levitt, J. & McIntosh, B.M. 1965, Survey for antibodies 
against arthropod-borne viruses in the sera of indigenous residents of the Caprivi 
Strip and Bechuanaland Protectorate, Transactions of the Royal Society of Tropical 
Medicine and Hygiene,  59,  5,  553-562.  
Kono, Y., Yusnita, Y., Mohd Ali, A.R., Maizan, M., Sharifah, S.H., Fauzia, O., Kubo, M. & 
Aziz, A.J. 2002, Characterization and identification of Oya virus, a Simbu serogroup 
virus of the genus Bunyavirus, isolated from a pig suspected of Nipah virus infection, 
Archives of Virology,  147,  8,  1623-1630.  
74 
 
Ksiazek, T.G. & Yuill, T.M. 1977, Viremia and antibody response to La Crosse virus in 
sentinel gray squirrels (Sciuris carolinensis) and chipmunks Tamias striatus), The 
American Journal of Tropical Medicine and Hygiene,  26,  4,  815-821.  
Kuno, G., Mitchell, C.J., Chang, G.J. & Smith, G.C. 1996, Detecting bunyaviruses of the 
Bunyamwera and California serogroups by a PCR technique, Journal of clinical 
microbiology,  34,  5,  1184-1188.  
Laloy, E., Breard, E., Sailleau, C., Viarouge, C., Desprat, A., Zientara, S., Klein, F., Hars, J. & 
Rossi, S. 2014, Schmallenberg virus infection among red deer, France, 2010-2012, 
Emerging infectious diseases,  20,  1,  131-134.  
Lambert, A.J., Fryxell, R.T., Freyman, K., Ulloa, A., Velez, J.O., Paulsen, D., Lanciotti, R.S. & 
Moncayo, A. 2015, Comparative sequence analyses of La Crosse virus strain isolated 
from patient with fatal encephalitis, Tennessee, USA, Emerging infectious diseases,  
21,  5,  833-836.  
Lambert, A.J., Nasci, R.S., Cropp, B.C., Martin, D.A., Rose, B.C., Russell, B.J. & Lanciotti, R.S. 
2005, Nucleic acid amplification assays for detection of La Crosse virus RNA, Journal 
of clinical microbiology,  43,  4,  1885-1889.  
Lavrent'ev, M.V., Prilipov, A.G., L'vov, S.D. & L'vov, D.K. 2008, Phylogenetic analysis of the 
nucleotide sequences of Chatanga virus strains, the new representative of California 
encephalitis serocomplex, isolated in different regions of the Russian Federation, 
Voprosy virusologii,  53,  6,  25-29.  
LeDuc, J.W. 1987, Epidemiology and ecology of the California serogroup viruses, The 
American Journal of Tropical Medicine and Hygiene,  37,  3 Suppl,  60S-68S.  
LeDuc, J.W., Burger, J.F., Eldridge, B.F. & Russell, P.K. 1975, Ecology of Keystone virus, a 
transovarially maintained arbovirus, Annals of the New York Academy of Sciences,  
266,  144-151.  
Lennette, E.H., Ota, M.I., Fujimoto, F.Y., Wiener, A. & Loomis, E.C. 1957, Turlock virus: a 
presumably new arthropod-borne virus; isolation and identification, The American 
Journal of Tropical Medicine and Hygiene,  6,  6,  1024-1035.  
Lewis, A.L., Hammon, W.M., Sather, G.E., Taylor, D.J. & Bond, J.O. 1965, Isolation of a 
California Group Arbovirus from Florida Mosquitoes, The American Journal of 
Tropical Medicine and Hygiene,  14,  451-455.  
Linden, A., Desmecht, D., Volpe, R., Wirtgen, M., Gregoire, F., Pirson, J., Paternostre, J., 
Kleijnen, D., Schirrmeier, H., Beer, M. & Garigliany, M.M. 2012, Epizootic spread of 
Schmallenberg virus among wild cervids, Belgium, Fall 2011, Emerging infectious 
diseases,  18,  12,  2006-2008.  
Liu, H., Shao, X.Q., Hu, B., Zhao, J.J., Zhang, L., Zhang, H.L., Bai, X., Zhang, R.X., Niu, D.Y., 
Sun, Y.G. & Yan, X.J. 2014, Isolation and complete nucleotide sequence of a Batai 
virus strain in Inner Mongolia, China, Virology journal,  11,  138-422X-11-138.  
Lopes Ode, S., Forattini, O.P., Fonseca, I.E., Lacerda, J.P., Sacchetta, L.A. & Rabello, E.X. 
1966, Boraceia virus. A new virus related to anopheles B virus, Proceedings of the 
75 
 
Society for Experimental Biology and Medicine.Society for Experimental Biology and 
Medicine (New York, N.Y.),  123,  2,  502-504.  
Lopez-Montero, N. & Risco, C. 2011, Self-protection and survival of arbovirus-infected 
mosquito cells, Cellular microbiology,  13,  2,  300-315.  
Lu, Z., Fu, S., Wang, F., Nasci, R.S., Tang, Q. & Liang, G. 2011, Circulation of Diverse 
Genotypes of Tahyna Virus in Xinjiang, People's Republic of China, The American 
Journal of Tropical Medicine and Hygiene,  85,  3,  442-445.  
Lu, Z., Lu, X., Fu, S., Zhang, S., Li, Z., Yao, X., Feng, Y., Lambert, A.J., Ni, D., Wang, F., Tong, 
S., Nasci, R.S., Feng, Y., Dong, Q., Zhai, Y., Gao, X., Wang, H., Tang, Q. & Liang, G. 
2009, Tahyna Virus and Human Infection, China, Emerging Infectious Diseases,  15,  
2,  306-309.  
Ludwig, G.V., Israel, B.A., Christensen, B.M., Yuill, T.M. & Schultz, K.T. 1991, Role of La 
Crosse virus glycoproteins in attachment of virus to host cells, Virology,  181,  2,  
564-571.  
Lutwama, J.J., Rwaguma, E.B., Nawanga, P.L. & Mukuye, A. 2002, Isolations of Bwamba 
virus from south central Uganda and north eastern Tanzania, African health sciences,  
2,  1,  24-28.  
Lynch, J.A., Binnington, B.D. & Artsob, H. 1985, California serogroup virus infection in a 
horse with encephalitis, Journal of the American Veterinary Medical Association,  
186,  4,  389.  
Madoff, D.H. & Lenard, J. 1982, A membrane glycoprotein that accumulates 
intracellularly: cellular processing of the large glycoprotein of LaCrosse virus, Cell,  
28,  4,  821-829.  
Mahy, B.W.J. 2001, A Dictionary of Virology, Elsevier  
Malkova, D. 1972, Yaba 1 virus in Czechoslovakia. I. Some physical and chemical 
properties of yaba 1 (Lednice 110) virus, Acta virologica,  16,  3,  264-266.  
Malkova, D., Holubova, J., Cerny, V., Daniel, M., Fernandez, A., de la Cruz, J., Herrera, M. 
& Calisher, C.H. 1985, Estero real virus: a new virus isolated from argasid ticks 
Ornithodoros tadaridae in Cuba, Acta virologica,  29,  3,  247-250.  
Mangiafico, J.A., Sanchez, J.L., Figueiredo, L.T., LeDuc, J.W. & Peters, C.J. 1988, Isolation of 
a newly recognized Bunyamwera serogroup virus from a febrile human in Panama, 
The American Journal of Tropical Medicine and Hygiene,  39,  6,  593-596.  
Marchette, N.J. 1994, Handbook of Zoonoses, Second Edition: Viral Zoonoses. Arboviral 
zoonoses of Asia, Second Edition uppl., CRC Press  
Marczinke, B.I. & Nichol, S.T. 2002, Nairobi sheep disease virus, an important tick-borne 
pathogen of sheep and goats in Africa, is also present in Asia, Virology,  303,  1,  146-
151.  
76 
 
Matsumori, Y., Inai, K., Yanase, T., Ohashi, S., Kato, T., Yoshida, K. & Tsuda, T. 2002, 
Serological and genetic characterization of newly isolated Peaton virus in Japan. Brief 
report, Archives of Virology,  147,  2,  401-410.  
McFarlane, B.L., Embil, J.A., Artsob, H., Spence, L. & Rozee, K.R. 1981a, Antibodies to the 
California group of arboviruses in the moose (Alces alces americana Clinton) 
population of Nova Scotia, Canadian journal of microbiology,  27,  11,  1219-1223.  
McFarlane, B.L., Embree, J.E., Embil, J.A., Artsob, H., Weste, J.B. & Rozee, K.R. 1981b, 
Antibodies to snowshoe hare virus of the California group in the snowshoe hare 
(Lepus americanus) and domestic animal populations of Prince Edward Island, 
Canadian journal of microbiology,  27,  11,  1224-1227.  
McIntosh, B.M., McGillivray, G.M. & Dickinson, D.B. 1965, Ingwavuma virus: an arbovirus 
isolated in South Africa, The South African journal of medical sciences,  30,  3,  67-70.  
McJunkin, J.E., de los Reyes, E.C., Irazuzta, J.E., Caceres, M.J., Khan, R.R., Minnich, L.L., Fu, 
K.D., Lovett, G.D., Tsai, T. & Thompson, A. 2001, La Crosse encephalitis in children, 
The New England journal of medicine,  344,  11,  801-807.  
McLean, D.M. 1983, Yukon isolates of snowshoe hare virus, 1972-1982, Progress in 
clinical and biological research,  123,  247-256.  
McLean, R.G., Calisher, C.H. & Parham, G.L. 1987, Isolation of Cache Valley virus and 
detection of antibody for selected arboviruses in Michigan horses in 1980, American 
Journal of Veterinary Research,  48,  7,  1039-1041.  
McLean, R.G., Kirk, L.J., Shriner, R.B., Cook, P.D., Myers, E.E., Gill, J.S. & Campos, E.G. 
1996, The role of deer as a possible reservoir host of potosi virus, a newly recognized 
arbovirus in the United States, Journal of wildlife diseases,  32,  3,  444-452.  
Mclintock, J., Curry, P.S., Wagner, R.J., Leung, M.K. & Iversen, J.O. 1976, Isolation of 
snowshoe hare virus from aedes implicatus larvae in saskatchewan canada, 
Mosquito News,  36(3),  233-237.  
Meier-Stephenson, V., Langley, J.M., Drebot, M. & Artsob, H. 2007, Encephalitis in the 
summer: a case of snowshoe hare (California serogroup) virus infection in Nova 
Scotia, Canada communicable disease report = Releve des maladies transmissibles au 
Canada,  33,  11,  23-26.  
Metselaar, D. 1966, Isolation of arboviruses of group A and group C in Surinam, Tropical 
and geographical medicine,  18,  2,  137-142.  
Miller, B.R., DeFoliart, G.R. & Yuill, T.M. 1979, Aedes triseriatus and La Crosse virus: lack 
of infection in eggs of the first ovarian cycle following oral infection of females, The 
American Journal of Tropical Medicine and Hygiene,  28,  5,  897-901.  
Mitchell, C.J., Lvov, S.D., Savage, H.M., Calisher, C.H., Smith, G.C., Lvov, D.K. & Gubler, D.J. 
1993, Vector and host relationships of California serogroup viruses in western 
Siberia, The American Journal of Tropical Medicine and Hygiene,  49,  1,  53-62.  
Mitchell, C.J., Monath, T.P., Sabattini, M.S., Cropp, C.B., Daffner, J.F., Calisher, C.H., Jakob, 
W.L. & Christensen, H.A. 1985, Arbovirus investigations in Argentina, 1977-1980. II. 
77 
 
Arthropod collections and virus isolations from Argentine mosquitoes, The American 
Journal of Tropical Medicine and Hygiene,  34,  5,  945-955.  
Mohamed, M., McLees, A. & Elliott, R.M. 2009, Viruses in the Anopheles A, Anopheles B, 
and Tete serogroups in the Orthobunyavirus genus (family Bunyaviridae) do not 
encode an NSs protein, Journal of virology,  83,  15,  7612-7618.   
Monath, T.P., Nuckolls, J.G., Berall, Bauer, H., Chappell, W.A. & Coleman, P.H. 1970, 
Studies on California encephalitis in Minnesota, American Journal of Epidemiology,  
92,  1,  40-50.  
Moussa, M.I., Imam, I.Z., Converse, J.D. & El-Karamany, R.M. 1974, Isolation of Matruh 
virus from Hyalomma marginatum ticks in Egypt, The Journal of the Egyptian Public 
Health Association,  49,  6,  341-348.  
Mullen, G.L. & Durden, L. 2002, Medical and Veterinary Entomology: Introduction, 
Academic Press, Burlington, MA, USA.  
Murphy, F.A., Harrison, A.K. & Whitfield, S.G. 1973, Bunyaviridae: morphologic and 
morphogenetic similarities of Bunyamwera serologic supergroup viruses and several 
other arthropod-borne viruses, Intervirology,  1,  4,  297-316.  
Nashed, N.W., Olson, J.G. & el-Tigani, A. 1993, Isolation of Batai virus 
(Bunyaviridae:Bunyavirus) from the blood of suspected malaria patients in Sudan, 
The American Journal of Tropical Medicine and Hygiene,  48,  5,  676-681.  
Niklasson, B., Espmark Aa., Jaenson, T.G.T. & Kjelsson, T. 1985, Inkoo virus isolated from 
Swedish mosquitoes for the first time, Lakartidningen,  82,  47,  4136.  
Noda, Y., Uchinuno, Y., Shirakawa, H., Nagasue, S., Nagano, N., Ohe, R. & Narita, M. 1998, 
Aino Virus Antigen in Brain Lesions of a Naturally Aborted Bovine Fetus, Veterinary 
pathology,  35,  5,  409-411.  
Ogg, M.M. & Patterson, J.L. 2007, RNA binding domain of Jamestown Canyon virus S 
segment RNAs, Journal of virology,  81,  24,  13754-13760.  
Okuno, T. 1961, Immunological studies relating two recently isolated viruses, Germiston 
virus from South Africa and Ilesha virus from West Africa, to the Bunyamwera group, 
The American Journal of Tropical Medicine and Hygiene,  10,  223-226.  
Ota, W.K., Watkins, H.M., Neri, P., Schmidt, M.L. & Schmidt, J.R. 1976, Arbovirus 
recoveries from mosquitoes collected in Gambela, Illubabor Province, Ethiopia, 
1970, Journal of medical entomology,  13,  2,  173-178.  
Oya, A., Okuno, T., Ogata, T., Kobayashii & Matsuyama, T. 1961, Akabane, a new arbor 
virus isolated in Japan, Japanese journal of medical science & biology,  14,  101-108.  
Pachler, K., Ruzek, D. & Nowotny, N. 2013, Molecular characterization of the African 
orthobunyavirus Ilesha virus, Infection, genetics and evolution : journal of molecular 
epidemiology and evolutionary genetics in infectious diseases,  20,  124-130.  
Pantuwatana, S., Thompson, W.H., Watts, D.M. & Hanson, R.P. 1972, Experimental 
infection of chipmunks and squirrels with La Crosse and Trivittatus viruses and 
78 
 
biological transmission of La Crosse virus by Aedes triseriatus, The American Journal 
of Tropical Medicine and Hygiene,  21,  4,  476-481.  
Pappu, H.R., Jones, R.A. & Jain, R.K. 2009, Global status of tospovirus epidemics in diverse 
cropping systems: successes achieved and challenges ahead, Virus research,  141,  2,  
219-236.  
Parkin, W.E., Hammon, W.M. & Sather, G.E. 1972, Review of current epidemiological 
literature on viruses of the California arbovirus group, The American Journal of 
Tropical Medicine and Hygiene,  21,  6,  964-978.  
Parsonson, I.M., Della-Porta, A.J. & Snowdon, W.A. 1981, Developmental disorders of the 
fetus in some arthropod-borne virus infections, The American Journal of Tropical 
Medicine and Hygiene,  30,  3,  660-673.  
Parsonson, I.M., Della-Porta, A.J. & Snowdon, W.A. 1977, Congenital abnormalities in 
newborn lambs after infection of pregnant sheep with Akabane virus, Infection and 
immunity,  15,  1,  254-262.  
Pastula, D.M., Hoang Johnson, D.K., White, J.L., Dupuis, A.P.,2nd, Fischer, M. & Staples, 
J.E. 2015, Jamestown Canyon Virus Disease in the United States-2000-2013, The 
American Journal of Tropical Medicine and Hygiene,  93,  2,  384-389.  
Patterson, J.L., Holloway, B. & Kolakofsky, D. 1984, La Crosse virions contain a primer-
stimulated RNA polymerase and a methylated cap-dependent endonuclease, Journal 
of virology,  52,  1,  215-222.  
Pinheiro, F.P., Travassos da Rosa, A.P., Travassos da Rosa, J.F., Ishak, R., Freitas, R.B., 
Gomes, M.L., LeDuc, J.W. & Oliva, O.F. 1981, Oropouche virus. I. A review of clinical, 
epidemiological, and ecological findings, The American Journal of Tropical Medicine 
and Hygiene,  30,  1,  149-160.  
Plassmeyer, M.L., Soldan, S.S., Stachelek, K.M., Roth, S.M., Martin-Garcia, J. & Gonzalez-
Scarano, F. 2007, Mutagenesis of the La Crosse Virus glycoprotein supports a role for 
Gc (1066-1087) as the fusion peptide, Virology,  358,  2,  273-282.  
Poglazov, A.B., Shliapnikova, O.V. & Prilipov, A.G. 2011, Characteristic of the new 
Khatanga virus genotype, Vestnik Rossiiskoi akademii meditsinskikh nauk / 
Rossiiskaia akademiia meditsinskikh nauk,  (5),  5,  45-49.  
Putkuri, N., Brummer-Korvenkontio, M., Vaheri, A. & Vapalahti, O. 2004, Inkoo-virus: 
hyttysten levittämä keskushermostoinfektion aiheuttaja Suomessa,,  21-22,  2247-
2250.  
Putkuri, N., Kurkela, S., Levanov, L., Huhtamo, E., Vaheri, A., Sironen, T. & Vapalahti, O. 
2014, Isolation and characterization of a California encephalitis serogroup 
orthobunyavirus from Finnish mosquitoes, Infection, Genetics and Evolution,  22,  
164-173.  
Putkuri, N., Kantele, A., Levanov, L., Kivistö, I., Brummer-Korvenkontio, M., Vaheri, A. & 
Vapalahti, O. 2016, Acute Human Inkoo and Chatanga Virus Infections, Finland, 
Emerging Infectious Diseases,  22,  5  
79 
 
Rasmussen, L.D., Kristensen, B., Kirkeby, C., Rasmussen, T.B., Belsham, G.J., Bodker, R. & 
Botner, A. 2012, Culicoids as vectors of Schmallenberg virus, Emerging infectious 
diseases,  18,  7,  1204-1206.  
Reese, S.M., Beaty, M.K., Gabitzsch, E.S., Blair, C.D. & Beaty, B.J. 2009, Aedes triseriatus 
Females Transovarially Infected With La Crosse Virus Mate More Efficiently Than 
Uninfected Mosquitoes, Journal of medical entomology,  46,  5,  1152 - 1158.  
Reeves, W.C., Scrivani, R.P., Hardy, J.L., Roberts, D.R. & Nelson, R.L. 1970, Buttonwillow 
virus, a new Arbovirus isolated from mammals and Culicoides midges in Kern 
County, California, The American Journal of Tropical Medicine and Hygiene,  19,  3,  
544-551.  
Reguera, J., Malet, H., Weber, F. & Cusack, S. 2013, Structural basis for encapsidation of 
genomic RNA by La Crosse Orthobunyavirus nucleoprotein, Proceedings of the 
National Academy of Sciences of the United States of America,  110,  18,  7246-7251.  
Reimann, C.A., Hayes, E.B., DiGuiseppi, C., Hoffman, R., Lehman, J.A., Lindsey, N.P., 
Campbell, G.L. & Fischer, M. 2008, Epidemiology of neuroinvasive arboviral disease 
in the United States, 1999-2007, The American Journal of Tropical Medicine and 
Hygiene,  79,  6,  974-979.  
Reisen, W.K. 2002, Medical and Veterinary Entomology: Epidemiology of vector-borne 
diseases, Academic Press, Burlington, MA, USA.  
Ritter, D.G. & Feltz, E.T. 1974, On the natural occurrence of California encephalitis virus 
and other arboviruses in Alaska, Canadian journal of microbiology,  20,  10,  1359-
1366.  
Roca-Garcia, M. 1944, The Isolation of Three Neurotropic Viruses from Forest Mosquitoes 
in Eastern Colombia, Journal of Infectious Diseases,  75,  2,  160-169.  
Rodrigues, F.M., Singh, P.B., Dandawate, C.N., Soman, R.S. & Bhatt, P.N. 1977, Kaikalur 
virus--a new arthropod-borne virus belonging to the Simbu group isolated in India 
from Culex tritaeniorhynchus (Giles), The Indian journal of medical research,  66,  5,  
719-725.  
Rogstad, D.K., Schiffman, E., Neitzel, D. & Baddour, L.M. 2015, Severe Sepsis Caused by 
California Serogroup Orthobunyavirus, Emerging infectious diseases,  21,  10,  1876-
1877.  
Russell, R.C., Cloonan, M.J., Wells, P.J. & Vale, T.G. 1991, Mosquito (Diptera: Culicidae) 
and arbovirus activity on the south coast of New South Wales, Australia, in 1985-
1988, Journal of medical entomology,  28,  6,  796-804.  
Sabattini, M.S., Shope, R.E. & Vanella, J.M. 1965, Serological survey for arboviruses in 
Cordoba Province, Argentina, The American Journal of Tropical Medicine and 
Hygiene,  14,  6,  1073-1078.  
Sahu, S.P., Landgraf, J., Wineland, N., Pedersen, D., Alstad, D. & Gustafson, G. 2000, 
Isolation of Jamestown Canyon virus (California virus group) from vesicular lesions of 
80 
 
a horse, Journal of veterinary diagnostic investigation : official publication of the 
American Association of Veterinary Laboratory Diagnosticians, Inc,  12,  1,  80-83.  
Sailleau, C., Boogaerts, C., Meyrueix, A., Laloy, E., Breard, E., Viarouge, C., Desprat, A., 
Vitour, D., Doceul, V., Boucher, C., Zientara, S., Nicolier, A. & Grandjean, D. 2013, 
Schmallenberg virus infection in dogs, France, 2012, Emerging infectious diseases,  
19,  11,  1896-1898.  
Saluzzo, J., Germain, M., Huard, M., Robin, Y., Gonzalez, J., Herve, J., Georges, A., Heme, 
G. & Digoutte, J. 1983, Le virus bozo (ArB 7343): Un nouvel arbovirus du groupe 
bunyamwera isolé en république centrafricaine; sa transmission expérimentale par 
Aedes aegypti, Annales de l'Institut Pasteur / Virologie,  134,  2,  221-232.   
Sanchez-Vargas, I., Travanty, E.A., Keene, K.M., Franz, A.W., Beaty, B.J., Blair, C.D. & 
Olson, K.E. 2004, RNA interference, arthropod-borne viruses, and mosquitoes, Virus 
research,  102,  1,  65-74.  
Sather, G.E. & Hammon, W.M. 1967, Antigenic patterns within the California-encephalitis-
virus group, The American Journal of Tropical Medicine and Hygiene,  16,  4,  548-
557.  
Savji, N., Palacios, G., Travassos da Rosa, A., Hutchison, S., Celone, C., Hui, J., Briese, T., 
Calisher, C.H., Tesh, R.B. & Lipkin, W.I. 2011, Genomic and phylogenetic 
characterization of Leanyer virus, a novel orthobunyavirus isolated in northern 
Australia, Journal of General Virology,  92,  7,  1676-1687.  
Schaffer, P.A. & Scherer, W.F. 1972, Growth of a candidate arbovirus (Tsuruse) in Aedes 
aegypti mosquitoes following intrathoracic inoculation, Proceedings of the Society 
for Experimental Biology and Medicine.Society for Experimental Biology and 
Medicine (New York, N.Y.),  139,  4,  1298-1304.  
Scherer, W.F., Anderson, K., Dickerman, R.W. & Ordonez, J.V. 1972, Studies of Patois 
group arboviruses in Mexico, Guatemala, Honduras, and British Honduras, The 
American Journal of Tropical Medicine and Hygiene,  21,  2,  194-200.  
Scherer, W.F., Campillo-Sainz, C., Dickerman, R.W., Diaz-Najera, A. & Madalengoitia, J. 
1967, Isolation of Tlacotalpan virus, a new Bunyamwera-group virus from Mexican 
mosquitoes, The American Journal of Tropical Medicine and Hygiene,  16,  1,  79-91.  
Scherer, W.F., Dickerman, R.W., Ordonez, J.V., Seymour, C.,3rd, Kramer, L.D., Jahrling, 
P.B. & Powers, C.D. 1976, Ecologic studies of Venezuelan encephalitis virus and 
isolations of Nepuyo and Patois viruses during 1968-1973 at a marsh habitat near 
the epicenter of the 1969 outbreak in Guatemala, The American Journal of Tropical 
Medicine and Hygiene,  25,  1,  151-162.  
Schmaljohn, C.S. & Hooper, J.W. 2007, Bunyaviridae: the viruses and their replication.In 
Fields' virology, Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, 
Pa.  
Service, M.W. 2008, Culicine mosquitoes, Medical Entomology for Students, 53.  
81 
 
Sexton, D.J., Rollin, P.E., Breitschwerdt, E.B., Corey, G.R., Myers, S.A., Dumais, M.R., 
Bowen, M.D., Goldsmith, C.S., Zaki, S.R., Nichol, S.T., Peters, C.J. & Ksiazek, T.G. 
1997, Life-threatening Cache Valley virus infection, The New England journal of 
medicine,  336,  8,  547-549.  
Seymour, C., Peralta, P.H. & Montgomery, G.G. 1983, Viruses isolated from Panamanian 
sloths, The American Journal of Tropical Medicine and Hygiene,  32,  6,  1435-1444.  
Shope, R.E., Causey, C.E. & Causey, O.R. 1961, Itaqui Virus, a New Member of Arthropod-
Borne Group C, The American Journal of Tropical Medicine and Hygiene,  10,  2,  264-
265.  
Simkova, A. & Sluka, F. 1973, Isolation of Tahyna virus from the blood of a case of 
influenza-like disease, Acta virologica, 17, 1, 94.  
Sirhongse, S. & Johnson, C.M. 1965, Wyeomyia Subgroup of Arbovirus: Isolation from 
Man, Science (New York, N.Y.), 149, 3686, 863-864.  
Sluka, F. 1969, Arboviruses of the California Complex and the Bunyamwera Group: The 
Clinical Picture of the Tahyna Virus Infection. Proceedings of the Symposium held at 
Smolenice near Bratislava October 18-21, 1966.  
Smithburn, K.C., Haddow, A.J. & Mahaffy, A.F. 1946, A neurotropic virus isolated from 
Aedes mosquitoes caught in the Semliki forest, The American Journal of Tropical 
Medicine and Hygiene,  26,  189-208.  
Smithburn, K.C., Kokernot, R.H., Heymann, C.S., Weinbren, M.P. & Zentkowsky, D. 1959, 
Neutralizing antibodies for certain viruses in the sera of human beings residing in 
Northern Natal, South African medical journal,  33,  27,  555-561.  
Smithburn, K.C., Mahaffy, A.F. & Paul, J.H. 1941, Bwamba Fever and Its Causative Virus, 
The American Journal of Tropical Medicine and Hygiene,  1-21,  1,  75-90.  
Soldan, S.S., Hollidge, B.S., Wagner, V., Weber, F. & Gonzalez-Scarano, F. 2010, La Crosse 
virus (LACV) Gc fusion peptide mutants have impaired growth and fusion 
phenotypes, but remain neurotoxic, Virology,  404,  2,  139-147.  
Spence, L., Anderson, C.R., Aitken, T.H. & Downs, W.G. 1967, Bushbush, Ieri and Lukuni 
viruses, three unrelated new agents isolated from Trinidadian forest mosquitoes, 
Proceedings of the Society for Experimental Biology and Medicine.Society for 
Experimental Biology and Medicine (New York, N.Y.),  125,  1,  45-50.  
Spence, L., Anderson, C.R., Aitken, T.H. & Downs, W.G. 1966, Nepuyo virus, a new group C 
agent isolated in Trinidad and Brazil. I. Isolation and properties of the Trinidadian 
strain, The American Journal of Tropical Medicine and Hygiene, 15, 1, 71-74.  
Spence, L., Anderson, C.R., Aitken, T.H. & Downs, W.G. 1962a, Bimiti virus, a new agent 
isolated from Trinidadian mosquitoes, The American Journal of Tropical Medicine 
and Hygiene,  11,  414-417.  
Spence, L., Anderson, C.R., Aitken, T.H. & Downs, W.G. 1962b, Melao virus, a new agent 
isolated from Trinidadian mosquitoes, The American Journal of Tropical Medicine 
and Hygiene,  11,  687-690.  
82 
 
Spence, L. & Downs, W.G. 1968, Virological investigations in Guyana, 1956-1966, The 
West Indian medical journal,  17,  2,  83-89.  
Srihongse, S., Galindo, P. & Grayson, M.A. 1966, Isolation of group C arboviruses in 
Panama including two new members, Patois and Zegla, The American Journal of 
Tropical Medicine and Hygiene,  15,  3,  379-384.  
Srihongse, S., Grayson, M.A. & Deibel, R. 1984, California serogroup viruses in New York 
State: the role of subtypes in human infections, The American Journal of Tropical 
Medicine and Hygiene, 33, 6, 1218-1227.  
St George, T.D., Cybinski, D.H., Filippich, C. & Carley, J.G. 1979, The isolation of three 
Simbu group viruses new to Australia, The Australian Journal of Experimental Biology 
and Medical Science,  57,  6,  581-582.  
St George, T.D., Standfast, H.A., Cybinski, D.H., Filippich, C. & Carley, J.G. 1980, Peaton 
virus: a new Simbu group arbovirus isolated from cattle and Culicoides brevitarsis in 
Australia, Australian Journal of Biological Sciences, 33, 2, 235-243.  
Standfast, H.A., Dyce, A.L., St George, T.D., Muller, M.J., Doherty, R.L., Carley, J.G. & 
Filippich, C. 1984, Isolation of arboviruses from insects collected at Beatrice Hill, 
Northern Territory of Australia, 1974-1976, Australian Journal of Biological Sciences,  
37,  5-6,  351-366.  
Stevenson, A.E. & Holmes, I.H. 1972, Electron microscopy of Koongol group arboviruses, 
Australian Journal of Biological Sciences, 25, 1, 53-60.  
Sudia, W.D., Fernandez, L., Newhouse, V.F., Sanz, R. & Calisher, C.H. 1975, Arbovirus 
vector ecology studies in Mexico during the 1972 Venezuelan equine encephalitis 
outbreak, American Journal of Epidemiology,  101,  1,  51-58.  
Sudia, W., Chamberl, RW, Calisher, C. & Newhouse, V. 1971, California Group Arboviruses 
- Isolations from Mosquitos in North-America, Mosquito News,  31,  4,  576-&.  
Tao, H., Xia, S.M., Chan, Z.Y., Song, G. & Yanagihara, R. 1987, Morphology and 
morphogenesis of viruses of hemorrhagic fever with renal syndrome. II. Inclusion 
bodies--ultrastructural markers of hantavirus-infected cells, Intervirology, 27, 1, 45-
52.  
Taylor, D.J., Lewis, A.L., Edman, J.D. & Jennings, W.L. 1971, California group arboviruses in 
Florida. Host-vector relations, The American Journal of Tropical Medicine and 
Hygiene,  20,  1,  139-145.  
Taylor, K.G. & Peterson, K.E. 2014, Innate immune response to La Crosse virus infection, 
Journal of neurovirology,  20,  2,  150-156.  
Tesh, R.B. & Beaty, B.J. 1983, Localization of California serogroup viruses in mosquitoes, 
Progress in clinical and biological research, 123, 67-75.  
Thompson, W.H. 1983, Vector-virus relationships, Progress in clinical and biological 
research, 123, 57-66.  
83 
 
Thompson, W.H., Anslow, R.O., Hanson, R.P. & Defoliart, G.R. 1972, La Crosse virus 
isolations from mosquitoes in Wisconsin, 1964-68, The American Journal of Tropical 
Medicine and Hygiene,  21,  2,  90-96.  
Thompson, W.H. & Beaty, B.J. 1977, Venereal transmission of La Crosse (California 
encephalitis) arbovirus in Aedes triseriatus mosquitoes, Science (New York, N.Y.),  
196,  4289,  530-531.  
Thompson, W.H., Kalfayan, B. & Anslow, R.O. 1965, Isolation of California Encephalitis 
Group Virus from a Fatal Human Illness, American Journal of Epidemiology,  81,  245-
253.  
Tignor, G.H., Burrage, T.G., Smith, A.L., Shope, R.E. & Bishop, D.H. 1983, California 
serogroup gene structure-function relationships: virulence and tissue tropisms, 
Progress in clinical and biological research, 123, 129-138.  
Tikasingh, E.S., Ardoin, P. & Williams, M.C. 1974, First isolation of Catu virus from a 
human in Trinidad, Tropical and geographical medicine, 26, 4, 414-416.  
Tingström, O., Wesula, L.O., Näslund, J., Spyckerelle, I., Engdahl, C., Von Schoenberg, P., 
Ahlm, C., Evander, M. & Bucht, G. 2016, Detection of Sindbis and Inkoo Virus RNA in 
Genetically Typed Mosquito Larvae Sampled in Northern Sweden, Vector Borne 
Zoonotic Disease, 16 (7), 461-467. 
Top, F.H.,Jr, Kraivapan, C., Grossman, R.A., Rozmiarek, H., Edelman, R. & Gould, D.J. 1974, 
Ingwavuma virus in Thailand. Infection of domestic pigs, The American Journal of 
Tropical Medicine and Hygiene, 23,  2,  251-257.  
Traavik, T., Mehl, R. & Wiger, R. 1985, Mosquito-borne arboviruses in Norway: further 
isolations and detection of antibodies to California encephalitis viruses in human, 
sheep and wildlife sera, The Journal of hygiene,  94,  1,  111-122.  
Traavik, T., Mehl, R. & Wiger, R. 1978, California encephalitis group viruses isolated from 
mosquitoes collected in Southern and Arctic Norway, Acta Pathologica et 
Microbiologica Scandinavica. Section B, Microbiology, 86B, 6, 335-341.  
Ushijima, H., Klimas, R., Kim, S., Cash, P. & Bishop, D.H. 1980, Characterization of the viral 
ribonucleic acids and structural polypeptides of Anopheles A, Bunyamwera, Group C, 
California, Capim, Guama, Patois, and Simbu bunyaviruses, The American Journal of 
Tropical Medicine and Hygiene,  29,  6,  1441-1452.  
Vaheri, A., Henttonen, H., Voutilainen, L., Mustonen, J., Sironen, T. & Vapalahti, O. 2013, 
Hantavirus infections in Europe and their impact on public health, Reviews in 
medical virology,  23,  1,  35-49.  
van Eeden, C., Williams, J.H., Gerdes, T.G., van Wilpe, E., Viljoen, A., Swanepoel, R. & 
Venter, M. 2012, Shuni virus as cause of neurologic disease in horses, Emerging 
infectious diseases,  18,  2,  318-321.  
Vanlandingham, D.L., Davis, B.S., Lvov, D.K., Samokhvalov, E., Lvov, S.D., Black, W.C., 
Higgs, S. & Beaty, B.J. 2002, Molecular characterization of California serogroup 
84 
 
viruses isolated in Russia, The American Journal of Tropical Medicine and Hygiene,  
67,  3,  306-309.  
Vapalahti, O., Kallio-Kokko, H., Narvanen, A., Julkunen, I., Lundkvist, A., Plyusnin, A., 
Lehvaslaiho, H., Brummer-Korvenkontio, M., Vaheri, A. & Lankinen, H. 1995, Human 
B-cell epitopes of Puumala virus nucleocapsid protein, the major antigen in early 
serological response, Journal of medical virology,  46,  4,  293-303.  
Vapalahti, O., Plyusnin, A., Cheng, Y., Manni, T., Brummer-Korvenkontio, M. & Vaheri, A. 
1996, Inkoo and Tahyna, the European California serogroup bunyaviruses: sequence 
and phylogeny of the S RNA segment, The Journal of general virology,  77 ( Pt 8),  Pt 
8,  1769-1774.  
Walder, R., Suarez, O.M. & Calisher, C.H. 1984, Arbovirus studies in southwestern 
Venezuela during 1973-1981. II. Isolations and further studies of Venezuelan and 
eastern equine encephalitis, Una, Itaqui, and Moju viruses, The American Journal of 
Tropical Medicine and Hygiene,  33,  3,  483-491.  
Watts, D.M., DeFoliart, G.R. & Yuill, T.M. 1976, Experimental transmission of trivittatus 
virus (California virus group) by Aedes trivittatus, The American Journal of Tropical 
Medicine and Hygiene,  25,  1,  173-176.  
Watts, D.M., Pantuwatana, S., DeFoliart, G.R., Yuill, T.M. & Thompson, W.H. 1973, 
Transovarial Transmission of LaCrosse Virus (California Encephalitis Group) in the 
Mosquito, Aedes triseriatus, Science,  182,  4117,  1140 -1141.  
Watts, D.M., Thompson, W.H., Yuill, T.M., DeFoliart, G.R. & Hanson, R.P. 1974, 
Overwintering of La Crosse virus in Aedes triseriatus, The American Journal of 
Tropical Medicine and Hygiene,  23,  4,  694-700.  
Weaver, S.C., Coffey, L.L., Nussenzveig, R., Ortiz, D. & Smith, D. 2004, Microbe-Vector 
Interactions in Vector-Borne Diseases: Vector competence, Cambridge University 
Press, West Nyack, NY, USA.  
Whitehouse, C.A. 2004, Crimean-Congo hemorrhagic fever, Antiviral Research, 64, 3, 145-
160.  
Whitman, L. & Shope, R.E. 1962, The California complex of arthropod-borne viruses and 
its relationship to the Bunyamwera group through Guaroa virus, The American 
Journal of Tropical Medicine and Hygiene, 11,  691-696.  
Williams, J.E., Imlarp, S., Top, F.H.,Jr, Cavanaugh, D.C. & Russell, P.K. 1976, Kaeng Khoi 
virus from naturally infected bedbugs (cimicidae) and immature free-tailed bats, 
Bulletin of the World Health Organization,  53,  4,  365-369.  
Williams, M.C., Woodall, J.P. & Corbet, P.S. 1965, Nyando Virus: a Hitherto Undescribed 
Virus Isolated from Anopheles Funestus Giles Collected in Kenya, Archiv fur die 
Gesamte Virusforschung, 15, 422-427.  
Wills, W., Pidcoe, V., Carroll, D.F. & Satz, J.E. 1974, Isolation of California group 
arboviruses from Pennsylvania mosquitoes--1971, 1972.  
85 
 
Woodring, J., Chandler, L.J., Oray, C.T., McGaw, M.M., Blair, C.D. & Beaty, B.J. 1998, Short 
report: Diapause, transovarial transmission, and filial infection rates in geographic 
strains of La Crosse virus-infected Aedes triseriatus, The American Journal of Tropical 
Medicine and Hygiene,  58,  5,  587-588.  
Yanase, T., Fukutomi, T., Yoshida, K., Kato, T., Ohashi, S., Yamakawa, M. & Tsuda, T. 2004, 
The emergence in Japan of Sathuperi virus, a tropical Simbu serogroup virus of the 
genus Orthobunyavirus, Archives of Virology,  149,  5,  1007-1013.  
Yanase, T., Kato, T., Aizawa, M., Shuto, Y., Shirafuji, H., Yamakawa, M. & Tsuda, T. 2012, 
Genetic reassortment between Sathuperi and Shamonda viruses of the genus 
Orthobunyavirus in nature: implications for their genetic relationship to 
Schmallenberg virus, Archives of Virology, 157, 8, 1611-1616.  
Yanase, T., Maeda, K., Kato, T., Nyuta, S., Kamata, H., Yamakawa, M. & Tsuda, T. 2005, 
The resurgence of Shamonda virus, an African Simbu group virus of the genus 
Orthobunyavirus, in Japan, Archives of Virology,  150,  2,  361-369.  
Yang, D.K., Kim, B.H., Kweon, C.H., Nah, J.J., Kim, H.J., Lee, K.W., Yang, Y.J. & Mun, K.W. 
2008, Serosurveillance for Japanese encephalitis, Akabane, and Aino viruses for 
Thoroughbred horses in Korea, Journal of veterinary science,  9,  4,  381-385.  
Yuill, T.M. 1983, The role of mammals in the maintenance and dissemination of La Crosse 
virus, Progress in clinical and biological research, 123, 77-87.  
Zamparo, J.M., Andreadis, T.G., Shope, R.E. & Tirrell, S.J. 1997, Serologic evidence of 
Jamestown Canyon virus infection in white-tailed deer populations from 
Connecticut, Journal of wildlife diseases,  33,  3,  623-627.  
Zarnke, R.L., Calisher, C.H. & Kerschner, J. 1983, SEROLOGIC EVIDENCE OF ARBOVIRUS 
INFECTIONS IN HUMANS AND WILD ANIMALS IN ALASKA, Journal of wildlife diseases,  
19,  3,  175-179.  
Zeller, H.G., Diallo, M., Angel, G., Traore-Lamizana, M., Thonnon, J., Digoutte, J.P. & 
Fontenille, D. 1996, Ngari virus (Bunyaviridae: Bunyavirus). First isolation from 
humans in Senegal, new mosquito vectors, its epidemiology, Bulletin de la Societe de 
pathologie exotique (1990), 89, 1, 12-16.  
Zhang, H.L., Zhang, Y.Z., Yang, W.H., Feng, Y., Nasci, R.S., Yang, J., Liu, Y.H., Dong, C.L., Li, 
S., Zhang, B.S., Yin, Z.L., Wang, P.Y., Fu, S.H., Li, M.H., Liu, F., Zhang, J., Sun, J., Li, 
C.W., Gao, X.Y., Liu, H., Wang, H.Y., Petersen, L.R. & Liang, G.D. 2013, Mosquitoes of 
Western Yunnan Province, China: seasonal abundance, diversity, and arbovirus 
associations, PloS one, 8, 10, e77017.  
Zhang, Z. 2011, Animal biodiversity: An introduction to higher-level classification and 
taxonomic richness, Zootaxa, 3148,  1-237.  
 
 
 
86
 
  AP
PE
N
D
IX
 1
.   
 Su
m
m
ar
y 
of
 th
e 
se
ro
gr
ou
ps
 in
 g
en
us
 o
rt
ho
bu
ny
av
iru
s.
 T
he
 ta
bl
e 
sh
ow
s 
th
e 
sp
ec
ie
s 
th
at
 b
el
on
g 
to
 e
ac
h 
se
ro
gr
ou
p,
 th
e 
iso
la
te
s 
of
 e
ve
ry
 
sp
ec
ie
s,
 th
ei
r d
ise
as
e 
as
so
ci
at
io
n,
 th
ei
r d
ist
rib
ut
io
n 
an
d 
ar
th
ro
po
d 
ve
ct
or
s f
ro
m
 w
hi
ch
 th
ey
 h
av
e 
be
en
 is
ol
at
ed
.  
 
Se
ro
gr
ou
p 
 
Sp
ec
ie
s 
St
ra
in
s/
ty
pe
s 
Di
se
as
e:
 
Is
ol
at
io
n 
/ 
an
tib
od
ie
s d
et
ec
te
d 
Is
ol
at
io
n 
ar
ea
/ 
Di
st
rib
ut
io
n 
Ar
th
ro
po
d 
ve
ct
or
 (i
so
la
te
d 
fr
om
) 
An
op
he
le
s A
  
(C
al
ish
er
 e
t a
l. 
19
80
) 
An
op
he
le
s A
 v
iru
s 
An
op
he
le
s A
 v
iru
s (
AN
AV
) 
- (
Ro
ca
-G
ar
ci
a 
19
44
) 
Co
lu
m
bi
a 
An
op
he
le
s (
Ke
rt
es
zia
) 
bo
liv
ie
ns
is 
La
s M
al
oy
as
 v
iru
s (
LM
V)
 
- (
M
itc
he
ll 
et
 a
l. 
19
85
) 
Ar
ge
nt
in
a 
An
op
he
le
s a
lb
ita
rs
is 
Lu
ku
ni
 v
iru
s (
LU
KV
) 
- (
Sp
en
ce
 e
t a
l. 
19
67
) 
Tr
in
id
ad
 
O
ch
le
ro
ta
tu
s s
ca
pu
la
ris
 
Tr
om
be
ta
s v
iru
s (
TR
M
V)
 
 - 
(C
al
ish
er
 e
t a
l. 
19
73
) 
 
 
Ta
ca
iu
m
a 
vi
ru
s 
Ta
ca
iu
m
a 
vi
ru
s (
TC
M
V)
 
- H
um
an
 (C
al
ish
er
 e
t a
l. 
19
80
, 
Ca
us
ey
 e
t a
l. 
19
61
) 
Br
az
il 
An
op
he
le
s s
p.
 
Co
Ar
10
71
 v
iru
s (
CA
10
71
 V
) 
- (
Ca
lis
he
r e
t a
l. 
19
80
) 
Co
lu
m
bi
a 
W
ye
om
yi
a 
sp
. 
Co
Ar
36
24
 v
iru
s (
CA
36
24
 V
) 
- (
Ca
lis
he
r e
t a
l. 
19
80
, C
al
ish
er
 e
t 
al
. 1
97
3)
 
Co
lu
m
bi
a 
An
op
he
le
s n
ei
ua
i 
Vi
rg
in
 R
iv
er
 v
iru
s (
VR
V)
 
- (
Ca
lis
he
r e
t a
l. 
19
80
) 
Ar
izo
na
, U
SA
 
An
op
he
le
s f
re
eb
on
ti 
An
op
he
le
s B
  
An
op
he
le
s B
 v
iru
s 
An
op
he
le
s B
 v
iru
s (
AN
BV
) 
- (
Ro
ca
-G
ar
ci
a 
19
44
) 
Co
lo
m
bi
a 
An
op
he
le
s (
Ke
rt
es
zia
) 
bo
liv
ie
ns
is 
Bo
ra
ce
ia
 v
iru
s (
BO
RV
) 
- (
Lo
pe
s O
de
 e
t a
l. 
19
66
) 
Br
as
ili
a 
 
Ba
ka
u 
 
Ba
ka
u 
vi
ru
s 
Ba
ka
u 
vi
ru
s (
BA
KV
) 
M
ac
ac
a 
fa
sc
ic
ul
ar
is,
 b
at
s,
 w
ild
 
bi
rd
s,
 fo
w
l (
M
ar
ch
et
te
 1
99
4)
 
M
al
ay
sia
/P
ak
ist
an
 
Cu
le
x 
sp
. 
Ke
ta
pa
ng
 v
iru
s (
KE
TV
) 
- (
M
ar
ch
et
te
 1
99
4)
  
M
al
ay
sia
 
Cu
le
x 
(L
op
ho
ce
ra
to
m
yi
a)
 sp
. 
N
ol
a 
vi
ru
s (
N
O
LA
V)
 
- (
M
ar
ch
et
te
 1
99
4)
  
Ce
nt
ra
l A
fr
ic
a 
Cu
le
x 
pe
rfu
sc
us
 
Ta
nj
on
g 
Ra
bo
k 
vi
ru
s (
TR
V)
 
M
. n
em
es
tr
in
a,
 h
um
an
s,
 sq
ui
rr
el
, 
ba
ts
, w
ild
 b
ird
s (
M
ar
ch
et
te
 1
99
4)
  
M
al
ay
sia
 
N
ot
 is
ol
at
ed
 fr
om
 a
rt
hr
op
od
s 
Te
lo
k 
Fo
re
st
 v
iru
s (
TF
V)
 
M
. n
em
es
tr
in
a 
(M
ar
ch
et
te
 1
99
4)
 
M
al
ay
sia
 
N
ot
 is
ol
at
ed
 fr
om
 a
rt
hr
op
od
s 
87
 
 
Bu
ny
am
w
er
a 
Bu
ny
am
w
er
a 
vi
ru
s 
Bu
ny
am
w
er
a 
vi
ru
s (
BU
N
V)
 
Hu
m
an
s,
 m
on
ke
ys
, d
om
es
tic
 
an
im
al
s,
 ro
de
nt
s,
 b
ird
s (
Ko
ke
rn
ot
 
et
 a
l. 
19
58
, S
m
ith
bu
rn
, H
ad
do
w
 &
 
M
ah
af
fy
 1
94
6)
  
Af
ric
a 
Ae
de
s s
pp
., 
M
an
so
ni
a 
sp
., 
Cu
le
x 
sp
. 
Ba
ta
i v
iru
s (
BA
TV
) 
Ca
tt
le
, h
um
an
s (
N
as
he
d,
 O
lso
n 
&
 
el
-T
ig
an
i 1
99
3,
 L
iu
 e
t a
l. 
20
14
, 
Hu
ba
le
k 
20
08
) 
Eu
ro
pe
, A
sia
, S
ud
an
 
Cu
le
x 
ge
lid
us
, A
n.
 m
ac
ul
ip
en
ni
s 
Ca
ch
e 
Va
lle
y 
vi
ru
s (
CV
V)
 
Ca
tt
le
, h
um
an
s,
 h
or
se
s,
 d
ee
r, 
ro
de
nt
s (
Ch
un
g 
et
 a
l. 
19
90
, S
ex
to
n 
et
 a
l. 
19
97
, H
ol
de
n,
 H
es
s 1
95
9,
 
Bu
es
ch
er
 e
t a
l. 
19
70
, M
cL
ea
n,
 
Ca
lis
he
r &
 P
ar
ha
m
 1
98
7)
 
N
or
th
 a
nd
 C
en
tr
al
 
Am
er
ic
a 
M
am
m
al
ph
ili
c m
os
qu
ito
 
(A
nd
re
ad
is 
et
 a
l. 
20
14
) 
Fo
rt
 S
he
rm
an
 v
iru
s (
FS
V)
 
Hu
m
an
s (
M
an
gi
af
ic
o 
et
 a
l. 
19
88
) 
Pa
na
m
a 
N
ot
 is
ol
at
ed
 fr
om
 a
rt
hr
op
od
s 
Ge
rm
ist
on
 v
iru
s (
GE
RV
) 
Hu
m
an
s,
 ro
de
nt
s (
Ko
ke
rn
ot
 e
t a
l. 
19
60
, H
en
de
rs
on
 e
t a
l. 
19
72
) 
Af
ric
a 
Cu
le
x 
Th
ei
le
ri,
 C
ul
ex
 R
ub
in
ot
us
 
Ile
sh
a 
vi
ru
s (
IL
EV
) 
re
as
so
rt
an
t 
Hu
m
an
s (
Pa
ch
le
r, 
Ru
ze
k 
&
 
N
ow
ot
ny
 2
01
3,
 O
ku
no
 1
96
1)
 
Af
ric
a 
An
op
he
le
s g
am
bi
ae
 
N
ga
ri 
vi
ru
s (
N
RI
G)
 
re
as
so
rt
an
t (
BU
N
M
V+
BA
TV
) 
Hu
m
an
s (
Ge
rr
ar
d 
et
 a
l. 
20
04
, Z
el
le
r 
et
 a
l. 
19
96
) 
Ea
st
, s
ub
-S
ah
ar
a 
Af
ric
a 
St
eg
om
yi
a 
sim
ps
on
i 
N
or
th
w
ay
 v
iru
s (
N
O
RV
) 
Hu
m
an
s,
 h
or
se
s,
 d
ee
r (
Za
rn
ke
, 
Ca
lis
he
r &
 K
er
sc
hn
er
 1
98
3,
 
Ca
m
pb
el
l e
t a
l. 
19
91
) 
N
or
th
 A
m
er
ic
a 
An
op
he
le
s f
re
eb
or
ni
, A
ed
es
 
sie
rr
en
sis
 
Sh
ok
w
e 
vi
ru
s (
SH
O
V)
 
Hu
m
an
s (
Hu
nt
, C
al
ish
er
 1
97
9)
 
Ar
bo
Ca
t*
 
So
ut
h 
Af
ric
a,
 S
en
eg
al
, 
Ke
ny
a,
 Iv
or
y 
Co
as
t 
Ae
de
s, 
An
op
he
le
s a
nd
 
M
an
so
ni
a 
m
os
qu
ito
es
 
Xi
ng
u 
vi
ru
s (
XI
N
V)
 Be
H 
38
84
64
 
st
ra
in
 
Hu
m
an
s (
M
ar
ch
et
te
 1
99
4,
 C
al
ish
er
 
et
 a
l. 
19
88
) 
Br
az
il 
N
ot
 is
ol
at
ed
 fr
om
 a
rt
hr
op
od
s 
Bi
ra
o 
vi
ru
s (
BI
RV
) D
ak
Ar
 B
 2
19
8  
- A
rb
oC
at
* 
 
Ce
nt
ra
l A
fr
ic
a 
An
op
he
le
s p
ha
ro
en
sis
, 
An
op
he
le
s s
qu
am
os
us
 
Bo
zo
 v
iru
s (
BO
ZO
V)
 
Hu
m
an
s (
Sa
lu
zz
o 
et
 a
l. 
19
83
) 
Ce
nt
ra
l A
fr
ic
a 
St
eg
om
yi
a 
op
ok
, A
. a
fri
ca
nu
s 
Lo
ke
rn
 v
iru
s (
LO
KV
) 
Hu
m
an
s,
 ro
de
nt
s,
 h
ar
es
, d
om
es
tic
 
U
SA
 
Cu
le
x 
ta
rs
al
is,
 c
ul
ic
oi
de
s 
88
 
 
an
im
al
s (
An
on
ym
ou
s1
97
0c
, 
Ca
lis
he
r e
t a
l. 
19
86
) 
M
ag
ua
ri 
vi
ru
s (
M
AG
V)
CA
CV
 
Be
Ar
72
72
 
Ho
rs
es
 (C
au
se
y 
et
 a
l. 
19
61
, S
pe
nc
e,
 
Do
w
ns
 1
96
8,
 S
ab
at
tin
i, 
Sh
op
e 
&
 
Va
ne
lla
 1
96
5)
 h
um
an
, c
at
tle
 
So
ut
h 
Am
er
ic
a 
M
am
m
al
ph
ili
c m
os
qu
ito
 
(C
al
ish
er
 e
t a
l. 
19
83
) 
M
bo
ke
 v
iru
s (
M
BO
V)
† 
- A
rb
oC
at
* 
Ca
m
er
oo
n 
O
ch
. i
ng
ra
m
i 
Pl
ay
as
 v
iru
s (
PL
AV
) 
- (
Ca
lis
he
r e
t a
l. 
19
83
) 
Ec
ua
do
r 
Ae
de
s t
ae
ni
or
hy
nc
hu
s 
Po
to
si 
vi
ru
s (
PO
TV
) 
re
as
so
rt
an
t (
CC
V+
KR
IV
) 
De
er
 (F
ra
nc
y 
et
 a
l. 
19
90
, M
cL
ea
n 
et
 
al
. 1
99
6)
  
U
SA
 
St
eg
om
yi
a 
al
bo
pi
ct
a,
 
M
am
m
al
ph
ili
c m
os
qu
ito
 
(A
nd
er
so
n 
et
 a
l. 
20
15
) 
Sa
nt
a 
Ro
sa
 v
iru
s (
SA
RV
) 
- (
Ca
lis
he
r e
t a
l. 
19
86
, S
ud
ia
 e
t a
l. 
19
75
) 
M
ex
ic
o 
Ae
de
s a
ng
us
tiv
itt
at
us
 
Te
ns
aw
 v
iru
s (
TE
N
V)
 
Hu
m
an
s,
 d
og
s,
 c
ow
s (
Co
le
m
an
 
19
69
, C
ha
m
be
rla
in
, S
ud
ia
 &
 
Co
le
m
an
 1
96
9)
  
U
SA
 
An
op
he
le
s s
p.
, P
so
ro
ph
or
a 
sp
., 
Ae
de
s s
p.
, C
ul
ex
 sp
., 
M
an
so
ni
a 
sp
. 
Tl
ac
ot
al
pa
n 
vi
ru
s (
TL
AV
) 
Hu
m
an
s,
 c
at
tle
, p
ig
s,
 c
hi
ck
en
s 
(S
ch
er
er
 e
t a
l. 
19
67
) 
M
ex
ic
o 
M
an
eo
ni
a 
tit
ill
an
s, 
An
op
he
le
s 
al
bi
m
an
us
, A
ed
es
 
ta
en
io
rh
yn
ch
us
, 
An
he
m
bi
 v
iru
s (
AM
BV
) 
Ro
de
nt
, h
um
an
s (
DE
 S
ou
za
 L
op
es
 
et
 a
l. 
19
75
) 
Br
az
il 
Ph
on
io
m
yi
a 
pi
lic
au
da
, 
Tr
ic
ho
pr
os
op
on
 p
al
lid
iv
en
te
r 
Ch
ol
ul
 v
iru
s (
CH
LV
) 
re
as
so
rt
an
t 
(C
VV
+P
O
TV
) 
Hu
m
an
s,
 h
or
se
s,
 sh
ee
p 
(B
lit
vi
ch
 e
t 
al
. 2
01
2a
, B
lit
vi
ch
 e
t a
l. 
20
12
b)
 
M
ex
ic
o 
M
os
qu
ito
es
 
Gu
ar
oa
 v
iru
s  
Gu
ar
oa
 v
iru
s (
GR
O
V)
 
Hu
m
an
s (
Gr
oo
t e
t a
l. 
19
59
) 
So
ut
h 
Am
er
ic
a 
An
op
he
le
s s
p.
 
Ka
iri
 v
iru
s  
Ka
iri
 v
iru
s (
KR
IV
) 
 
Ho
rs
es
, h
um
an
s,
 d
on
ke
ys
 (C
al
ish
er
 
et
 a
l. 
19
88
, A
nd
er
so
n 
et
 a
l. 
19
60
)  
So
ut
h 
Am
er
ic
a 
O
ch
le
ro
ta
tu
s s
ca
pu
la
ris
, 
W
ye
om
yi
a 
sp
., 
Ps
or
op
ho
ra
 sp
. 
an
d 
Cu
le
x 
sp
iss
ip
es
 
M
ai
n 
Dr
ai
n 
vi
ru
s 
M
ai
n 
Dr
ai
n 
vi
ru
s (
M
DV
) 
re
as
so
rt
an
t (
CC
V+
KR
IV
) 
Ho
rs
es
, L
ep
us
 C
al
ifo
rn
ic
us
, 
ru
m
in
an
ts
 (E
m
m
on
s e
t a
l. 
19
83
) 
 
U
SA
 
Cu
lic
oi
de
s v
ar
iip
en
ni
s, 
O
ch
le
ro
ta
tu
s  t
ae
ni
or
hy
nc
hu
s 
89
 
 
Bw
am
ba
  
(G
ro
se
th
 e
t a
l. 
20
14
) 
Bw
am
ba
 v
iru
s 
Bw
am
ba
 v
iru
s (
BW
AV
) 
Hu
m
an
s,
 d
on
ke
ys
, b
ird
s,
 m
on
ke
ys
 
(S
m
ith
bu
rn
, M
ah
af
fy
 &
 P
au
l 1
94
1,
 
Lu
tw
am
a 
et
 a
l. 
20
02
)  
Af
ric
a 
An
op
he
le
s f
un
es
tu
s, 
An
op
he
le
s 
ga
m
bi
ae
 
Po
ng
ol
a 
vi
ru
s (
PG
AV
) 
Hu
m
an
s,
 ru
m
in
an
ts
 (K
ok
er
no
t e
t 
al
. 1
95
7,
 K
al
un
da
 e
t a
l. 
19
85
) 
Af
ric
a 
N
eo
m
el
an
ico
ni
on
 
ci
rc
um
lu
te
ol
us
, o
th
er
 A
ed
es
 sp
., 
M
an
so
ni
a 
sp
., 
An
op
he
le
s s
p.
 
Ca
lif
or
ni
a 
 
(C
al
ish
er
 1
98
3)
 
Ca
lif
or
ni
a 
en
ce
ph
al
iti
s v
iru
s 
Ca
lif
or
ni
a 
en
ce
ph
al
iti
s v
iru
s 
(C
EV
) 
Hu
m
an
s,
 h
or
se
s,
 c
ow
s,
 ra
bb
its
, 
gr
ou
nd
 sq
ui
rr
el
s (
Ha
m
m
on
, R
ee
ve
s 
&
 S
at
he
r 1
95
2,
 H
am
m
on
, R
ee
ve
s 
19
52
)  
U
SA
, C
an
ad
a 
Ae
de
s d
or
sa
lis
, C
ul
ex
 ta
rs
al
is,
 
ot
he
r A
ed
es
 sp
., 
Cu
lis
et
a 
sp
.  
In
ko
o 
vi
ru
s (
IN
KV
) 
Hu
m
an
s,
 c
ow
s,
 d
ee
r, 
ha
re
s 
(B
ru
m
m
er
-K
or
ve
nk
on
tio
 e
t a
l. 
19
73
, B
ru
m
m
er
-K
or
ve
nk
on
tio
 
19
73
a)
   
N
or
th
er
n 
Eu
ro
pe
 
O
ch
le
ro
ta
tu
s 
co
m
m
un
is/
pu
nc
to
r 
Ja
m
es
to
w
n 
Ca
ny
on
 v
iru
s 
(JC
V)
 
Hu
m
an
s,
 d
ee
r, 
ho
rs
es
, m
oo
se
 
(D
eF
ol
ia
rt
 e
t a
l. 
19
69
, Z
am
pa
ro
 e
t 
al
. 1
99
7,
 G
rim
st
ad
 e
t a
l. 
19
86
, S
ah
u 
et
 a
l. 
20
00
, M
cF
ar
la
ne
 e
t a
l. 
19
81
a)
 U
SA
, C
an
ad
a 
Ae
de
s s
p.
, C
ul
ise
ta
 sp
., 
ho
rs
ef
ly
 
an
d 
de
er
fly
 
La
 C
ro
ss
e 
vi
ru
s (
LA
CV
) 
Hu
m
an
s,
 c
hi
pm
un
ks
, s
qu
irr
el
s 
(T
ho
m
ps
on
, K
al
fa
ya
n 
&
 A
ns
lo
w
 
19
65
, B
al
fo
ur
 e
t a
l. 
19
73
, G
au
ld
 e
t 
al
. 1
97
5,
 K
sia
ze
k,
 Y
ui
ll 
19
77
)  
U
SA
 
O
ch
le
ro
ta
tu
s t
ris
er
ia
tu
s, 
ot
he
r 
Ae
de
s s
p.
 a
nd
 C
ul
ex
 sp
. 
Sn
ow
sh
oe
 h
ar
e 
vi
ru
s (
SS
HV
) 
Le
pu
s a
m
er
ic
an
us
, h
um
an
s,
 h
or
se
s,
 
m
oo
se
, d
ee
r (
Bu
rg
do
rf
er
, 
N
ew
ho
us
e 
&
 T
ho
m
as
 1
96
1,
 H
ea
th
 
et
 a
l. 
19
89
, M
ei
er
-S
te
ph
en
so
n 
et
 
al
. 2
00
7,
 M
cL
ea
n 
19
83
, M
cF
ar
la
ne
 
et
 a
l. 
19
81
b)
  
N
or
th
 A
m
er
ic
a,
 R
us
sia
 
Ae
de
s s
p.
 a
nd
 C
ul
ise
ta
 sp
. 
So
ut
h 
riv
er
 v
iru
s (
SO
RV
) 
Ho
rs
es
, s
he
ep
, d
og
s (
Su
di
a 
et
 a
l. 
19
71
, B
lit
vi
ch
 e
t a
l. 
20
12
d,
 B
lit
vi
ch
 
et
 a
l. 
20
12
c)
  
So
ut
h 
Am
er
ic
a,
 N
or
th
 
Am
er
ic
a 
Ae
de
s s
p.
, A
no
ph
el
es
 sp
., 
Cu
le
x 
sp
. a
nd
 C
ul
ise
ta
 sp
. 
90
 
 
Ta
hy
na
 v
iru
s (
TA
HV
) 
Hu
m
an
 “
Va
lti
ce
 fe
ve
r”
, h
ar
es
, 
he
dg
eh
og
s,
 ro
de
nt
s,
 c
at
tle
, h
or
se
s,
 
w
ild
 b
ird
s (
Ba
rd
os
 e
t a
l. 
19
75
, 
Hu
ba
le
k 
20
08
, L
u 
et
 a
l. 
20
09
)  
Eu
ro
pe
, A
fr
ic
a,
 A
sia
 
Ae
de
s s
p.
, O
ch
le
ro
ta
tu
s s
p.
  
an
d 
Cu
lis
et
a 
sp
., 
Cu
le
x 
sp
., 
An
op
he
le
s s
p.
 
Ke
ys
to
ne
 v
iru
s (
KE
YV
) 
Ho
rs
es
, h
um
an
s,
 ra
bb
its
, r
at
s 
(B
on
d 
et
 a
l. 
19
66
, P
ar
ki
n,
 H
am
m
on
 
&
 S
at
he
r 1
97
2)
  
U
SA
 
O
ch
le
ro
ta
tu
s s
p.
, C
ul
ex
, s
p,
 
An
op
he
le
s s
p.
 
M
el
ao
 v
iru
s (
M
EL
V)
 
Hu
m
an
s,
 h
or
se
s  
(S
pe
nc
e 
et
 a
l. 
19
62
b,
 C
al
ish
er
 e
t a
l. 
19
87
)  
Tr
in
id
ad
, B
ra
zil
, 
Ar
ge
nt
in
a 
Ae
de
s s
p.
 a
nd
 P
so
ro
ph
or
a 
sp
 
Sa
n 
An
ge
lo
 v
iru
s (
SA
V)
 
De
er
 (S
ud
ia
 e
t a
l. 
19
71
, S
at
he
r, 
Ha
m
m
on
 1
96
7)
  
U
SA
 
An
op
he
le
s p
se
ud
op
un
ct
ip
en
ni
s 
Se
rr
a 
do
 N
av
io
 v
iru
s (
SD
N
V)
 
Hu
m
an
s, 
la
rg
e 
Am
er
ic
an
 
op
os
su
m
s,
 P
ro
ec
hi
m
ys
 (S
ou
th
 
Am
er
ic
an
 sp
in
y 
ra
ts
) (
Le
Du
c 
19
87
, 
Ka
ra
ba
ts
os
 1
98
5)
  
Br
az
il 
O
ch
le
ro
ta
tu
s f
ul
vu
s 
Tr
iv
itt
at
us
 v
iru
s (
TV
TV
) 
Hu
m
an
s (
Sa
th
er
, H
am
m
on
 1
96
7,
 
Le
w
is 
et
 a
l. 
19
65
)  
U
SA
 
O
ch
le
ro
ta
tu
s t
riv
itt
at
us
 a
nd
 
ot
he
r A
ed
es
 sp
., 
Cu
le
x 
sp
. a
nd
 
M
an
so
ni
a 
sp
. 
Ch
at
an
ga
 v
iru
s (
CH
AT
V)
 
Hu
m
an
 (L
av
re
nt
'e
v 
et
 a
l. 
20
08
, 
Pu
tk
ur
i e
t a
l. 
20
14
) 
Ru
ss
ia
, F
in
la
nd
 
O
ch
le
ro
ta
tu
s s
p.
, A
ed
es
 sp
. 
Ca
pi
m
 
(U
sh
iji
m
a 
et
 a
l. 
19
80
) 
Ac
ar
a 
vi
ru
s 
Ac
ar
a 
vi
ru
s (
AC
AV
) 
- (
Ca
lis
he
r e
t a
l. 
19
83
)  
Pa
na
m
a,
 B
ra
zil
 
Cu
le
x 
sp
. 
M
or
ic
he
 v
iru
s (
M
O
RV
) 
- (
Jo
nk
er
s e
t a
l. 
19
68
a)
 
Tr
in
id
ad
 
Cu
le
x 
am
az
on
en
sis
 
Be
ne
vi
de
s v
iru
s 
Be
ne
vi
de
s v
iru
s (
BV
SV
) 
- A
rb
oC
at
* 
Br
az
il 
Cu
le
x 
sp
. 
Bu
sh
bu
sh
 v
iru
s 
Bu
sh
bu
sh
 v
iru
s (
BS
BV
) 
- (
Sp
en
ce
 e
t a
l. 
19
67
, J
on
ke
rs
 e
t a
l. 
19
68
a)
 
Br
az
il,
 T
rin
id
ad
 
Cu
le
x 
am
az
on
en
sis
,  
Cx
. a
cc
el
er
an
s 
Be
nf
ic
a 
vi
ru
s (
BE
N
V)
 
Ro
de
nt
s,
  A
rb
oC
at
* 
 
Br
az
il 
Cu
le
x 
sp
. 
Ju
an
 D
ia
z v
iru
s (
JD
V)
 
- (
An
on
ym
ou
s1
97
0b
) 
Pa
na
m
a 
N
ot
 is
ol
at
ed
 fr
om
 a
rt
hr
op
od
s 
Gu
aj
ar
a 
vi
ru
s 
Gu
aj
ar
a 
vi
ru
s (
GJ
AV
) 
- (
Ca
lis
he
r e
t a
l. 
19
83
) 
Pa
na
m
a 
Cu
le
x 
sp
.  
Ca
pi
m
 v
iru
s 
Ca
pi
m
 v
iru
s (
CA
PV
) 
Ro
de
nt
s,
  A
rb
oC
at
* 
 
Br
az
il 
Cu
le
x 
sp
. 
91
 
 
Gr
ou
p 
C 
 
(H
an
g 
et
 a
l. 
20
14
) 
                   
Ca
ra
pa
ru
 v
iru
s 
Ca
ra
pa
ru
 v
iru
s (
CA
PV
) 
Hu
m
an
s,
 ro
de
nt
s  
(C
au
se
y 
et
 a
l. 
19
61
, I
ve
rs
so
n 
et
 a
l. 
19
87
) 
So
ut
h 
Am
er
ic
a 
Cu
le
x 
sp
., 
W
ye
om
yi
a 
sp
., 
Ae
de
s 
sp
. 
Ap
eu
 v
iru
s (
AP
EU
V)
 
Hu
m
an
s (
Ca
us
ey
 e
t a
l. 
19
61
, G
ib
bs
, 
Br
uc
kn
er
 &
 S
ch
en
ke
r 1
96
4)
 
Br
az
il 
Ae
de
s s
p.
, C
ul
ex
 sp
. 
O
ss
a 
vi
ru
s (
O
SS
AV
) 
Hu
m
an
s (
De
ro
da
ni
ch
e,
 
Pa
es
de
an
dr
ad
e 
&
 G
al
in
do
 1
96
4)
 
Pa
na
m
a 
Cu
le
x 
sp
. 
Br
uc
on
ha
 v
iru
s (
BR
U
V)
 
- (
Ca
lis
he
r e
t a
l. 
19
83
)  
Br
az
il 
Cu
le
x 
sp
. 
Vi
nc
es
 v
iru
s (
VI
N
V)
 
- (
Ca
lis
he
r e
t a
l. 
19
83
) 
Ec
ua
do
r 
Cu
le
x 
vo
m
er
ife
r 
Ita
ya
 v
iru
s 
re
as
so
rt
an
t 
Hu
m
an
s (
Ho
nt
z e
t a
l. 
20
15
) 
Pe
ru
 
N
ot
 is
ol
at
ed
 fr
om
 a
rt
hr
op
od
s 
M
ad
rid
 v
iru
s 
M
ad
rid
 v
iru
s (
M
AD
V)
 
Hu
m
an
s (
De
ro
da
ni
ch
e,
 
Pa
es
de
an
dr
ad
e 
&
 G
al
in
do
 1
96
4)
 
Pa
na
m
a 
Cu
le
x 
sp
. 
M
ar
itu
ba
 v
iru
s 
M
ar
itu
ba
 v
iru
s (
M
TB
V)
 
Hu
m
an
s (
Ca
us
ey
 e
t a
l. 
19
61
)  
Br
az
il 
Cu
le
x 
sp
. 
M
ur
ut
uc
u 
vi
ru
s (
M
U
RV
) 
Hu
m
an
s,
 ro
de
nt
s (
Ca
us
ey
 e
t a
l. 
19
61
)  
Br
az
il 
Sa
be
th
in
e 
sp
. 
N
ep
uy
o 
vi
ru
s (
N
EP
V)
 
Hu
m
an
s,
 ro
de
nt
s,
 b
at
s,
 h
or
se
s 
(C
al
ish
er
 e
t a
l. 
19
71
, S
pe
nc
e 
et
 a
l. 
19
66
, S
ch
er
er
 e
t a
l. 
19
76
)  
Br
az
il,
 T
rin
id
ad
, 
Ho
nd
ur
an
s,
 M
ex
ic
o,
 
Pa
na
m
a 
Cu
le
x 
sp
.  
Re
st
an
 v
iru
s (
RE
SV
) 
Hu
m
an
s,
 h
or
se
s,
 b
at
s,
 b
ird
s 
(C
al
ish
er
 e
t a
l. 
19
71
, J
on
ke
rs
 e
t a
l. 
19
67
)  
Tr
in
id
ad
, S
ur
in
am
, 
Ho
nd
ur
an
s 
Cu
le
x 
po
rt
es
i 
Gu
m
bo
 L
im
bo
 v
iru
s (
GL
V)
 
Co
tt
on
 ra
ts
, h
or
se
s  
(C
al
ish
er
 e
t a
l. 
19
71
, H
en
de
rs
on
 e
t 
al
. 1
96
9)
  
So
ut
h 
Fl
or
id
a,
 
Ho
nd
ur
an
s 
Cu
le
x 
sp
. A
ed
es
 ta
en
io
rh
yn
ch
us
 
O
rib
oc
a 
vi
ru
s 
O
rib
oc
a 
vi
ru
s (
O
RI
V)
 
Hu
m
an
s,
 ro
de
nt
s (
M
et
se
la
ar
 1
96
6,
 
Ca
us
ey
 e
t a
l. 
19
61
) 
Su
rin
am
, B
ra
zil
 
M
an
so
ni
a 
sp
., 
Ps
or
op
ho
ra
 sp
. 
Cu
le
x 
sp
. A
ed
es
 sp
. S
ab
et
hi
ni
 sp
. 
Ita
qu
i v
iru
s (
IT
Q
V)
 
Hu
m
an
s,
 ro
de
nt
s  
(S
ho
pe
, C
au
se
y 
&
 C
au
se
y 
19
61
, 
W
al
de
r, 
Su
ar
ez
 &
 C
al
ish
er
 1
98
4)
 
Br
az
il,
 V
en
ez
ue
la
 
Cu
le
x 
vo
m
er
ife
r, 
ot
he
r C
ul
ex
 sp
. 
Ps
or
op
ho
ra
 sp
. 
92
 
 
Ga
m
bo
a 
 
(C
al
ish
er
 e
t a
l. 
19
81
) 
Ga
m
bo
a 
vi
ru
s 
Ga
m
bo
a 
vi
ru
s (
G
AM
V)
 
- (
Ca
lis
he
r e
t a
l. 
19
81
, C
al
ish
er
 e
t 
al
. 1
98
3)
 
Pa
na
m
a 
Ae
de
om
yi
a 
sq
ua
m
ip
en
ni
s 
Pu
eb
lo
 V
ie
jo
 v
iru
s (
PV
V)
 
- (
Ca
lis
he
r e
t a
l. 
19
81
, C
al
ish
er
 e
t 
al
. 1
98
3)
  
Ec
ua
do
r 
Ae
de
om
yi
a 
sq
ua
m
ip
en
ni
s 
Al
aj
ue
la
 v
iru
s 
Al
aj
ue
la
 v
iru
s (
AL
JV
) 
- (
Ca
lis
he
r e
t a
l. 
19
81
) 
Pa
na
m
a 
Ae
de
om
yi
a 
sq
ua
m
ip
en
ni
s 
Sa
n 
Ju
an
 v
iru
s (
SJ
V)
 
W
ild
 a
nd
 d
om
es
tic
 b
ird
s (
Ca
lis
he
r 
et
 a
l. 
19
81
, C
al
ish
er
 e
t a
l. 
19
83
)  
Ec
ua
do
r, 
Ar
ge
nt
in
a 
Ae
de
om
yi
a 
sq
ua
m
ip
en
ni
s 
Gu
am
a 
 
(U
sh
iji
m
a 
et
 a
l. 
19
80
) 
Be
rt
io
ga
 v
iru
s 
Be
rt
io
ga
 v
iru
s (
BE
RV
) 
-(D
e 
So
uz
a 
Lo
pe
s e
t a
l. 
19
75
)  
Br
az
il 
N
ot
 is
ol
at
ed
 fr
om
 a
rt
hr
op
od
s 
Ca
na
ne
ia
 v
iru
s (
CN
AV
) 
-(C
al
ish
er
 e
t a
l. 
19
83
)  
Br
az
il 
Cu
le
x 
sa
cc
he
tt
e 
Gu
ar
at
ub
a 
vi
ru
s (
G
TB
V)
 
Bi
rd
s (
Ca
lis
he
r e
t a
l. 
19
83
) 
Br
az
il 
O
ch
. s
er
ra
tu
s, 
an
op
he
le
s c
ru
zii
 
Iti
m
iri
m
 v
iru
s (
IT
IV
) 
Ro
de
nt
s (
Ca
lis
he
r e
t a
l. 
19
83
) 
Br
az
il 
N
ot
 is
ol
at
ed
 fr
om
 a
rt
hr
op
od
s 
M
iri
m
 v
iru
s (
M
IR
V)
 
Ro
de
nt
s (
Ca
lis
he
r e
t a
l. 
19
83
)  
Br
az
il 
Cu
le
x 
sp
., 
Ae
de
s s
p.
 P
so
. f
er
ox
 
Bi
m
iti
 v
iru
s 
Bi
m
iti
 v
iru
s (
M
IM
V)
 
Ro
de
nt
s,
 h
um
an
s (
Sp
en
ce
 e
t a
l. 
19
62
a)
  
Tr
in
id
ad
, B
ra
zil
, 
Fr
en
ch
 G
ui
an
a,
 
Su
rin
am
 
Cu
le
x 
sp
ec
ie
s 
Ca
tu
 v
iru
s 
Ca
tu
 v
iru
s (
CA
TU
V)
 
Hu
m
an
s,
 ro
de
nt
s,
 b
at
s (
Ca
us
ey
 e
t 
al
. 1
96
1,
 T
ik
as
in
gh
, A
rd
oi
n 
&
 
W
ill
ia
m
s 1
97
4,
 Jo
nk
er
s e
t a
l. 
19
68
b)
 A
rb
oC
at
* 
Br
az
il,
 T
rin
id
ad
, 
Fr
en
ch
 G
ui
an
a 
Cu
le
x 
po
rt
es
i, 
ot
he
r C
ul
ex
 sp
., 
An
op
he
le
s s
p.
 
Gu
am
a 
vi
ru
s 
Gu
am
a 
vi
ru
s (
GM
AV
) 
Hu
m
an
s,
 ro
de
nt
s,
 b
at
s (
Ca
lis
he
r e
t 
al
. 1
98
3,
 C
au
se
y 
et
 a
l. 
19
61
, 
Jo
nk
er
s e
t a
l. 
19
68
b)
 A
rb
oC
at
* 
Pa
na
m
a,
 B
ra
zil
, 
Tr
in
id
ad
 
M
am
m
al
ph
ili
c m
os
qu
ito
, C
ul
ex
, 
Ae
de
s, 
M
an
so
ni
a,
 L
im
at
us
, 
Ps
or
op
ho
ra
, T
ric
ho
pr
os
op
on
, 
Lu
tz
om
yi
a 
An
an
in
de
ua
 v
iru
s (
AN
U
V)
 
O
po
ss
um
, w
ild
 b
ird
s,
 ro
de
nt
s 
(C
al
ish
er
 e
t a
l. 
19
83
), 
Ar
bo
Ca
t*
 
Br
az
il 
Cu
le
x 
sp
ec
ie
s 
M
oj
u 
vi
ru
s (
M
O
JU
V)
 
Ro
de
nt
s (
W
al
de
r, 
Su
ar
ez
 &
 C
al
ish
er
 
19
84
)  
Br
az
il,
 V
en
ez
ue
la
 
Cu
le
x 
sp
., 
M
an
so
ni
a,
 S
ab
et
hi
ni
 
sp
., 
Ps
or
op
ho
ra
 
M
ah
og
an
y 
Ha
m
m
oc
k 
vi
ru
s 
(M
HV
) 
Ro
de
nt
s (
Co
le
m
an
, R
yd
er
 &
 W
or
k 
19
69
)*
* 
Fl
or
id
a 
Cu
le
x 
sp
. 
Ti
m
bo
te
ua
 v
iru
s 
Ti
m
bo
te
ua
 v
iru
s (
TB
TV
) 
Ro
de
nt
s,
 A
rb
oC
at
* 
Br
az
il 
N
ot
 is
ol
at
ed
 fr
om
 a
rt
hr
op
od
s 
93
 
 
Ko
on
go
l  
(D
oh
er
ty
 e
t a
l. 
19
70
, S
te
ve
ns
on
, 
Ho
lm
es
 1
97
2,
 
M
ah
y 
20
01
)  
Ko
on
go
l v
iru
s 
 
Ko
on
go
l v
iru
s (
KO
O
V)
 
Ca
tt
le
, d
om
es
tic
 fo
w
l, 
w
al
la
bi
es
, 
w
ild
 b
ird
s,
 a
nd
 b
an
di
co
ot
s (
HI
 
tit
re
s)
 (D
oh
er
ty
 e
t a
l. 
19
63
)  
Au
st
ra
lia
, N
ew
 G
ui
ne
a 
Cu
le
x 
sp
., 
An
op
he
le
s s
p.
, 
Fi
ca
lb
ia
 ss
p.
 
W
on
ga
l v
iru
s (
W
O
N
V)
 
Ca
tt
le
, d
om
es
tic
 fo
w
l, 
w
al
la
bi
es
, 
w
ild
 b
ird
s,
 a
nd
 b
an
di
co
ot
s (
HI
 
tit
re
s)
 (D
oh
er
ty
 e
t a
l. 
19
63
)  
Au
st
ra
lia
 
Cu
le
x 
an
nu
lir
os
tr
is,
 
Co
qu
ill
et
tid
ia
 c
ra
ss
ip
es
 
M
in
at
itl
an
  
(C
al
ish
er
 e
t a
l. 
19
83
) 
M
in
at
itl
an
 v
iru
s 
M
in
at
itl
an
 v
iru
s (
M
N
TV
) 
- (
Ca
lis
he
r e
t a
l. 
19
83
) 
M
ex
ic
o,
 G
ua
te
m
al
a 
N
ot
 is
ol
at
ed
 fr
om
 a
rt
hr
op
od
s 
Pa
le
st
in
a 
vi
ru
s 
- (
Ca
lis
he
r e
t a
l. 
19
83
) 
Ec
ua
do
r 
Cu
le
x 
pa
ra
cr
yb
da
 
N
ya
nd
o 
 
(G
ro
se
th
 e
t a
l. 
20
14
) 
N
ya
nd
o 
vi
ru
s 
N
ya
nd
o 
vi
ru
s (
N
DV
) 
Hu
m
an
s (
Gr
os
et
h 
et
 a
l. 
20
14
, 
W
ill
ia
m
s,
 W
oo
da
ll 
&
 C
or
be
t 1
96
5)
  
Ke
ny
a,
 U
ga
nd
a 
An
op
he
le
s f
un
es
tu
s  
M
an
ér
a 
vi
ru
s *
* 
Er
et
-1
47
 v
iru
s (
ER
ET
V)
 
(G
ro
se
th
 e
t a
l. 
20
14
) 
Et
hi
op
ia
, C
am
er
on
 
Ae
di
m
or
ph
us
 d
al
zie
li,
 
Er
et
m
ap
od
ite
s s
pp
. 
Ka
en
g 
Kh
oi
 v
iru
s 
Ka
en
g 
Kh
oi
 v
iru
s (
KK
V)
 
Ba
ts
, h
um
an
s (
Gr
os
et
h 
et
 a
l. 
20
14
, 
W
ill
ia
m
s e
t a
l. 
19
76
)  
Th
ai
la
nd
, C
am
bo
di
a 
be
db
ug
s 
M
oj
uı
 d
os
 
Ca
m
po
s v
iru
s*
* 
Be
An
 2
76
1 
iso
la
te
 (M
DC
V)
 
ba
ts
 (G
ro
se
th
 e
t a
l. 
20
14
) A
rb
oC
at
* 
Br
az
il 
N
ot
 is
ol
at
ed
 fr
om
 a
rt
hr
op
od
s 
O
lif
an
ts
vl
ei
  
(M
ur
ph
y,
 
Ha
rr
iso
n 
&
 
W
hi
tf
ie
ld
 1
97
3)
 
O
lif
an
ts
vl
ei
 v
iru
s 
O
lif
an
ts
vl
ei
 v
iru
s (
O
LI
V)
 
- (
M
ur
ph
y,
 H
ar
ris
on
 &
 W
hi
tf
ie
ld
 
19
73
, O
ta
 e
t a
l. 
19
76
) 
So
ut
h 
Af
ric
a,
 S
ud
an
, 
Et
hi
op
ia
 
Cu
le
x 
pi
pi
en
, C
x.
 P
oi
ci
lip
es
, 
M
an
so
ni
a 
un
ifo
rm
is 
Bo
bi
a 
vi
ru
s (
BI
AV
) 
- A
rb
oC
at
* 
Ce
nt
ra
l A
fr
ic
a 
Cu
le
x 
Ti
gr
ip
en
s 
Da
ba
ka
la
 v
iru
s (
DA
BV
) 
- A
rb
oC
at
* 
Iv
or
y 
co
as
t 
Cu
le
x 
gu
ia
rt
i/i
ng
ra
m
i 
O
ub
i v
iru
s (
O
U
BI
V)
 
- A
rb
oC
at
* 
Iv
or
y 
co
as
t 
Cu
le
x 
(E
um
el
an
om
yi
a)
 ri
m
a 
gr
ou
p 
Bo
ta
m
bi
 v
iru
s 
Bo
ta
m
bi
 v
iru
s (
BO
TV
) 
- A
rb
oC
at
* 
Ce
nt
ra
l A
fr
ic
a 
Cu
le
x 
gu
ia
rt
i 
Pa
to
is 
 
(U
sh
iji
m
a 
et
 a
l. 
19
80
) 
Pa
to
is 
vi
ru
s 
Pa
to
is 
vi
ru
s (
PA
TV
) 
Co
tt
on
 ra
ts
 (S
rih
on
gs
e,
 G
al
in
do
 &
 
Gr
ey
so
n 
19
66
) 
Pa
na
m
a 
N
ot
 is
ol
at
ed
 fr
om
 a
rt
hr
op
od
s 
Ab
ra
s v
iru
s (
AB
RV
) 
- (
Ca
lis
he
r e
t a
l. 
19
83
) 
Ec
ua
do
r 
Cu
le
x 
pa
ra
cr
yb
da
, C
x.
 a
da
m
es
i 
Ba
ba
ho
ya
 v
iru
s (
PA
HV
) 
- (
Ca
lis
he
r e
t a
l. 
19
83
) 
Ec
ua
do
r 
Cu
le
x 
oc
os
sa
 
Sh
ar
k 
Ri
ve
r v
iru
s (
SR
V)
 
Co
tt
on
 ra
ts
 (F
ie
ld
s e
t a
l. 
19
69
) 
Fl
or
id
a,
 M
ex
ic
o,
 
Gu
at
em
al
a 
Cu
le
x 
sp
., 
Cu
le
x 
ni
gr
ip
al
pu
s, 
An
op
he
le
s c
ru
ci
an
s 
94
 
 
Es
te
ro
 re
al
 v
iru
s 
Es
te
ro
 re
al
 v
iru
s (
ER
V)
 
- (
M
al
ko
va
 e
t a
l. 
19
85
) 
Cu
ba
 
O
rn
ith
od
or
os
 ta
da
rid
ae
 ti
ck
s 
Ze
gl
a 
vi
ru
s 
Ze
gl
a 
vi
ru
s (
ZE
G
V)
 
Co
tt
on
 ra
ts
, h
um
an
s (
Sr
ih
on
gs
e,
 
Ga
lin
do
 &
 G
re
ys
on
 1
96
6,
 S
ch
er
er
 
et
 a
l. 
19
72
)  
Pa
na
m
a,
 M
ex
ic
o,
 
Ho
nd
ur
as
, G
ua
te
m
al
a 
N
ot
 is
ol
at
ed
 fr
om
 a
rt
hr
op
od
s 
Si
m
bu
  
(K
in
ne
y,
 C
al
ish
er
 
19
81
) 
Ak
ab
an
e 
vi
ru
s 
Ak
ab
an
e 
vi
ru
s (
AK
AV
) 
Ca
tt
le
, s
he
ep
, g
oa
ts
, h
or
se
s 
(P
ar
so
ns
on
, D
el
la
-P
or
ta
 &
 
Sn
ow
do
n 
19
77
, Y
an
g 
et
 a
l. 
20
08
, 
Br
ya
nt
 e
t a
l. 
20
05
, P
ar
so
ns
on
, 
De
lla
-P
or
ta
 &
 S
no
w
do
n 
19
81
)  
 
Ja
pa
n,
 A
us
tr
al
ia
, 
Ke
ny
a,
 V
ie
tn
am
, K
or
ea
 C
ul
ic
oi
de
s b
re
vi
ta
rs
is,
 
Ae
di
m
or
ph
us
 v
ex
an
s, 
Cu
le
x 
tr
ita
en
io
rh
yn
ch
us
 
Sa
bo
 v
iru
s (
SA
BO
V)
 
Ca
tt
le
, g
oa
ts
, s
he
ep
, s
w
in
e 
(C
au
se
y 
et
 a
l. 
19
72
)  
N
ig
er
ia
 
Cu
lic
oi
de
s 
Ti
na
ro
o 
vi
ru
s (
TI
N
V)
 
Ru
m
in
an
ts
 (S
t G
eo
rg
e 
et
 a
l. 
19
79
, 
Cy
bi
ns
ki
 1
98
4)
  
Au
st
ra
lia
 
Cu
lic
oi
de
s b
re
vi
ta
rs
is 
Ya
ba
-7
 v
iru
s (
Y7
V)
 
- (
M
ah
y 
20
01
) 
N
ig
er
ia
 
M
an
so
ni
a 
Af
ric
an
a 
m
os
qu
ito
es
 
M
an
za
ni
lla
 v
iru
s 
In
gw
av
um
a 
vi
ru
s (
IN
GV
) 
W
ild
 b
ird
s,
 p
ig
s,
 b
uf
fa
lo
, d
og
s,
 
hu
m
an
s (
To
p 
et
 a
l. 
19
74
, M
cI
nt
os
h,
 
M
cG
ill
iv
ra
y 
&
 D
ic
ki
ns
on
 1
96
5)
  
So
ut
h 
Af
ric
a,
 N
ig
er
ia
, 
Ce
nt
ra
l A
fr
ic
an
, I
nd
ia
, 
Th
ai
la
nd
, C
yp
ru
s 
Cu
le
x 
sp
. 
M
an
za
ni
lla
 v
iru
s (
M
AN
V)
 
M
on
ke
ys
 (A
nd
er
so
n 
et
 a
l. 
19
60
, 
Fe
ng
 e
t a
l. 
20
15
) 
Tr
in
id
ad
, C
hi
na
 
Ae
de
s s
p.
, C
ul
ex
 sp
. 
Bu
tt
on
w
ill
ow
 v
iru
s (
BU
TV
) 
Ha
re
s,
 ro
de
nt
s (
Re
ev
es
 e
t a
l. 
19
70
)  
U
SA
 
Cu
lic
oi
de
s v
ar
iip
en
ni
s 
In
in
i v
iru
s (
IN
IV
) 
Pt
er
og
lo
ss
us
 a
ra
ca
ri 
bi
rd
 A
rb
oC
at
* 
 F
re
nc
h 
Gu
ia
na
 
N
ot
 is
ol
at
ed
 fr
om
 a
rt
hr
op
od
s 
M
er
m
et
 v
iru
s (
M
ER
V)
 
W
ild
 b
ird
s (
Ca
lis
he
r e
t a
l. 
19
69
, 
Ca
lis
he
r e
t a
l. 
19
81
)  
U
SA
 
Cu
le
x 
re
st
ua
ns
, C
ul
ex
 p
ip
ie
ns
 
O
ro
po
uc
he
 v
iru
s 
O
ro
po
uc
he
 v
iru
s (
O
RO
V)
 
Hu
m
an
s,
 sl
ot
hs
, r
od
en
ts
 m
on
ke
ys
, 
do
m
es
tic
 a
nd
 w
ild
 b
ird
s,
 (P
in
he
iro
 
et
 a
l. 
19
81
, A
nd
er
so
n 
et
 a
l. 
19
61
)  
Br
az
il,
 P
er
u,
 P
an
am
a,
 
an
d 
Tr
in
id
ad
 a
nd
 
To
ba
go
 
Cu
lic
oi
de
s p
ar
ae
ns
is,
 O
ch
. 
se
rr
at
us
, C
ul
ex
 
qu
in
qu
ef
as
ci
at
us
, M
an
so
ni
a 
sp
  
Fa
ce
y’
s P
ad
do
ck
 v
iru
s (
FP
V)
 
- (
Do
he
rt
y 
et
 a
l. 
19
79
, S
ta
nd
fa
st
 e
t 
al
. 1
98
4)
  
Au
st
ra
lia
 
Cu
lic
oi
de
s, 
Cu
le
x 
an
nu
lir
os
tr
is
 
U
tin
ga
 v
iru
s (
U
TI
V)
 
Sl
ot
hs
, h
um
an
s (
Se
ym
ou
r, 
Pe
ra
lta
 
&
 M
on
tg
om
er
y 
19
83
)  
Br
az
il 
N
ot
 is
ol
at
ed
 fr
om
 a
rt
hr
op
od
s 
95
 
 
U
tiv
e 
vi
ru
s (
U
VV
) 
Sl
ot
hs
 (S
ey
m
ou
r, 
Pe
ra
lta
 &
 
M
on
tg
om
er
y 
19
83
) 
Pa
na
m
a 
N
ot
 is
ol
at
ed
 fr
om
 a
rt
hr
op
od
s 
Pi
nt
up
o 
vi
ru
s (
PI
N
V)
 
Sl
ot
hs
 (S
ey
m
ou
r, 
Pe
ra
lta
 &
 
M
on
tg
om
er
y 
19
83
) 
Pa
na
m
a 
Cu
lic
oi
de
s d
ia
bo
lic
us
 
Sa
th
up
er
i v
iru
s 
Sa
th
up
er
i v
iru
s (
SA
TH
V)
 
Ca
tt
le
 (C
au
se
y 
et
 a
l. 
19
72
, Y
an
as
e 
et
 a
l. 
20
04
)  
In
di
a,
 N
ig
er
ia
, J
ap
an
 
Cu
lic
oi
de
s, 
Cu
le
x 
vi
sh
nu
i 
Do
ug
la
s v
iru
s (
DO
U
V)
 
Ca
tt
le
, r
um
in
an
ts
, h
or
se
s (
St
 
Ge
or
ge
 e
t a
l. 
19
79
)  
Au
st
ra
lia
 
Cu
lic
oi
de
s b
re
vi
ta
rs
is 
Sh
am
on
da
 v
iru
s 
Pe
at
on
 v
iru
s (
PE
AV
) 
Ca
tt
le
, r
um
in
an
ts
, h
or
se
s,
 p
ig
s,
 
de
er
 (S
t G
eo
rg
e 
et
 a
l. 
19
80
, 
M
at
su
m
or
i e
t a
l. 
20
02
)  
Au
st
ra
lia
, J
ap
an
 
Cu
lic
oi
de
s b
re
vi
ta
rs
is 
Sh
am
on
da
 v
iru
s (
SH
AV
) 
Ca
tt
le
 (K
in
ne
y,
 C
al
ish
er
 1
98
1,
 
Ca
us
ey
 e
t a
l. 
19
72
, Y
an
as
e 
et
 a
l. 
20
05
) 
N
ig
er
ia
, J
ap
an
 
Cu
lic
oi
de
s i
m
ic
ol
a 
pa
lli
di
pe
nn
is 
 
Sa
ng
o 
vi
ru
s (
SA
N
V)
 
Ca
tt
le
, g
oa
t (
Ki
nn
ey
, C
al
ish
er
 1
98
1,
 
Ca
us
ey
 e
t a
l. 
19
72
)  
N
ig
er
ia
, K
en
ya
 
Cu
lic
oi
de
s s
p.
, M
an
so
ni
a 
un
ifo
rm
is 
Sc
hm
al
le
nb
er
g 
vi
ru
s (
SC
HV
)
 
 
 
Ca
tt
le
, s
he
ep
, g
oa
ts
, d
og
s,
 d
ee
r 
(H
of
fm
an
n 
et
 a
l. 
20
12
, L
in
de
n 
et
 a
l. 
20
12
, R
as
m
us
se
n 
et
 a
l. 
20
12
, 
Sa
ill
ea
u 
et
 a
l. 
20
13
) 
Eu
ro
pe
 
Cu
lic
oi
de
s s
p 
Si
m
bu
 v
iru
s 
Si
m
bu
 v
iru
s (
SI
M
V)
  
Hu
m
an
s (
Ko
ke
rn
ot
 e
t a
l. 
19
65
, 
Sm
ith
bu
rn
 e
t a
l. 
19
59
)  
So
ut
h 
Af
ric
a,
 S
en
eg
al
, 
Ca
m
er
ou
n,
 C
en
tr
al
 
Af
ric
an
 
Ae
de
s s
p.
, C
oq
ui
lle
tt
id
ia
 sp
., 
 
Sh
un
i v
iru
s 
Sh
un
i v
iru
s (
SH
U
V)
 
Hu
m
an
s,
 c
at
tle
, s
he
ep
, h
or
se
s (
va
n 
Ee
de
n 
et
 a
l. 
20
12
, C
au
se
y 
et
 a
l. 
19
72
)  
N
ig
er
ia
, S
ou
th
 A
fr
ic
a 
Cu
lic
oi
de
s s
p.
, C
ul
ex
 th
ei
le
ri 
Ai
no
 v
iru
s (
AI
N
O
V)
 
Ca
tt
le
, h
or
se
s (
Ya
ng
 e
t a
l. 
20
08
, 
N
od
a 
et
 a
l. 
19
98
, D
oh
er
ty
 e
t a
l. 
19
72
)  
Ja
pa
n,
 A
us
tr
al
ia
, 
Ko
re
a 
Cu
lic
oi
de
s b
re
vi
ta
rs
is,
 C
ul
ex
 sp
. 
Ka
ik
al
ur
 v
iru
s (
KA
IV
) 
- (
Ro
dr
ig
ue
s e
t a
l. 
19
77
) 
In
di
a 
Cu
le
x 
tr
ita
en
io
rh
yn
ch
us
 
96
 
 
Th
im
iri
 v
iru
s 
Th
im
iri
 v
iru
s (
TH
IV
) 
W
ild
 b
ird
s (
Ki
nn
ey
, C
al
ish
er
 1
98
1,
 
Ca
re
y 
et
 a
l. 
19
71
) 
In
di
a,
 A
us
tr
al
ia
, E
gy
pt
 
Cu
lic
oi
de
s h
ist
rio
 
O
ya
 v
iru
s†
† 
O
ya
 v
iru
s (
O
YV
) 
Pi
gs
 (K
on
o 
et
 a
l. 
20
02
, B
ry
an
t e
t a
l. 
20
05
, Z
ha
ng
 e
t a
l. 
20
13
) 
M
al
ay
sia
, V
ie
tn
am
, 
Ch
in
a 
Cu
le
x 
Q
ui
nq
ue
fa
sc
ia
tu
s, 
Cu
le
x 
sp
., 
An
op
he
le
s s
pp
., 
M
an
so
ni
a 
sp
. 
Te
te
  
(C
al
ish
er
 e
t a
l. 
19
90
) 
Te
te
 v
iru
s 
Te
te
 v
iru
s (
TE
TE
V)
 
W
ild
 b
ird
s (
An
on
ym
ou
s1
97
0d
)  
So
ut
h 
Af
ric
a,
 N
ig
er
ia
 
N
ot
 is
ol
at
ed
 fr
om
 a
rt
hr
op
od
s 
Ba
hi
g 
vi
ru
s (
BA
HV
) 
W
ild
 b
ird
s (
Hu
ba
le
k,
 R
ud
ol
f 2
01
2,
 
An
on
ym
ou
s1
97
0a
)  
Ita
ly
, C
yp
ru
s,
 E
gy
pt
 
Hy
al
om
m
a 
m
ar
gi
na
tu
m
 ti
ck
s  
M
at
ru
h 
vi
ru
s (
M
TR
V)
 
W
ild
 b
ird
s (
Hu
ba
le
k,
 R
ud
ol
f 2
01
2)
  
Ita
ly
, C
yp
ru
s,
 E
gy
pt
 
Hy
al
om
m
a 
m
ar
gi
na
tu
m
 ti
ck
s 
Ts
ur
us
e 
vi
ru
s (
TS
U
V)
 
W
ild
 b
ird
 (S
ch
af
fe
r, 
Sc
he
re
r 1
97
2)
 
Ja
pa
n 
N
ot
 is
ol
at
ed
 fr
om
 a
rt
hr
op
od
s 
W
el
do
na
 v
iru
s (
W
EL
V)
 
W
ild
 b
ird
s,
 w
at
er
fo
w
l (
Ca
lis
he
r e
t 
al
. 1
99
0)
  
U
SA
 
ce
ra
to
po
go
ni
da
e 
m
id
ge
s 
Ba
ta
m
a 
vi
ru
s 
Ba
ta
m
a 
vi
ru
s (
BM
AV
) 
W
ild
 b
ird
s,
 A
rb
oC
at
* 
Ce
nt
ra
l A
fr
ic
a 
N
ot
 is
ol
at
ed
 fr
om
 a
rt
hr
op
od
s 
Tu
rlo
ck
 
(K
lim
as
 e
t a
l. 
19
81
, C
al
ish
er
 e
t 
al
. 1
98
4)
  
Tu
rlo
ck
 v
iru
s 
Tu
rlo
ck
 v
iru
s (
TU
RV
) 
W
ild
 b
ird
s,
 h
ar
es
, h
or
se
s (
Le
nn
et
te
 
et
 a
l. 
19
57
, H
ay
es
, L
aM
ot
te
 &
 
Ho
ld
en
 1
96
7)
  
U
SA
, B
ra
zil
, C
an
ad
a,
 
Tr
in
id
ad
 
Cu
le
x 
sp
ec
ie
s 
U
m
br
e 
vi
ru
s (
U
M
BV
) 
Bi
rd
s,
 h
um
an
s,
 A
rb
oC
at
* 
 
In
di
a,
 M
al
ay
sia
 
Cu
le
x 
sp
ec
ie
s 
M
’P
ok
o 
vi
ru
s 
M
’P
ok
o 
vi
ru
s (
M
PO
V)
 
- A
rb
oC
at
* 
Ca
m
er
oo
n 
O
ch
le
ro
ta
tu
s i
ng
ra
m
i 
Ya
ba
-1
 v
iru
s (
Y1
V)
 
- (
Ca
lis
he
r e
t a
l. 
19
84
) 
Af
ric
a 
 
Le
dn
ic
e 
vi
ru
s (
LE
DV
) 
W
at
er
fo
w
l (
Hu
ba
le
k 
20
08
, M
al
ko
va
 
19
72
)  
Eu
ro
pe
 
Cu
le
x 
m
od
es
tu
s 
W
ye
om
yi
a 
**
 
(C
ho
w
dh
ar
y 
et
 a
l. 
20
12
) 
W
ye
om
yi
a 
vi
ru
s 
W
ye
om
yi
a 
vi
ru
s (
W
YO
V)
 
Hu
m
an
s (
Si
rh
on
gs
e,
 Jo
hn
so
n 
19
65
) 
Co
lo
m
bi
a,
 P
an
am
a,
 
Gu
ia
na
 
W
ye
om
yi
a 
m
el
an
oc
ep
ha
la
 
m
os
qu
ito
es
 
An
he
m
bi
 v
iru
s (
AM
BV
) 
Hu
m
an
s (
De
 S
ou
za
 L
op
es
 e
t a
l. 
19
75
) 
Br
az
il 
Ph
on
io
m
yi
a 
pi
lic
au
da
 
Be
Ar
 3
28
20
8 
=C
ac
ho
ei
ra
 
Po
rt
ei
ra
 v
iru
s 
- (
Ch
ow
dh
ar
y 
et
 a
l. 
20
12
) 
Br
az
il 
Sa
be
th
es
 g
la
uc
ad
ae
m
on
 
M
ac
au
a 
vi
ru
s (
M
CA
V)
 
Hu
m
an
s,
 A
rb
oC
at
* 
 
Br
az
il 
Sa
be
th
es
 so
pe
ri 
So
ro
ro
ca
 v
iru
s (
SO
RV
) 
- A
rb
oC
at
* 
Br
az
il 
Sa
be
th
in
i s
pp
. 
Ta
ia
ss
ui
 v
iru
s (
TA
IA
V)
 
- (
Ch
ow
dh
ar
y 
et
 a
l. 
20
12
) 
Br
az
il 
Sa
be
th
in
i s
pp
. 
97
 
 
Ia
co
 v
iru
s (
IA
CO
V)
 
- A
rb
oC
at
*a
nd
 (C
ho
w
dh
ar
y 
et
 a
l. 
20
12
) 
Br
az
il 
W
ye
om
yi
a 
sp
p.
 
Tu
cu
nd
ub
a 
vi
ru
s (
TU
CV
) 
Hu
m
an
s (
Ch
ow
dh
ar
y 
et
 a
l. 
20
12
) 
Br
az
il 
W
ye
om
yi
a 
sp
p.
 
M
ap
pu
tt
a*
* 
(G
au
ci
 e
t a
l. 
20
15
) 
 
M
ap
ut
ta
 v
iru
s (
M
AP
V)
 
Ka
ng
ar
oo
s,
 w
al
la
bi
es
  (
Do
he
rt
y 
et
 
al
. 1
96
3,
 D
oh
er
ty
 e
t a
l. 
19
70
) 
Au
st
ra
lia
 
An
op
he
le
s m
er
au
ke
ns
is 
M
ap
rik
 v
iru
s (
M
PK
V)
 
Ru
m
in
an
ts
, p
ig
s (
Ga
uc
i e
t a
l. 
20
15
)  
N
ew
 G
ui
ne
a 
Ae
de
s f
un
er
eu
s 
Tr
ub
an
am
an
 v
iru
s (
TR
U
V)
 
Ca
tt
le
, h
or
se
s,
 k
an
ga
ro
os
, 
w
al
la
bi
es
 (A
no
ny
m
ou
s1
97
0e
) 
Au
st
ra
lia
 
An
op
he
le
s s
pp
. 
Ga
n 
Ga
n 
vi
ru
s (
G
GV
) 
- (
Do
he
rt
y 
et
 a
l. 
19
79
, G
ar
d,
 
M
ar
sh
al
l &
 W
oo
dr
oo
fe
 1
97
3)
 
Au
st
ra
lia
 
Ae
de
s s
pp
. 
Bu
ffa
lo
 C
re
ek
 v
iru
s (
BU
CV
; 
iso
la
te
 D
PP
01
86
) 
Hu
m
an
, c
at
tle
, p
ig
s (
Ga
uc
i e
t a
l. 
20
15
) 
Au
st
ra
lia
 
An
op
he
le
s m
er
au
ke
ns
is 
Sa
lt 
As
h 
vi
ru
s (
SA
SH
V)
 
(G
au
ci
 e
t a
l. 
20
15
, C
of
fe
y 
et
 a
l. 
20
14
) 
Au
st
ra
lia
 
O
ch
le
ro
ta
tu
s v
ig
ila
x 
M
ur
ru
m
bi
dg
ee
 v
iru
s 
(M
U
RB
V)
 
(G
au
ci
 e
t a
l. 
20
15
, C
of
fe
y 
et
 a
l. 
20
14
) 
Au
st
ra
lia
 
An
op
he
le
s a
nn
ul
ip
es
 
N
ot
 c
la
ss
ifi
ed
 to
 
an
y 
se
ro
gr
ou
p 
 
 
 
 
 
Le
an
ye
r v
iru
s*
* 
(L
EA
V)
 N
T 
16
70
1 
iso
la
te
 
(S
av
ji 
et
 a
l. 
20
11
, D
oh
er
ty
 e
t a
l. 
19
77
) 
Au
st
ra
lia
 
An
op
he
le
s m
er
au
ke
ns
is 
Te
rm
ei
l v
iru
s *
* 
(T
ER
V)
 B
P8
09
0 
(R
us
se
ll 
et
 a
l. 
19
91
) 
Au
st
ra
lia
 
Ae
de
s v
ig
ila
x,
 C
q.
 L
in
ea
lis
 
Se
dl
ec
 v
iru
s 
iso
la
te
**
 
 (S
ED
V)
 A
V1
72
 
Re
ed
 w
ar
bl
er
 (H
ub
al
ek
 e
t a
l. 
19
90
, 
Ba
ko
ny
i e
t a
l. 
20
13
)  
Cz
ec
ho
slo
va
ki
a 
N
ot
 is
ol
at
ed
 fr
om
 a
rt
hr
op
od
s 
 † 
M
bo
ke
 v
iru
s i
s a
 p
os
sib
le
 Il
es
ha
 v
iru
s i
so
la
te
 (P
ac
hl
er
, R
uz
ek
 &
 N
ow
ot
ny
 2
01
3)
   
††
 O
ya
 v
iru
s p
os
sib
ly
 b
el
on
gs
 to
 th
e 
M
an
za
ni
lla
 v
iru
s c
om
pl
ex
 (F
en
g 
et
 a
l. 
20
15
) 
* 
ht
tp
s:
//
w
w
w
n.
cd
c.
go
v/
Ar
bo
ca
t/
De
fa
ul
t.a
sp
x 
**
te
nt
at
iv
e 
se
ro
gr
ou
ps
 o
r s
pe
ci
es
 a
fte
r m
or
e 
se
qu
en
ci
ng
 d
at
a 
ar
e 
av
ai
la
bl
e 
  
